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Chapter 1: Introduction and literature review for polyhydroxyalkanoates 
1.1 Introduction to polyhydroxyalkanoates 
Petroleum-based plastics have been rapidly accumulating in the environment for the last 
50 years, a process which has only been accelerating. An estimated 250,000 tons of plastic 
contaminates the world’s oceans, posing a significant threat to wildlife that we are unable to 
remediate, and that may ultimately end up in our own food supply (Barboza et al., 2018; Eriksen 
et al., 2014). This has led to growing concerns for the health of the environment, and there is 
increasing demand for sustainable plastic alternatives (Lazarevic et al., 2010). 
Poly-[(R)-3-hydroxyalkanoates] (PHAs) comprise a large class of natural polyesters 
originally found in bacteria. In native PHA-producing microorganisms, these materials are 
biosynthesized from intracellular fatty acid derivatives or central metabolites and accumulated as 
a response to increased levels of carbon rich nutrients while experiencing a shortage of other 
essential elements in the environment (e.g. N, P, O, etc.) (Lu et al., 2009). These biopolymers have 
enjoyed increasing interest worldwide and have influenced and driven studies in a multitude of 
disciplines such as microbiology, metabolic engineering, biochemistry, and materials chemistry. 
Much of the research to date has focused on the organisms, pathways, and enzymes used to produce 
PHA materials.  
The predominant class of PHA materials are characterized by a polyester backbone product 
of the biosynthetic polycondensation of (R)-3-hydroxyacyl-CoA thioesters. These polymers and 
their bulk physical properties are differentiated and classified by the length of their hydrocarbon 
sidechains. Whereas PHAs with sidechains containing 0-2 carbon atoms are referred to as short-
chain-length (SCL) PHAs, those with sidechains containing 3-11 carbon atoms are commonly 
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identified as medium-chain-length (MCL) PHAs. The former display physical properties typically 
associated with crystalline thermoplastics while the latter generally possess low crystallinity and 
elastomeric character (Barham et al., 1992). Poly[(R)-3-hydroxybutyrate] (PHB) is the most well 
characterized, being the first PHA discovered and the most commonly produced in nature 
(Lemoigne, 1926). However, the physical properties of PHB are relatively unattractive, producing 
a stiff and brittle material (Barham et al., 1992). Copolymerization of PHB and with other 
monomers such as MCL 3-hydroxyacyl species can significantly increase the flexibility and 
toughness, and current research is increasingly dominated by these endeavors (Hassan et al., 2006; 
Noda et al., 2010). 
1.2 PHA composition and physical properties 
There is great diversity in the structure of PHAs, which is predominantly localized to the 
side chains. As previously mentioned,  these are most often categorized as SCL (0-2 carbons per 
side chain) and MCL (3-11 carbons per side chain), although long chain-length (LCL) PHAs have 
been observed with side chains up to 13 carbons (Lee et al., 1995). Most PHAs form an ester 
linkage via a β-hydroxyl group, but notable exceptions such as poly(4-hydroxybutyrate) do exist 
(Hein et al., 1997; Söhling and Gottschalk, 1996; Valentin and Dennis, 1997). A selection of some 
representative PHAs is shown in Fig. 1.1, which includes the commercially available group of 




Figure 1.1: Chemical structures of common representative polyhydroxyalkanoates (PHAs). 
Abbreviations: P3HB, poly[(R)-3-hydroxybutyrate]; P4HB, poly(4-hydroxybutyrate); PHHx, 
poly[(R)-3-hydroxyhexanoate]; PHO, poly[(R)-3-hydroxyoctanoate]; PHD, poly[(R)-3-







In addition to the common PHAs shown in Fig. 1.1, numerous examples are documented 
in the literature of uncommon PHAs containing functional groups. These are addressed in greater 
detail at the end of this Chapter. The composition of PHAs depends largely on the type of 
microorganism that produces them; Pseudomonas putida and P. oleovorans are two well-studied 
examples of MCL PHA producers that can incorporate 3-hydroxyacyl monomers of varying 
lengths and degrees of saturation, while other commonly described organisms such as Cupriavidus 
necator and Aeromonas caviae biosynthesize PHB and PHBHHx, respectively (Lu et al., 2009). 
Through metabolic engineering and the selection of unique carbon substrates, an even greater 
variety than what is observed in nature can be achieved (Dong et al., 2019; Matsumoto and 
Kageyama, 2019; Mizuno et al., 2018; Sparks and Scholz, 2008; Thuronyi et al., 2017). Some 
examples of these can be found in Fig. 1.2. 
 
Figure 1.2: Examples of uncommon and functional PHAs. Abbreviations: P2M3HB, poly(2-
methyl-3-hydroxybutyrate); P2MHV, poly(2-methyl-3-hydroxyvalerate); P2H4MV, poly(2-
hydroxy-4-methylvalerate); P2F3HB, poly(2-fluoro-3-hydroxybutyrate); PHUe, poly(3-hydroxy-
10-undecenoate); PHUy, poly(3-hydroxy-10-undecynoate); PHDN3, poly(3-hydroxy-10-




 The physical properties of PHAs are largely determined by their chemical composition. 
Homopolymeric PHB is highly crystalline, generally ranging from 60-80% crystallinity depending 
on the method of extraction and/or post-isolation processing (Chanprateep, 2010; Doi and Abe, 
1990; Tappel et al., 2012b). In addition, PHB has a high Young’s modulus similar to the 
petrochemically-derived plastic polypropylene (Werber and Baptist, 1964). However, PHB has 
considerably lower toughness and elongation to break than polypropylene, rendering it quite brittle 
(Chanprateep, 2010; Sudesh et al., 2000). In comparison, several other PHA homopolymers exhibit 
elastomeric properties and a greater degree of toughness. Poly(4-hydroxybutyrate), a PHA first 
isolated from the anaerobic bacterium Clostridium kluyverii, has an elongation to break of 1000%, 
and the copolymerization of 3HB with 4HB monomers confers an increasing degree of toughness 
to the resulting material as the monomer % of 4HB increases (Doi and Abe, 1990; Saito and Doi, 
1994). Copolymers of 3HB and MCL monomer units also have attractive physical properties, with 
increasing MCL monomer content conferring increasingly elastomeric qualities, although these 
are relatively uncommon in nature (Noda et al., 2005). MCL copolymers, which are most often 
ter- and quadripolymers of various MCL monomers, are amorphous and characterized by low or 
indiscernible melting points (Gagnon et al., 1992). A summary of the physical properties of some 

















Tg (°C) Tc (°C) Tm (°C) References 




177 (Chanprateep, 2010; Doi and 
Abe, 1990; Tappel et al., 
2012b) 
PHBV (%3HV)         
9 58 1900 37  6  125 (Doi and Abe, 1990) 
17.2 55 ~775 ~22 ~25   172 (Gogotov et al., 2010) 
22.2 47 ~450 ~14 ~10   166 (Gogotov et al., 2010) 
P4HB 34 70 to 149 50 to 104 1000 -51 to 
 -46 
  (Martin and Williams, 2003; 
Saito and Doi, 1994) 
PHBHHx         
7  289 17.3 23.6   125/135 (Asrar et al., 2002) 
9.5  155 8.8 43.0    (Asrar et al., 2002) 
MCL PHAs (dominant 
monomers) 
        
3HO,3HHx     -37  59 (Preusting et al., 1990) 
3HOU,3HO,3HHU,3HHx     -37   (Preusting et al., 1990) 
3HD,3HO,3HHx  12 to 15 7 to 10 300 to 450 -35  55 (Gagnon et al., 1992) 
3HO,3HB  12 to 170 1.7 to 10.5 53 to 230 -26 to -
1.4 
 158 (Tappel et al., 2012a) 
Conventional Plastics         
LDPE  200 10 620 -30  130 (Thompson et al., 2004) 
PP 50 to 70 1700 38 400 -10  176 (Thompson et al., 2004) 
PETE 30 to 50 2900 70 1000 69  267 (Doi and Abe, 1990) 
PS  76.8  0.36    (Chanprateep, 2010) 
Blank cells indicate the value was not determined from the referenced study. Tg (glass-transition temperature), Tc (crystallization 
temperature by differential scanning calorimetry, DSC), Tm (melting temperature). Polymer abbreviations; PHB, poly[(R)-3-
hydroxybutyrate; PHBV, poly[(R)-3-hydroxybutyrate-co-3-hydroxyvalerate]; P4HB, poly(4-hydroxybutyrate); PHBHHx, poly[(R)-3-
hydroxybutyrate-co-3-hydroxyhexanoate]; 3HO, 3-hydroxyoctanoate; 3HHx, 3-hydroxyhexanoate; 3HOU, 3-hydroxy-7-octenoate; 
3HHU, 3-hydroxy-5-hexenoate; 3HD, 3-hydroxydecanoate; 3HB, 3-hydroxybutyrate; LPDE, low-density poly(ethylene); PP, 




1.3 PHA biosynthesis in native producers 
 PHA biosynthesis pathways in native organisms generally fall into one of two categories, 
SCL biosynthesis and MCL biosynthesis. PHB, the most common SCL PHA, is produced by a 
wide variety of organisms using the same set of three enzymes; (1) a β-ketothiolase (PhaA) that 
catalyzes the condensation of two molecules of acetyl-CoA to form acetoacetyl-CoA,  (2) an 
acetoacetyl-CoA reductase (PhaB) that catalyzes the reduction of acetoacetyl-CoA to form (R)-3-
hydroxybutyryl-CoA, and (3) a PHA synthase (PhaC) which catalyzes the formation of an ester 
bond between two (R)-3-hydroxybutyryl-CoA molecules and begins the elongation of a growing 
polymer chain (Lu et al., 2009). 
 PhaC can often accept other hydroxyacyl-CoA substrates, resulting in the formation of 
PHV, P4HB, or the copolymers PHBV and P3HB4HB. PHV is formed from the metabolism of 
propionate, which can be supplied exogenously or formed from oxaloacetate in a reversible 
reaction of gluconeogenesis (Robbins, 1988). Propionate is then converted into propionyl-CoA 
and condensed with a molecule of acetyl-CoA by an alternative β-ketothiolase (BktB) to form β-
ketovaleryl-CoA (Slater et al., 1998). This intermediate is then reduced by PhaB and subsequently 
polymerized by PhaC, resulting in PHV or PHBV. 
 P4HB is produced by Clostridium kluyverii from succinyl-CoA, which is converted into 
succinate semialdehyde by a succinate semialdehyde dehydrogenase (SucD) (Steinbüchel and 
Valentin, 1995). This intermediate is reduced to 4HB by 4-hydroxybutyrate dehydrogenase 
(4hbD), converted to 4-hydroxybutyryl-CoA by a succinyl-CoA:CoA transferase (OrfZ, aka Cat1), 




Figure 1.3: Examples of SCL PHA biosynthesis pathways in native producers. (A) Production of 
PHB from sugars (acetyl-CoA). (B) Production of PHV from oxaloacetate. (C) Biosynthesis of 
P4HB from succinyl-CoA. 
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1.4 PHA biosynthesis in Escherichia coli LSBJ 
In order to address the difficulties observed with controlling PHA composition, Tappel et 
al. engineered a recombinant E. coli strain that was able to exhibit precise control in both SCL and 
MCL monomer incorporation from fatty acid substrates (2012b). E. coli was chosen as a 
production chassis for several reasons: its genome is very well understood and there are simple 
methods described to manipulate it, it can grow rapidly to high density and tolerate a wide variety 
of growth conditions and media, and it cannot naturally produce PHA which allows for greater 
control over the PHA biosynthesis pathway. The construction of this strain is briefly described 
below. 
1.4.1 Engineering of E. coli LS5218 
Since control of repeating unit composition is critical to produce polymers with desirable, 
reproducible properties, the Nomura lab engineered E. coli to produce PHA polymers with defined 
repeating unit compositions from fatty acids (Tappel et al., 2012a). The parental strain used was 
E. coli LS5218 (Spratt et al., 1981), which carries two significant mutations that make it ideal for 
producing PHA polymers from fatty acids: (1) a fadR mutation for enhanced expression of genes 
encoding enzymes involved in β-oxidation, described in more detail below; and (2) an atoC(Con) 
mutation which results in the constitutive expression of the Ato short-chain-fatty acid uptake 
enzymes in E. coli. This strain was further engineered to control the production of enoyl-CoA by 
deleting the fadB (Yang et al., 1995) and fadJ (Campbell et al., 2003) genes (E. coli LSBJ), both 
of which can catalyze the (S)-specific hydration of enoyl-CoA, resulting in a roadblock in β-
oxidation (Figure 1.5). This resulted in a strain where any exogenous fatty acid supplied was 
pooled as its enoyl-CoA intermediate with no loss of carbon from the substrate. For example, 
supplementation with a 4-carbon fatty acid (butyrate) results in a butenoyl-CoA intermediate, and 
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supplementation with an 8-carbon fatty acid (octanoate) results in pooling of an octenoyl-CoA 
intermediate. Thus, specific fatty acid feeding regimens, coupled with expression of the (R)-
specific enoyl-CoA hydratase (PhaJ4) and PhaC1(STQK) engineered synthase, results in 
production of PHA polymers with defined repeating unit compositions (Takase et al., 2003; Tappel 
et al., 2012b). 
1.4.2 SCL and MCL biosynthesis pathways 
SCL PHA biosynthesis can be accomplished in E. coli LSBJ from glycolytically-derived 
acetyl-CoA via the heterologous expression of three enzymes: a β-ketothiolase (PhaA), an 
acetoacetyl-CoA reductase (PhaB), and a PHA synthase (PhaC). This process is functionally the 





Figure 1.4: De novo biosynthesis of PHB from acetyl-CoA by recombinant E. coli LSBJ. 
 
The biosynthesis of PHA in E. coli LSBJ utilizing short-chain-length (SCL) and medium-
chain-length (MCL) fatty acids is shown in Fig. 1.5. The absence of fadB and fadJ in E. coli LSBJ 
in combination with the plasmid-borne recombinant enzymes PhaC1(STQK) and PhaJ4 
establishes a linear pathway for the production of PHA polymers from free fatty acids. 
Extracellular fatty acids are transported across the outer membrane dependent on size; SCL and 
shorter MCL fatty acids can diffuse across the outer membrane, while longer MCL fatty acids (12 
carbons and higher) can be transported by the long-chain fatty acid transporter FadL (Lepore et 
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al., 2011). Inner membrane transport and activation is accomplished by the SCL-specific Ato 
system (AtoEAD) or the MCL-specific acyl-CoA synthetase FadD (Kameda and Nunn, 1981; 
Theodorou et al., 2006). Acyl-CoA substrates are converted into enoyl-CoA by the acyl-CoA 
dehydrogenase enzyme FadE (Campbell and Cronan, 2002), and are unable to proceed further 
through β-oxidation due to the absence of FadB and FadJ. The enoyl-CoA pool is then converted 
to (R)-3-hydroxyacyl-CoA by the R-specific enoyl-CoA hydratase PhaJ4 (Tsuge et al., 2003), and 
finally polymerized by the PHA synthase PhaC1(STQK) (Takase et al., 2004, 2003). This system 
allows for the biosynthesis of PHA polymers with tightly controlled repeating unit composition, 
as the number of carbons present in the fatty acid substrate is retained as the total number of 
carbons in each repeating unit. This was previously demonstrated by Tappel et al. with both single 
fatty acid substrates, resulting in PHA homopolymers with the same number of carbon atoms as 
the fatty acid precursors, as well as dual fatty acid co-substrates to produce PHA copolymers with 




Figure 1.5: Biosynthesis of PHA in E. coli LSBJ utilizing short-chain-length (SCL) and medium-
chain-length (MCL) fatty acids. 
 
1.4.3 Transcriptional regulation of MCL PHA biosynthesis pathway 
Due to the inability of E. coli to natively biosynthesize PHA, regulation of MCL PHA 
biosynthesis primarily occurs at the level of fatty acid uptake and catabolism. These processes are 
tightly regulated by a number of transcription factors, which will be described here. 
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1.4.3.1 Regulation by FadR 
One of the primary regulators of fatty acid metabolism is the transcriptional dual regulator 
FadR, or the fatty acid degradation regulon (Overath et al., 1969). FadR is responsible for 
repressing genes necessary for fatty acid degradation (β-oxidation) and activating genes necessary 
for fatty acid biosynthesis to control carbon metabolism in response to exogenous fatty acids. FadR 
interacts with the upstream region of genes within its regulon by binding to the palindromic 
consensus binding sequence -TGGNNNNNCCA- (Xu et al., 2001). When this consensus sequence 
overlaps the -35 or -10 region (and the region immediately upstream of the -10), as is the case for 
fad genes, FadR binding prevents the recruitment of RNA polymerase (RNAP) and inhibits 
transcription (Black and DiRusso, 1994; Cronan and Subrahmanyam, 1998; Henry and Cronan, 
1992). If the FadR binding site lie upstream of the -35 region, as it does for the fab genes (fatty 
acid biosynthesis), then the binding of FadR activates transcription by enhancing RNAP 
recruitment. 
Crystal structures have been determined for FadR, the FadR-acyl-CoA complex, and FadR 
bound to DNA, which have helped to develop a mechanistic understanding of this enzyme (van 
Aalten et al., 2000; Xu et al., 2001). The FadR regulator functions as a homodimer, and binds to 
DNA through the interaction of the two DNA-Binding domains of the apoenzyme (Fig. 1.6) 
(Raman et al., 1997). The DNA-binding domain, which has been determined to be within the first 
66 amino acid residues of the N-terminus (Raman et al., 1997), forms a winged helix motif 
common in prokaryotic transcriptional regulators and is highly conserved in fadR homologs of 
other prokaryotes (Brennan, 1993; Iram and Cronan, 2005). A large region of the C-terminus forms 
the dimerization and acyl-CoA binding domains; although the exact residues involved in 
dimerization are currently unknown, three residues necessary for acyl-CoA binding (G216, S219, 
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W223) have been identified in E. coli MG1655 (DiRusso et al., 1998). This region is much less 
conserved than the DNA binding domain (~25% homology), and is responsible for significant 
differences in the preferred fatty acid substrates among bacteria (Iram and Cronan, 2005). In E. 
coli LS5218, the parental strain of LSBJ, a single nucleotide polymorphism (SNP, L55Q) in the 
DNA binding domain prevents DNA binding and relieves fad repression by FadR (Rand et al., 
2017). This mutation, also known as fadR601, is believed to disrupt a hydrophobic interaction 




Figure 1.6 FadR domain map. N-Terminal DNA binding domain contains a SNP in E. coli LS5218 
and its derivatives that results in a nonfunctioning FadR. This domain is separated from the C-
terminal dimerization / acyl-CoA binding domain by a short linker. Acyl-CoA binding requires 
three residues in E. coli MG1655 and LS5218, G216, S219, and W223. 
 
The FadR sensing mechanism hinges on the binding of fatty acyl-CoA molecules to the 
bound apo-enzyme complex (Xu et al., 2001). The binding of a fatty acyl-CoA triggers 
conformational changes in the protein which releases DNA from the N-terminal DNA-binding 
domain (Fig. 1.7). This means that the presence of fatty acyl-CoA molecules relieves the 
repression of β-oxidation genes while simultaneously abolishing FadR-mediated activation of fatty 
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acid biosynthesis. In E. coli MG1655 and many related strains, FadR will only bind long chain-
length (LCL) fatty acyl-CoAs, and has the highest affinity towards oleoyl-CoA (Feng and Cronan, 
2012; Iram and Cronan, 2006). For this reason, these strains cannot grow on MCL fatty acids such 
as decanoate due to the inhibition of the β-oxidation pathway. The FadR601 mutation is therefore 




Figure 1.7: Mechanism of transcriptional regulation by FadR and FadR601(L55Q). (A) In the 
absence of acyl-CoA, FadR binds to the promoter region of fad genes and represses transcription. 
DNA binding is blocked in the nonfunctioning FadR601. (B) In the presence of acyl-CoA, FadR 
binds acyl-CoA and releases DNA through due to conformational changes. Acyl-CoA binding is 
not blocked in FadR601, however it has no effect on transcription. This figure was adapted from 
Feng and Cronan (2012). 
 
1.4.3.2 Regulation by ArcA/ArcB 
Another important regulator of fatty acid catabolism is the transcriptional dual regulator 
ArcA, which forms the central hypothesis in Chapter 2 and will therefore be reviewed in detail. In 
E. coli, ArcA serves as the response regulator of the ArcAB two-component signal transduction 
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system, and plays a pivotal role in controlling the switch from aerobic to anaerobic metabolic 
processes in response to oxygen availability (Iuchi and Lin, 1988; Lynch and Lin, 1996). 
Due to the large number of genes affected by ArcA, researchers initially had difficulty 
characterizing the protein, and subsequently there are several synonyms present in the literature. 
In 1973 and 1976, researchers from Australia published articles in which they identified and named 
the seg gene (arcA), so named because a strain harboring a mutant gene prevented segregation and 
replication of the F-factors (Hathaway and Bergquist, 1973; Jamieson and Bergquist, 1976). In 
1978, a separate group found that strains with this particular mutation were resistant to male-
specific bacteriophages, and later studies in the early 1980’s revealed that these mutants showed 
inhibition of F-pilus expression, leading to the classification msp and fex, respectively (Buxton et 
al., 1978; Lerner and Zinder, 1982). Within the same time period, several studies explored the 
effects of this gene using chemical mutagenesis, producing a set of mutants with varying impacts 
on sex factor regulation, which led to the new synonym sfrA (Beutin et al., 1981; Beutin and 
Achtman, 1979). 
 The realization that this putative sex factor gene had a larger role in transcriptional 
regulation did not occur until 1983, when an article was published which made connections 
between the sex factor regulation studies and a seemingly unrelated paper on the dye gene. Mutants 
lacking this dye gene were previously shown in 1979 to have increased sensitivity to the dye 
toluidine blue and several antibiotics (Roeder and Somerville, 1979). Researchers from the UK 
(Buxton et al.) found that the putative dye gene occupied the same chromosomal position as the 
putative fex gene, and through a series of complementation studies determined that dye, fex, and 
sfrA were all the same gene (Buxton et al., 1983; Buxton and Drury, 1983). They also revealed 
that the envelope protein profile in Δdye mutants had several differences compared to strains with 
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functional dye protein product, which was believed to be the cause for increased sensitivity to dyes 
and antibiotics, and the researchers concluded that the dye gene may be involved in the regulation 
of envelope proteins in addition to sex factor expression (Buxton et al., 1983). This team of 
researchers continued their exploration of the now-named dye gene, publishing several more 
articles in which they characterized the Dye protein, analyzed the DNA and amino acid sequences, 
and found some similarity to the transcriptional regulator OmpR (Buxton and Drury, 1984; Drury 
and Buxton, 1985). 
 The final piece of evidence necessary for discovering the true function of the dye(arcA) 
gene came from an unrelated study published in 1988. Researchers from Harvard Medical School 
under Dr. Edmund Lin, while studying the transcriptional regulation of aerobic and anaerobic 
metabolic pathways, created a mutant E. coli strain that retained very high anaerobic expression 
of many enzymes normally expressed predominantly during aerobic growth (Iuchi and Lin, 1988). 
They isolated the gene responsible for this phenotype, which they labelled as arcA (aerobic 
respiration control), and by mapping the gene to the genome they were able to determine that it 
occupied the same locus as the previously described dye gene. The group confirmed that the two 
genes were identical by observing that the arcA mutant was both sensitive to the dye toluidine blue 
and resistant to the male-specific phage M13 (Iuchi and Lin, 1988). This study became the 
foundation for the modern understanding of arcA, and its role as a transcriptional dual-regulator. 
ArcA belongs to the OmpR family of proteins, which is a typical family of two-component 
response regulators (Cho et al., 2006; Itou and Tanaka, 2001; West and Stock, 2001). The arcA 
gene has a nucleotide sequence of 717 bases, encoding a protein of 238 amino acids in length and 
a molecular weight (MW) of 27,346 Da, as determined computationally and analytically (Buxton 
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and Drury, 1984; Drury and Buxton, 1985). The ArcA protein purifies along with other soluble 
cytosolic proteins (Buxton and Drury, 1984). 
 The domain structure for ArcA is relatively simple; as in other OmpR-family proteins, the 
active enzyme forms a homodimer, and the two domains present include a receiver domain and a 
DNA-binding domain (Fig. 1.8) (Cho et al., 2006; Drury and Buxton, 1985). The crystal structure 
of ArcA has been solved by X-ray crystallography, enhancing our understanding of these domain 
interactions (Toro-Roman et al., 2005). The receiver domain, also known as the dimerization 
domain (D1’), is located from amino acids 6-113 (N-terminal) and serves both as the site of 
dimerization and as the site where the ArcB histidine kinase interacts with and transphosphorylates 
ArcA (Drury and Buxton, 1985; Finn et al., 2014; West and Stock, 2001). It is within this domain 
that the catalytic aspartic acid residue (D54) resides, which activates the enzyme upon its 
phosphorylation (Drury and Buxton, 1985; Finn et al., 2014). The DNA-binding domain (DB1) is 
responsible for interacting with the promoter regions of regulons under the control of ArcA, and 
is located from amino acids 156-232 (C-terminal) (Drury and Buxton, 1985; Finn et al., 2014). 
The bound ArcA-P acts as a dual-regulator, capable of inhibiting or activating various genes (Cho 
et al., 2006). 
 
Figure 1.8: ArcA domain map. N-Terminal dimerization domain contains a catalytic aspartic acid 




 For a complete understanding of the function of ArcA, it is also necessary to discuss the 
structure of ArcB due to its important role in the activation of ArcA. The sensor protein ArcB is 
classified as a tripartite hybrid histidine kinase, and contains several important domains; two 
transmembrane domains (TM1 & 2) separated by a short periplasmic domain (P1), a dimerization 
domain (D1) which also acts as a linker, and primary and secondary transmitter domains (T1 & 2) 
separated by a receiver domain (R1), shown below in Fig. 1.9 (Ishige et al., 1994; Iuchi and Lin, 
1992; Kwon et al., 2000; Nuñez Oreza et al., 2012). The two transmembrane domains serve to 
anchor the complete enzyme in the inner membrane, but neither they nor the periplasmic domain 
play an active role in sensing; instead, the cytosolic portion of the enzyme interacts directly with 
quinones involved in the electron transport chain (Ishige et al., 1994; Iuchi and Lin, 1992; Kwon 
et al., 2000; Nuñez Oreza et al., 2012). The dimerization domain has the characteristics of a leucine 
zipper, and forms a homodimer by a coiled-coil motif (Nuñez Oreza et al., 2012). The two 
transmitter domains along with the receiver all play a role in the phosphorelay system (Nuñez 
Oreza et al., 2012; Peña-Sandoval and Georgellis, 2010). 
 
Figure 1.9: ArcB domain map. The N-terminal transmembrane domain consists of two membrane 
spanning regions (TM1&2) separated by a short periplasmic linker. The dimerization domain (D1) 
separates the transmembrane domain from the cytosolic phosphorelay domains, which contains 
the primary and secondary transmitter domains (T1&2) separated by a receiver domain (R1), each 




 ArcA is activated by phosphorylation under reducing conditions, or conditions of low 
oxygen, by a phosphorelay system involving the electron transport chain, ArcB, and an aspartic 
acid residue of ArcA (Iuchi and Lin, 1992; Peña-Sandoval and Georgellis, 2010). Under reducing 
conditions, the His292 residue of ArcB (T1, Fig. 1.10A) autophosphorylates through interaction 
with cystosolic ATP( Iuchi and Lin, 1992; Peña-Sandoval and Georgellis, 2010). Through 
intramolecular reactions, the phosphoryl group is passed to the Asp576 residue (R1, Fig. 1.10A) 
and finally to the His717 residue (T2, Fig. 1.10A) located near the C-Terminus (Iuchi and Lin, 
1992; Peña-Sandoval and Georgellis, 2010). The phosphoryl group is then transferred to the Asp54 
residue in the dimerization domain of ArcA (D1’, Fig 1.10A), resulting in the activated form of 
ArcA, ArcA-P (Iuchi and Lin, 1992; Peña-Sandoval and Georgellis, 2010). This activated ArcA-
P then proceeds to bind DNA in order to alter gene expression. 
 Under aerobic conditions, ArcA-P undergoes a reverse phosphorelay and is de-activated. 
First, quinones involved in electron transport become oxidized, and silence the kinase function of 
ArcB by forming disulfide bonds in the dimerization domain, preventing the phosphorelay in the 
activating direction (Georgellis et al., 2001, 1998). The phosphorylated ArcA-P proceeds to 
transfer its phosphoryl group back to the His717 residue of ArcB (T2, Fig. 1.10B), which then 
transfers it to the receiver domain (R1, Fig. 1.10B) at Asp576 (Georgellis et al., 2001, 1998). 
Together, the forward and reverse phosphorelay systems serve to control gene regulation by ArcA 




Figure 1.10: Simplified, proposed model of the activation of ArcA by ArcB. QH2 and Q refer to 
the reduced and oxidized forms of quinones, respectively. (A) Autophosphorylation of ArcB (The 
membrane-bound protein) cleaves a phosphoryl group (yellow “P”) from ATP, then transfers this 
phosphoryl group along the relay to ArcA (orange), which allows DNA binding through allosteric 
modification. (B) De-phosphorylation of ArcA occurs in aerobic conditions, where quinone-
induced disulfide bonds form between ArcB molecules, preventing the cleavage of ATP and 
forcing the relay in the opposing direction, preventing DNA binding (Georgellis et al., 2001, 1998; 
Malpica et al., 2004; Nuñez Oreza et al., 2012; Peña-Sandoval and Georgellis, 2010). 
 
As a transcriptional dual regulator, ArcA has the capacity to both repress and activate 
certain genetic elements. In order to determine which genes ArcA was most likely to regulate, it 
was necessary for researchers to identify a consensus binding sequence; an extensive 1996 article 
written by Lynch and Lin used a series of electrophoretic mobility shift assays and restriction 
enzyme digests to hone in on where ArcA was binding in relation to several model genes, and to 
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determine the consensus binding sequence (Lynch and Lin, 1996). They characterized a putative 
consensus binding site with the sequence [5’ (A/T)GTTAATTA(A/T) 3’] and used this 
information to verify that genes known to be regulated by ArcA contained sequences with high 
similarity to this consensus (Lynch and Lin, 1996). 
 Once a putative sequence was determined, computational analysis revealed that several 
genes contained two or three potential ArcA binding sites rather than just one (Lynch and Lin, 
1996). These sequences generally appear upstream of the transcription start site in the promoter 
region, though they can also appear downstream or overlapping the transcription start site as well 
(Lynch and Lin, 1996). Since this initial experiment, more in-depth computational analyses have 
determined that there are as many as 150 potential operons under the direct influence of ArcA, and 
a revised consensus sequence of [5’ GTTAATTAAATGTT 3’] was proposed and is used as the 
current consensus for genetic analysis (Keseler et al., 2013; Liu and Wulf, 2004). 
 Due to the high number of genes and operons affected by ArcA, the overall transcriptional 
effects are generally reported as large families involved in certain metabolic functions. In 
anaerobic conditions, when ArcA is phosphorylated and active, several metabolic pathways 
required for efficient energy utilization in aerobic conditions are repressed (Jiang et al., 2015; 
Salmon et al., 2005). These pathways include; the tricarboxylic acid cycle, glycolysis, amino acid 
transport and catabolism, fatty acid transport and degradation, and quinone oxidation, among many 
others (Salmon et al., 2005). There are also several metabolic functions that are activated by ArcA 
under anaerobic conditions, which mainly involved small molecule transport and metabolism, 
nitrate reduction, and DNA repair (Salmon et al., 2005). 
 The implications of these changes in cellular metabolism is that cells are able to utilize 
various energy sources more efficiently in response to oxygen availability. Pathways involving 
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oxygen utilization become down-regulated as the availability of oxygen decreases, and 
concurrently the expression of pathways needed for alternative electron transport (such as nitrate) 
and fermentation become up-regulated (Salmon et al., 2005). 
 Among the many genes regulated by ArcA, there are several transcriptional regulators; this 
greatly increases the complexity of ArcA regulation through the addition of indirect effects 
(Keseler et al., 2013; Salmon et al., 2005). Perhaps the most interesting of these indirect effects is 
the suppression of the sigma factor RpoS through the down-regulation of the small regulatory 
RNA, arcZ (Mandin and Gottesman, 2010; Soper et al., 2010). The small regulatory RNA arcZ 
acts as a translational activator of rpoS, binding to the rpoS mRNA and recruiting the Hfq 
chaperone protein, which stabilizes the molecular construct in an “active” conformation where 
translation can proceed (Soper et al., 2010). 
 Under anaerobic conditions, when ArcA is active, the expression of arcZ is highly down-
regulated, which in turn inhibits the translation of rpoS (Mandin and Gottesman, 2010; Soper et 
al., 2010). In addition, activated ArcA-P binds to the promoter region of rpoS and inhibits 
transcription, which further down-regulates rpoS expression (Liu and Wulf, 2004; Mandin and 
Gottesman, 2010). Conversely, under aerobic conditions rpoS expression is up-regulated both by 
the removal of ArcA-P inhibition and by the translational activation of arcZ (Liu and Wulf, 2004; 
Mandin and Gottesman, 2010; Soper et al., 2010). However, determining the whole transcriptome 
effects of this indirect regulation is difficult to discern. 
 RpoS, or sigma-factor S (σS), is involved in the transcription of a diverse group of genes 
making up approximately 10% of the E. coli genome (Franchini et al., 2015; Patten et al., 2004; 
Rahman et al., 2006). Many of these genes are involved in stress response, and there is a large 
amount of regulatory overlap between σS and σ70, which have similar consensus sequences, and 
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other stress-response sigma factors (σ54 and σ28) (Dong et al., 2011; Franchini et al., 2015; Patten 
et al., 2004; Rahman et al., 2006). This complex regulatory network makes it difficult to 
definitively attribute transcriptional effects to σS. However, studies have found that RpoS (σS) is 
involved in functions such as stress response, secondary metabolism, nucleic acid synthesis, as 
well as sugar and polyamine metabolism in response to stress (Keseler et al., 2013; Maciag et al., 
2011). The control of RpoS by ArcA increases the widespread transcriptional effects of the ArcAB 
two-component signal transduction pathway, and likely assists in the metabolic shift that occurs 
between anaerobic and aerobic conditions. Fig. 1.11 below displays a summary of the ArcA 
regulon, which includes aerobic respiration, the tricarboxylic acid cycle, glycolysis, amino acid 






Figure 1.11: Summary of ArcA transcriptional regulation. Transphosphorylation of ArcA by ArcB 
leads to the up-regulation of small molecule metabolism and nitrate reduction, the down regulation 
of aerobic respiration, fatty acid degradation, amino acid catabolism, and RpoS expression, among 
other pathways (Jiang et al., 2015; Liu and Wulf, 2004; Mandin and Gottesman, 2010; Salmon et 
al., 2005; Soper et al., 2010). Green arrows refer to activation, and red arrows refer to inhibition. 
 
1.4.3.3 Regulation by CRP-cAMP 
The cyclic AMP receptor protein (CRP) – cyclic AMP complex (CRP-cAMP) is another 
important regulator of fatty acid metabolism in E. coli, responsible for activating transcription of 
the fad regulon in the absence of a preferred carbon source, glucose (Fic et al., 2009). This is part 
of larger process known as carbon catabolite repression, which is mediated by a protein 
phosphorylation cascade via components of the phosphoenolpyruvate (PEP):carbohydrate 
phosphotransferase system, or PTS (Deutscher, 2008; Franchini et al., 2015). Glucose is 
transported into the cell by the glucose-specific membrane permease EIICGlc, concomitant with its 
27 
 
phosphorylation by the EIIB subunit to form glucose-6-phosphate (Kundig et al., 1964). 
Transphosphorylation of EIIB is catalyzed by EIIA to ensure continued glucose transport, which 
results in an elevated pool of the dephosphorylated EIIA. This in turn reduces the activity of 
adenylate cyclase (CyaA), which requires phosphorylation to catalyze the synthesis of cAMP. A 
reduction in available cAMP in reduces the concentration of CRP-cAMP, ultimately down-
regulating fad regulon expression. Conversely, when glucose in unavailable the pool of CRP-
cAMP in the cytosol is high, activating the transcription of both fadD and fadE (Feng and Cronan, 
2012). This has implications for the biosynthesis of MCL PHAs in E. coli LSBJ. 
1.4.3.4 Regulation by OmpR/EnvZ 
One member of the fad regulon, the LCL fatty acid transporter FadL, is additionally 
regulated by the OmpR/EnvZ two component response regulator (Aiba and Mizuno, 1990; Forst 
and Roberts, 1994). Although this regulatory system was implicated in the hypotheses in Chapter 
2, it was found to not play a role in MCL PHA biosynthesis in E. coli LSBJ and will therefore only 
be reviewed briefly. 
The OmpR/EnvZ regulatory system is primarily responsible for controlling the expression 
of outer membrane porins in response to osmolarity, with OmpR serving as the response regulator 
for this system (Mizuno and Mizushima, 1990). OmpR is a well-characterized transcriptional 
regulator in E. coli, belonging to a large family of transcription factors with a winged helix DNA 
binding motif (the OmpR family) (Kato et al., 1995). The outer membrane porins OmpF and 
OmpC, both of which form ion-permeable channels and aid in the diffusion of small hydrophilic 
molecules across the inner membrane, are the primary targets of OmpR regulation (Foo et al., 
2015). Although both porins allow transport of similar molecules, OmpF is characterized by a 
faster flow rate and is its expression is activated in conditions of low osmolarity. OmpC plays an 
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opposing role; in conditions of high osmolarity ompC expression is activated, and slower flow 
rates through OmpC help maintain ion homeostasis (Nikaido, 1992; Silhavy and Pratt, 1995). 
Regulation by OmpR is controlled by the sensor kinase EnvZ, which autophosphorylates 
in response to extracellular and intracellular osmolarity and transphosphorylates OmpR, which 
proceeds to bind to the upstream promoter region of target genes (Forst and Roberts, 1994; 
Matsubara and Mizuno, 1999; Wang et al., 2012). Although ompF and ompC are the primary 
targets for OmpR binding, it has also been shown to modulate the expression of amino acid 
metabolism, flagellar biosynthesis, and LCL fatty acid transport via the outer membrane porin 
FadL (Higashitani et al., 1993; Oshima et al., 2002). Although FadL is sometimes implicated in 
MCL PHA biosynthesis, it has been shown to exhibit no activity on fatty acids of 12 carbons or 
less (Black, 1990). 
1.5 Recent developments in the biosynthesis of chemically modifiable PHAs 
Significant research effort has centered on expanding the capability of PHA-producing 
bacteria to incorporate, in a controlled fashion, MCL/SCL and unnatural monomers into 
copolymers by engineering biosynthetic pathways and expanding the substrate specificities of their 
enzymatic constituents.  There have been several successful examples of this approach, including 
chimeric PHA synthases with broad substrate specificity (Matsumoto et al., 2009), the 
development of controllable production platforms such as E. coli LSBJ (Tappel et al., 2012b), and 
engineered recombinant pathways capable of synthesizing unique copolymers (Li et al., 2017, 
2016). These research efforts have yielded slow-yet-steady gains in the production of uncommon 
PHA copolymers from a variety of related and unrelated feedstocks. 
An underdeveloped area of PHA research, however, has been that of finding solutions to 
the limited chemical tractability of PHA side chains. Thus far this challenge has been circumvented 
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by applying multistep synthetic routes post-polymerization to adapt them to specific applications 
and designs. Besides some excellent examples from a few laboratories, meaningful efforts to 
augment the chemical tractability of PHAs via incorporation of unnatural or uncommon monomers 
have been sporadic and inadequate. Similarly, organisms such as Pseudomonas oleovorans have 
been shown to produce exotic and uncommon PHAs biosynthetically, however there has been little 
progress towards scaling up their production (Lenz et al., 1992). 
 A great variety of uncommon functional groups have been observed in PHAs, including; 
terminal alkenes and alkynes (Lageveen et al., 1988; Levine et al., 2015; Tappel et al., 2012b), 
halogens (Doi and Abe, 1990; Kim et al., 1996; Lenz et al., 1992), esters (Scholz et al., 1994), 
epoxides (Bear et al., 1997), aromatic rings (Aróstegui et al., 1999; Kim et al., 1991; Takagi et al., 
1999), and nitrile groups (Lenz et al., 1992). Although these are fascinating examples of the 
diversity of PHAs, several more recent advances in functionalization have great potential for 
commercial significance and more advances applications.  
1.5.1 Fluorination of the PHA α-carbon 
Fluoropolymers are incredibly useful materials that have transformed the fields of polymer 
chemistry and materials science, with the classic example being that of poly(tetrafluoroethylene) 
(PTFE) which has extraordinary physical properties (Plunkett, 1941). These properties arise from 
the C-F bond, which is the strongest single bond to carbon that can be made, and the unique 
electronic interactions that result from the high electronegativity of fluorine (O’Hagan, 2008). 
Organofluorine compounds have also been used extensively in the pharmaceutical industry, where 
substitutions with fluorine often dramatically alter enzymatic interactions (Kirsch, 2005; Purser et 
al., 2008). This utility is enhanced by the dearth of organofluorine compounds found in nature; 
very few metabolic pathways exist that can manipulate C-F bonds, and there are a limited number 
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of biologically produced organofluorine structures (Dong et al., 2004; Leong et al., 2017; Twigg 
and Socha, 2001; Walker and Bong Chui Lien, 1981). 
Recently, a biosynthetic approach for producing fluorinated PHAs was reported by 
Thuronyi et al. (2017). This novel recombinant pathway has been included here as an excellent 
example of the chemical modification of existing PHAs through non-synthetic means (Fig. 1.12), 
and because there is increasing interest in developing chemistries for modification of the 




Figure 1.12: Recombinant pathway for 2-fluoro-PHA synthesis in Escherichia coli. Using 
biologically available fluoromalonate as a feedstock, poly[2-fluoro-(R)-3-hydroxybutyrate] can be 




Exogenous fluoromalonate is imported into the cell by one of several potential transporter 
systems; Thuronyi et al. found that the most effective system was the two-component 
Na+:malonate symporter MadLM isolated from Pseudomonas fluorescens (Schaffitzel et al., 1998; 
Thuronyi et al., 2017). The intracellular fluoromalonate is then converted to fluoromalonyl 
coenzyme A (fluoromalonyl-CoA) in a two-step reaction by the malonate-CoA ligase MatB 
isolated from Rhodopseudomonas palustris (Crosby et al., 2012). The unique acetoacetyl-CoA 
synthase NphT7 isolated from Streptomyces sp. CL190 catalyzes the condensation of one molecule 
of acetyl-CoA with one molecule of fluoromalonyl-CoA to yield one molecule of 
acetofluoroacetyl-CoA concomitant with the release of CO2 and free coenzyme A (Okamura et al., 
2010; Walker et al., 2013). PhaB, an acetoacetyl-CoA reductase isolated from Ralstonia eutropha 
(Peoples and Sinskey, 1989a), catalyzes the chemoselective reduction of the beta keto group of 
acetofluoroacetyl-CoA to yield 2-fluoro-(R)-3-hydroxybutyryl-CoA. This substrate, along with the 
non-fluorinated analog (R)-3-hydroxybutyrate which occurs due to the presence of the key fatty 
acid biosynthesis metabolite malonyl-CoA, is finally polymerized by the PHA synthase PhaC 
isolated from Ralstonia eutropha (Peoples and Sinskey, 1989b) to generate the copolymer poly[2-
fluoro-(R)-3-hydroxybutyrate-co-(R)-3-hydroxybutyrate]. This is the first described biosynthesis 
of a fluoro-PHA, and represents a novel approach to diversifying the portfolio of chemically 
modified PHAs by the manipulation of the ɑ-carbon. 
With the increasing number of synthetic organofluorine compounds, driven in large part 
by the development of pharmaceuticals, there has been increasing interest in the activation and 
scission of C-F bonds for further modification. This is a challenge however, given the strength of 
the C-F bond and its unsuitability as a leaving group (O’Hagan, 2008), which necessitates the use 
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of harsh reaction conditions such as strong nucleophiles (e.g. organolithium reagents) and high 
temperatures (Fuchibe et al., 2009; Perutz and Braun, 2007; Pigeon et al., 2010). More recently, 
mild reaction conditions have been found that exploit the fluorophilicity of silicon to cleave non-
activated, aliphatic C-F bonds (Tanaka et al., 2016). 
Defluorosilylation of alkyl fluorides with relatively mild conditions has been recently 
achieved independently by several groups (Cui et al., 2018; Liu et al., 2019; Mallick et al., 2019). 
Two examples of these defluorosilylation reactions with alkyl fluorides are shown in Fig. 1.13. It 
is possible that these reaction conditions could be applied to poly[2-fluoro-(R)-3-hydroxybutyrate] 
in which the fluorine is in an activated position on the α-carbon, allowing further modification of 
the organosilicon moiety (Komiyama et al., 2017).  However, as the ester linkage in PHAs exhibits 
poor acid/base resistance, more research is needed to determine whether these new methods 
employed for defluorosilylation are capable of cleaving the C-F bond without destruction of the 
polymer. Chemical modification of the PHA α-carbon, if possible, would offer an interesting 
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alternative to the current portfolio of functionalizations, most of which utilize reactive groups on 
the branch chain. 
 
Figure 1.13: Recent methods for base-mediated defluorosilylation. (A) Two examples of 
independently-devised methods for defluorosilylation of alkyl fluorides (Cui et al., 2018; Liu et 
al., 2019). (B) It may be possible to adapt these methods for the modification of 2-fluoro-PHA. 
 An important aspect to consider in the development of fluoropolymers is their 
environmental impact. Perfluoropolymers such as poly(tetrafluoroethylene) are persistent in the 
environment, owing to their high stability and chemical inertness. However, many of these 
materials have been found to be nontoxic and meet the criteria for “polymers of low concern,” 
which has been extensively reviewed by Henry et al. (2018). The primary concern of these 
materials, with respect to environmental toxicology, is the toxicity of perfluoroalkyl acids 
(PFAAs) which are used as surfactants for fluoropolymer synthesis, or in the case of side-chain 
fluorinated polymers can be generated by polymer degradation (Liu and Mejia Avendaño, 2013). 
PFAAs are regarded as persistent bioaccumulative toxins and have been shown to be carcinogenic 
(Takacs and Abbott, 2007), hepatotoxic (Seacat et al., 2002), and teratogenic (Wolf et al., 2007) 
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in a variety of mammalian studies. These compounds have also been implicated in thyroid disease 
in humans (Melzer David et al., 2010; Winquist and Steenland, 2014), and these combined 
toxicological effects make it imperative to prevent environmental pollution with PFAAs and 
potential fluoropolymer precursors. In the case of α-fluorinated PHAs, there are documented 
pathways of microbial defluorination that may be capable of maintaining the biodegradability 
typical of PHA polymers, however the toxic potential of 2-fluorobutyrate and its degradation 
products must still be investigated (Leong et al., 2017; Walker and Bong Chui Lien, 1981). For 
these reasons, we should exercise caution in the development of fluoro-PHAs. 
 
1.5.2 Development and biosynthesis of azido-PHAs 
Click reactions comprise a group of synthetic, chemoselective strategies that have no side 
products, occur under mild reaction conditions, and proceed rapidly with high yields (Kolb et al., 
2001). Considered the paradigm among click reactions is the so-called copper alkyne-azide 
cycloaddition reaction (CuAAC), which reliably yields 1,2,3-triazole moieties under mild 
conditions (Fig. 1.14) (Rostovtsev et al., 2002). The reaction involves a thermodynamically-
favored non-concerted cycloaddition featuring Cu(I) as the reactive coordination center by which 
alkynes and organoazides rearrange to regioselectively form triazole heterocycles.  The 
extraordinary chemoselectivity of the CuAAC and its recognized value as a model reaction in 
pharmaceutical applications has led to an expanded availability of commercial sources of azido- 
or alkynyl-conjugated biomolecules. More recently, strain-promoted variants of the alkyne-azide 
cycloaddition (SPAAC) were developed, with substituted cyclooctynes as their centerpiece, born 
out of the desire to employ these popular reactions in organisms, avoid the use of deleterious 
copper, and preserve the reaction’s kinetic parameters in vivo (Agard et al., 2004; Baskin et al., 
2007). Progress in the budding field of orthogonal and bioorthogonal chemical transformations 
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has been rapidly developing and has produced examples which include, but are not limited to; UV-
promoted thiol-ene click reactions between thiols and alkenes/alkynes (Dondoni, 2008; Hoyle and 
Bowman, 2010), (4+2) cycloadditions between dienes and dienophiles such as normal and reverse-
electron-demand Diels-Alder reactions (Pipkorn et al., 2009; Shi and Shoichet, 2008), and the 
Staudinger ligation between organoazides and organophosphorus reagents (Saxon and Bertozzi, 




Figure 1.14: Examples of how click reactions can be used to expand functionality of PHA 
polymers. In addition to the copper catalyzed azide-alkyne cycloaddition reaction, thiol-ene click 
reactions and copper-free cycloadditions with strained alkynes are also possible. 
 
In view of the need to develop simple and efficient solutions to the chemical modification 
of PHAs, Nomura et al. led an effort to produce PHAMCL polymers containing sidechains with 
reactive organoazide functional groups (Pinto et al., 2016). This modification would allow 
researchers to bridge the latent reactivity of these polymers with a vast library of click-chemistry 
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based reagents, commercial and otherwise, and offers the potential to expand the reach of PHA 
applications into high-value areas such as biomedicine, advanced materials, and others.  
The implementation of a bacterial strain like E. coli LSBJ, able to uptake and redirect fatty 
acid feedstocks towards the production of PHA as described previously in this chapter, inspired 
the development of a short synthetic route to produce chemically tractable azidofatty acids. For 
this purpose, 8 and 12-carbon α,ω-diols were converted in three steps to the corresponding ω-
azidofatty acids in approximately 35% overall yields (Pinto et al., 2016). In addition to the ω-
azidofatty acids, 10-azidodecanoic acid was synthesized from commercially available 10-
bromodecanoic acid in a single step and with 87% yield. The metabolic incorporation of the 
synthetic azidofatty acids into PHA copolymers was assessed by fermentation studies employing 
E. coli LSBJ and octanoic acid as a primary monomer. E. coli LSBJ was able to uptake all three 
azidofatty acids, leading to the production of copolymers of variable % azide compositions. Of the 
materials obtained, poly-[(R)-3-hydroxyoctanoate-co-10-azido-(R)-3-hydroxydecanoate] was 
employed by the researchers in SPAAC conjugation experiments with the commercially-available 
cyclooctyne (1R,8S,9s)-bicyclo[6.1.0]non-4-yn-9-ylmethanol. 
Nomura et al.’s exploratory study provided a clear answer about the feasibility of 
introducing organoazides into PHA copolymers and using strain-promoted click chemistry 
conditions to modify them. More recently, Scholz et al. expanded on this work by providing 
examples of how copper catalyzed click chemistry conditions could be applied to the modification 
of PHAs (Nkrumah-Agyeefi and Scholz, 2017). Their study centered on the evaluation of two 
distinct yet functionally complementary copolymers with nonanoate as the primary monomer: one 
displaying an azide, and another an alkyne functional group (Fig. 1.15). Optimized production of 
the alkyne-containing polyester was performed by fermentation with P. oleovorans ATCC 29347 
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in the presence of a 1:1 molar ratio of sodium nonanoate and 10-undecynoic acid (a 40 mM total 
concentration), and 10 mM sodium acetate over 20h. As opposed to employing synthetic azidofatty 
acid feedstocks to fermentatively incorporate into PHA, Scholz et al reported an alternative 
approach that involved the production of a brominated PHA intermediate to be subsequently 
converted to AzidoPHA by nucleophilic substitution with NaN3. Incorporation of brominated fatty 
acids into PHA was confirmed by 1H NMR as represented by the methylene signal at 3.41 ppm (-
CH2Br). The brominated side chains were converted by substitution to organoazides by reaction 
with sodium azide in DMF and their presence confirmed by their characteristic FTIR stretch at 
2093 cm-1. 
 
Figure 1.15: Examples of alkynyl-PHA and bromo-PHA biosynthesis by Pseudomonas 
oleovorans. 
The azido-PHA copolymers obtained were modified by copper-catalyzed click chemistry. 
The authors emphasized the need to test methodologies for this step as they found difficulties when 
attempting to use a single copper-catalyzed method across polymer systems. The alkynyl-PHA 
copolymer was conjugated with methyl-2-azidoacetate in the presence of CuBr(PPh3)3, a copper 
catalyst soluble in tetrahydrofuran (THF) (Malkoch et al., 2005). The reaction progress was 
monitored by the disappearance of the stretch at 3292 cm-1, representative of terminal alkynes in 
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FTIR spectroscopy. Formation of the triazole adduct was confirmed by 1H NMR spectroscopy. An 
analogous method was employed in the click chemistry reaction of azido-PHA copolymer with 
propargyl benzoate. The key difference was the use of the more common click chemistry 
conditions of CuSO4 5H2O as catalyst in an aqueous/THF solvent mixture containing sodium 
ascorbate. Under similar reaction conditions the conjugation of azido-PHA with propargyl acetate 
failed to yield product. 
1.5.3 Biosynthesis and modifications of unsaturated PHAs 
One type of chemically modifiable monomer unit that has been incorporated into PHAs 
are ω-unsaturated fatty-acids of varying chain lengths (e.g. 10-undecenoic acid and 7-octenoic 
acid). The terminal alkenes featured in these polymers have become an attractive chemical handle 
for their modification post polymerization, mainly by oxidative cleavage reactions. These 
strategies have been the subject of much scrutiny and have been featured and well described 
elsewhere (Kai and Loh, 2014). 
This notwithstanding, a few salient examples have surfaced in recent years such as that by 
Scholz et al. which showed that PHAs containing 10-undecenoate repeating units can be modified 
to produce ionizable and hydrophilic PHAs (Sparks and Scholz, 2008). In their study, the terminal 
alkene moieties in poly-[(R)-3-hydroxyoctanoate-co-(R)-3-hydroxyundecenoate] were epoxidized 
by treatment with 3-chloroperbenzoic acid and ring-opened by nucleophilic reaction with 
diethanolamine. The resulting ionizable PHA polymer was characterized by 1D and 2D NMR 
spectroscopy and solubility tests confirmed its miscibility in water. The polycationic character of 
the modified PHA polymer served as the basis for investigating its value as a plasmid DNA 
delivery system. The authors demonstrated the polymer’s ability to tightly bind and protect 
plasmid DNA from endonuclease degradation (Sparks and Scholz, 2009). 
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Other novel approaches for the modification and application of unsaturated PHA polymers 
have been performed by employing thiol-ene click chemistry. This type of click reaction involves 
the radical-driven covalent coupling of alkene and thiol functional groups in the presence of 
ultraviolet light (UV) and in the presence of a photoinitiator (Kade et al., 2010). This reaction has 
been successfully demonstrated by Levine et al. using poly(3-hydroxybutyrate-co-3-hydroxy-10-
undecenoate) (PHBUe) copolymers biosynthesized by E. coli LSBJ (2015). Copolymers were 
cross-linked using pentaerythritol tetrakis(3-mercaptopropionate) (PETMP) and the radical 
photoinitiator 2,2-dimethoxy-2-phenylacetophenone (DMPA) (Fig. 1.16), resulting in a 200% 
increase in tensile strength. Cytotoxicity assays conducted with human mesenchymal stem cells 
(hMSC) showed that cell viability was unaffected by the cross-linking, with hMSC-seeded PHBUe 
and PHBUX scaffolds exhibiting no difference between each other or a positive control. This 
represents an exciting new PHA material with potential use in tissue engineering. 
 
 
Figure 1.16: Cross-linked poly(3-hydroxybutyrate-co-3-hydroxy-10-undecenoate) (PHBUe) 
produced via thiol-ene click chemistry. 
 
The potential use of PHAs in biomedical applications such as drug delivery and tissue 
engineering has generally been limited by the methodologies available to chemically modify and 
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fine-tune their properties (Hazer et al., 2012; Poletto et al., 2008). Recent advances in the 
biosynthesis of azide-, fluorine-, and alkyne-containing PHAs are an excellent first step towards 
the production of useful chemically modifiable materials. 
1.6 Objectives of this dissertation 
A number of PHAs have been studied in great detail as biodegradable alternatives to 
conventional plastics, particularly SCL PHAs  such as PHB and PHBV or the SCL-co-MCL 
polymer PHBHHx, which can be more readily produced at an industrial scale (Chanprateep, 2010; 
Noda et al., 2010). MCL PHAs and diverse SCL-co-MCL PHAs offer exciting new material 
properties and chemical handles for functionalization; however, controlled biosynthesis of these 
polymers has only recently been achieved and is hindered by low yields and prohibitive production 
costs (Chen and Albertsson, 2019; Tappel et al., 2012b). 
 MCL PHA biosynthesis in recombinant E. coli LSBJ most commonly occurs via β-
oxidation intermediates, and can produce a variety of MCL homopolymers and copolymers with 
controlled compositions. This process is limited in its production capacity due to the poor growth 
of E. coli on fatty acid substrates and the limiting effect of catabolite repression when 
supplemented with a preferred carbon source such as glucose (Deutscher, 2008; Feng and Cronan, 
2012; Nunn, 1986). The first objective of this dissertation is to evaluate the role of transcriptional 
regulators of fatty acid catabolism in the PHA biosynthesis pathway of E. coli LSBJ, with a focus 
on enhancing MCL PHA yields (Chapter 2). The hypothesis presented in this chapter is that the 
deletion of the negative transcriptional regulators arcA and ompR from E. coli LSBJ will increase 




In a separate effort to address the prohibitive cost of PHA biosynthesis, the second 
objective of this dissertation is to explore alternative lignocellulosic feedstocks as cheaper 
alternatives to pure sugars (Chapter 3). Using a combination of the de novo biosynthesis pathway 
(Fig. 1.4) from acetyl-CoA and PhaG-mediated MCL monomer incorporation, both PHB and 
PHB-co-MCL PHAs were successfully produced from hydrolyzed paper mill waste pulp. 
Biosynthesis of many desired chemicals and materials can be achieved in high yields using 
fed-batch, high-density fermentation processes in a scalable vessel such as a stirred tank reactor 
(Lau et al., 2004; Lee, 1996; Riesenberg and Guthke, 1999). These techniques have been applied 
to PHA biosynthesis as well, resulting in significant improvements to productivity primarily for 
SCL polymers (Amini et al., 2020; Blunt et al., 2018; Koller, 2018; Lee et al., 1999). However, 
there have been comparatively few studies to investigate the production of MCL PHAs using high-
density fermentation, and fewer still that have maintained control over monomer composition 
(Follonier et al., 2015; Gao et al., 2018; Gopi et al., 2018; Jiang et al., 2013). The work presented 
in Chapter 4 describes a process optimization for the biosynthesis of MCL PHAs with controlled 
composition via high-density fed-batch fermentation with E. coli LSBJ. The objective of this work 
was to significantly improve MCL PHA yields from those observed in previous studies that relied 
on unscalable shake flask culture techniques, including the biosynthesis of functional azido PHA 
polymers. 
Chapter 5 expands on the novel azido PHAs produced in Chapter 4 and in previous work 
by Pinto et al. to develop functionalized polymeric nanoparticles for targeted drug delivery (2016). 
This chapter presents promising preliminary data for the production of endotoxin-free 
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Chapter 2: Enhancing poly(3-hydroxyalkanoate) production in Escherichia coli by the 
removal of the regulatory gene arcA 
The work presented here was published in AMB Express (2016). Please see Appendix G for 
publication cover. My contributions include the gene deletion experiments, the growth and 
harvest of all bacterial cultures, the GC preparation and analysis, the polymer extraction and 
purification, the compositional verification using H-NMR, the molecular weight analysis using 
GPC, the gene expression analysis, and the drafting of the manuscript in its entirety. 
2.1 Abstract 
Recombinant Escherichia coli is a desirable platform for the production of many biological 
compounds including poly(3-hydroxyalkanoates), a class of naturally occurring biodegradable 
polyesters with promising biomedical and material applications. Although the controlled 
production of desirable polymers is possible with the utilization of fatty acid feedstocks, a central 
challenge to this biosynthetic route is the improvement of the relatively low polymer yield, a 
necessary factor of decreasing the production costs. In this study we sought to address this 
challenge by deleting arcA and ompR, two global regulators with the capacity to inhibit the uptake 
and activation of exogenous fatty acids. We found that polymer yields in a ΔarcA mutant increased 
significantly with respect to the parental strain. In the parental strain, PHV yields were very low 
but improved 64-fold in the ΔarcA mutant (1.92 mg L-1 to 124 mg L-1) The a ΔarcA mutant also 
allowed for modest increases in some medium chain length polymer yields, while weight average 
molecular weights improved by approximately 1.5-fold to 12-fold depending on the fatty acid 
substrate utilized. These results were supported by an analysis of differential gene expression, 
which showed that the key genes (fadD, fadL, and fadE) encoding fatty acid degradation enzymes 
were all upregulated by 2-, 10-, and 31-fold in an ΔarcA mutant, respectively. Additionally, the 
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short chain length fatty acid uptake genes atoA, atoE and atoD were upregulated by 103-, 119-, 
and 303-fold respectively, though these values are somewhat inflated due to low expression in the 
parental strain. Overall, this study demonstrates that arcA is an important target to improve PHA 
production from fatty acids. 
2.2 Introduction 
Poly(3-hydroxyalkanoates), or PHAs, are a group of biodegradable polyesters produced by 
a variety of microorganisms as a form of carbon storage (Lu et al. 2009). These PHAs are typically 
classified as short chain-length (SCL) PHAs, which contain repeating units of 3 to 5 carbons, and 
medium chain-length (MCL) PHAs containing 6 to 14 carbons. The physical properties of PHAs 
are dependent on monomer composition; SCL PHAs are generally stiff and brittle while MCL 
PHAs are more elastomeric, and co-polymerization of the two groups allows for great variability 
in material properties (Laycock et al. 2013). Previous studies have shown that MCL PHAs can be 
effectively produced in recombinant E. coli lacking the fatty acid degradation gene fadB when 
utilizing a related carbon source such as fatty acids, although the monomer composition of the 
resulting polymers was heterogenous and uncontrolled (Langenbach et al. 1997; Qi et al. 1997). 
Recently, it was shown that the monomer identity can be precisely controlled in both PHA 
homo- and co-polymers synthesized by recombinant Escherichia coli strain LSBJ (Tappel et al. 
2012a; Tappel et al. 2012b). This was accomplished by deleting both the fadB and fadJ genes in 
E. coli LS5218, recombinantly co-expressing the phaJ4 gene from Pseudomonas putida KT2440 
with the highly active and broad substrate utilizing phaC1(STQK) genes, and feeding in specific 
ratios of fatty acids for conversion to PHAs (Fig. 2.1).  This system allowed for strict control of 
repeating unit composition which enables great control over the physical properties of PHA 
polymers produced using this system, unlocking the potential for tailoring PHA materials for click-
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chemistry modifications (Levine et al. 2015; Levine et al. 2016; Pinto et al. 2016). Although these 
previous studies addressed control of the monomer composition and thus physical and chemical 
properties of PHA polymers, overall polymer yields were still relatively low and some fatty acid 
substrates had poor incorporation into either PHA homo- or copolymers. The previously defined 
system relied heavily on the deletion of the fadR gene in E. coli LS5218 for constitutive expression 
of the genes encoding enzymes from the β-oxidation pathway (Spratt et al. 1981). In a previous 
study, researchers demonstrated that the inhibition of β-oxidation intermediates using acrylic acid 
was an effective strategy for improving PHA biosynthesis, particularly in combination with a fadR 
deletion (Qi et al. 1998). In addition to FadR, there are three other transcriptional regulators, ArcA, 
OmpR, and CRP-cAMP, that are known to inhibit the expression of genes involved in β-oxidation. 
For this study, we focused on the regulators ArcA and OmpR because CRP-cAMP is known to act 
as a transcriptional activator of β-oxidation in the absence of glucose, and only exhibits repression 
when glucose is present (Fic et al. 2009). We hypothesized that removal of transcriptional 
regulators that inhibit expression of β-oxidation related genes would result in improved flux 
through fatty acid catabolic pathways to increase PHA polymer yields in our engineered system. 
Therefore, in this study E. coli LSBJ was engineered to improve the biosynthesis of PHA from 





Figure 2.1: Biosynthesis of PHA in E. coli LSBJ utilizing short-chain-length (SCL) and medium-
chain-length (MCL) fatty acids. The absence of fadB and fadJ in E. coli LSBJ in combination with 
the plasmid-borne recombinant enzymes PhaC1(STQK) and PhaJ4 establishes a linear pathway 
for the production of PHA polymers from free fatty acids. Extracellular fatty acids are transported 
across the outer membrane dependent on size; SCL and shorter MCL fatty acids can diffuse across 
the outer membrane, while longer MCL fatty acids can be transported by the long-chain fatty acid 
transporter FadL (Lepore et al. 2011). Inner membrane transport and activation is accomplished 
by the SCL-specific Ato system (AtoEAD) or the MCL-specific acyl-CoA synthetase FadD 
(Kameda and Nunn 1981; Theodorou et al. 2006). Acyl-CoA substrates are converted into enoyl-
CoA by the acyl-CoA dehydrogenase enzyme FadE (Campbell and Cronan 2002), and are unable 
to proceed further through β-oxidation due to the absence of FadB and FadJ. The enoyl-CoA pool 
is then converted to (R)-3-hydroxyacyl-CoA by the R-specific enoyl-CoA hydratase PhaJ4 (Tsuge 
et al. 2003), and finally polymerized by the PHA synthase PhaC1(STQK) (Takase et al. 2003; 
Takase et al. 2004). This system allows for the biosynthesis of PHA polymers with tightly 
controlled repeating unit composition, as the number of carbons present in the fatty acid substrate 




The transcriptional regulator OmpR functions as a response regulator of the two component 
regulatory EnvZ/OmpR system, which exhibits control over the expression of outer membrane 
porins in response to osmolarity (Mizuno and Mizushima 1990). The sensor kinase EnvZ 
autophosphorylates in response to extracellular osmolarity and transphosphorylates OmpR 
(OmpR-P), which binds to DNA and alters expression of genes within the OmpR regulon (Forst 
and Roberts 1994; Matsubara and Mizuno 1999).  The most well-studied members of the OmpR 
regulon are OmpF and OmpC, outer membrane porins that control the diffusion of small 
hydrophilic molecules (Aiba and Mizuno 1990; Mizuno and Mizushima 1990; Silhavy and Pratt 
1995). However, OmpR controls numerous other transporter genes including fadL (Table 2.1), as 
well as genes involved in amino acid metabolism and flagellar biosynthesis (Higashitani et al. 
1993; Oshima et al. 2002). 
The global transcriptional dual regulator ArcA functions as the response regulator of the 
two-component regulatory ArcAB system, which regulates the expression of genes involved in 
aerobic and anaerobic metabolism in response to oxygen availability (Iuchi and Lin 1988; Lynch 
and Lin 1996). During conditions of decreasing oxygen availability, ArcA is activated through a 
phosphorelay mechanism and binds to the consensus sequence 5’-wGTTAATTAw-3’ (w is A or 
T) located in numerous genes, including several genes involved in β-oxidation shown in Table 
2.1, and acts as either a repressor or activator (Iuchi and Lin 1992; Lynch and Lin 1996; Liu and 
Wulf 2004; Cho et al. 2006; Peña-Sandoval and Georgellis 2010). It has previously been shown 
that the redox biochemistry and transcriptional regulation of an ΔarcA mutant strain is significantly 
altered during microaerobic growth conditions, and to a lesser degree during aerobic growth 
conditions (Oshima et al. 2002; Alexeeva et al. 2003; Shalel-Levanon et al. 2005). The work 
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presented here demonstrates for the first time an arcA deletion mutant combined with a fadR 
mutation to improve the biosynthesis of PHA polymers derived from fatty acid substrates. 
Table 2.1: Regulation Targets of ArcA and OmpR 
Target Gene Description Reference 
arcA   
    fadL Long-chain fatty acid transporter, experimental evidence. Cho et al., 2006 
    fadD Acyl-CoA synthetase, experimental evidence. Cho et al., 2006 
    fadE Acyl-CoA dehydrogenase, experimental evidence. Cho et al., 2006 
   
ompR   




A complete list of strains, plasmids, and primers used for this study is shown in Table 2.2. 
All strains were grown in Lennox Broth (LB; composition per liter: 10 g tryptone, 5 g yeast extract, 
and 5 g sodium chloride, pH 7.0) purchased from Difco, and the antibiotics kanamycin (50 mg L-
1) and ampicillin (100 mg L-1) were added to media throughout the experiment as appropriate. The 
fatty acids sodium butyrate (Alfa Aesar), pentanoic acid (Alfa Aesar), hexanoic acid (Alfa Aesar), 
heptanoic acid (Alfa Aesar), sodium octanoate (Sigma Aldrich), decanoic acid (Alfa Aesar), and 
dodecanoic acid (Acros Organics) were used as feed supplements for PHA production (12 mM), 
along with the surfactant Brij-35 (Fisher Scientific, 4.0 g L-1). Sodium phosphate dodecahydrate 
(Acros Organics, 8 mM) was added when noted. Sodium hydroxide (5 M) was used to adjust the 
pH to 7.0 when necessary. Primers were ordered from Integrated DNA Technologies (IDT). ACS 
HPLC-grade chloroform and methanol were used for gas chromatography (GC) sample 




Table 2.2: Strains, plasmids, and primers. 
Escherichia coli Relevant characteristics Source or reference 
LSBJ ΔfadB, ΔfadJ, atoC512 (Const), fadR601 Tappel et al., 2012 
RSC02 ΔarcA LSBJ This study 
RSC04 ΔompR LSBJ This study 
RSC06 ΔarcA, ΔompR LSBJ This study 
   
Plasmids   
pKD46 λ Red recombinase expression plasmid; expresses exo, β, and γ genes 
from λ phage; ParaB promoter; araC; AmpR; temperature sensitive replicon 
Datsenko and 
Wanner, 2000 
pKD13 Neomycin phosphotransferase flanked by FLP recombinase recognition 
targets, AmpR, KmR 
Datsenko and 
Wanner, 2000 




pBBR-C1J4SII pBBR1MCS-2 derivative ΔphaAB, phaJ4, phaC1 (STQK) Tappel et al. 2012 
   





arcA.check.F/R GTTAATTTGCAGCATGCATCAGG / GACGATGAGTTACGTATCTGG  
ompR.check.F/R AAATTGTTGCGAACCTTTGG / GCAATAACGTACGGGCAAAT 
qAtoA.F/R GGTGCAGCCATGTTTGATAG / CGCGAGGTTTGCTTCTTC 
qAtoD.F/R ACTTGGCAACCTGACCTATC / GACCAGTTCATCTGGCTCTAC 
qAtoE.F/R ACTCGGTATCGCTTACCTTG / GCAGACCCGCAATCATAAAC 
qFadD.F/R TCTCCAGTCTGCATCTTTCC / CCATAGCCTTCCAGCAGATAC 
qFadE.F/R TTACCCGTCTGGATGAACTG / GACGGCTTTCTTCAGCTTTC 
qFadL.F/R GGGCGCTTCTATTACCTCTAA / TTTCAAGGTCGGTTGTACCC 
qRpoD.F/R GAGCAAGGCTATCTGACCTATG / GCCCATGTCGTTGATCATTTG 
a Underlined sequences are homologous to the gene to be deleted. 
b Forward and reverse primers are denoted with an F or R, respectively, and primers used for qPCR 
are denoted with a q. 
 
2.3.2 Gene deletions 
The deletion of the arcA and ompR genes was accomplished using the λ red recombinase 
protocol, a commonly used method for nonpolar gene deletion, as previously described (Datsenko 
and Wanner 2000; Tappel et al. 2012b). Briefly, knockout cassettes were generated using PCR 
with gene-specific primers and the kanamycin resistance marker from pKD13 (Table 2.2). PCR 
was performed using PrimeSTAR HS polymerase (Takara) following the manufacturers 
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recommended protocol. The λ red recombinase was expressed using plasmid pKD46, and 
knockout cassettes introduced by electroporation (1500V, 5ms; BTX ECM 399). Successful 
recombination was determined by antibiotic selection and loci screening using check primers 
(Table 2.2). Antibiotic resistance was removed by the expression of FLP recombinase from the 
pCP20 plasmid, and successful deletions were confirmed by loss of antibiotic resistance and by 
PCR using loci check primers (Table 2.2). Deletion mutants ΔarcA, ΔompR, and the double 
deletion ΔarcA ΔompR) were named RSC02, RSC04, and RSC06, respectively (Table 2.2). 
2.3.3 PHA production  
Protocols for PHA production and cell harvest were adapted from a previous study (Tappel 
et al. 2012b), with several modifications. For initial preliminary experiments, LSBJ, RSC02, 
RSC04, and RSC06 were made chemically competent and transformed with pBBR-C1J4SII 
following standard procedures (Sambrook and Russell 2001), to express PHA synthase and enoyl-
CoA hydratase. Transformants were grown on LB-agar plates, and single colonies were used to 
inoculate separate 2 mL LB seed cultures, in triplicate for each strain. Seed cultures were grown 
for 16 h at 37°C and 200 rpm, and used to inoculate 100 mL of growth media in 500-mL baffled 
shake flasks (to final concentration of 0.5%). Growth media contained LB, Brij-35, decanoic acid, 
and kanamycin. Cultures were grown for 48 h at 30°C and 250 rpm on a rotary shaker, and were 
then harvested following previously published methods (Tappel et al. 2012b). 
A more robust test of PHA homopolymer production was performed between LSBJ and 
RSC02 using the methods described above, with two key differences. A variety of fatty acids were 
tested in the growth media: sodium butyrate, pentanoic, hexanoic, heptanoic, sodium octanoate, 
decanoic, and dodecanoic. In addition, sodium phosphate dodecahydrate was added to the growth 
media for these experiments, which acts as a buffer for the shorter chain fatty acids. This addition 
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also provides a significant source of phosphate to the media, so to keep growth conditions 
consistent, sodium phosphate dodecahydrate was added to every other experiment in this study. 
2.3.4 GC analysis 
The yields and repeating unit compositions of PHA polymers were determined using GC, 
as previously described (Braunegg et al. 1978; Tappel et al. 2012b). Briefly, dried cells (15-20 mg) 
were dissolved in 2 mL of sulfuric acid: methanol solution (15:85) and 2 mL of chloroform and 
heated at 100°C for 140 min in a 10 mL pressure vial (Kimax). The samples were cooled to room 
temperature followed by the addition of 1 mL of Nanopure filtered water, after which all samples 
were mixed by vortex. Aqueous and organic layers were allowed to separate for 20 min. The 
organic layer was passed through a 0.45 μm polytetrafluoroethylene (PTFE) syringe filter (Restek). 
An aliquot of 500 μL of each filtered sample was mixed with 500 μL of methyl octanoate standard 
(1 gL-1) in chloroform in a 2 mL GC vial. Samples were injected and separated using a GC 2010 
Gas Chromatograph with an AOC-20i autoinjector with a flame ionization detector. Shimadzu’s 
GCSolution software was used to analyze the data, and statistical significance of triplicate samples 
was determined using a two-tailed Student’s t-test with a 95% confidence interval (α = 0.05). 
2.3.5 Polymer purification and molecular weight determination 
 PHA homopolymers were extracted from residual dried cell samples from the LSBJ and 
RSC02 biosynthesis experiments by combining each set of triplicate samples into single 10 mL 
pressure vials (Kimax), adding 6 mL of chloroform, and incubating at 100 °C for 1 h. Each sample 
was filtered through a 0.45 μm PTFE syringe filter (Restek) into a 20-mL scintillation vial and 
rinsed twice with 2 mL aliquots of chloroform. Samples were concentrated to relative dryness 
using a rotary evaporator, and redissolved in 1 mL chloroform. Crude polymers were purified by 
non-solvent precipitation in cold methanol as described previously (Pinto et al. 2016), with several 
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modifications. Briefly, dissolved samples were added dropwise to 10 mL of ice-cold methanol 
(4°C) with rapid stirring. The solution was centrifuged (3,452 x g, 30 min, 4°C) to pellet the PHA, 
decanted and washed with an additional 5 mL of methanol, and re-centrifuged. The supernatant 
was decanted, and the pellet dissolved in approximately 2 mL of chloroform to transfer to a 
scintillation vial. Samples were concentrated in a rotary evaporator and evaporated to dryness 
under high vacuum for 4 h. 
The weight average (Mw) and number average (Mn) molecular weights for each sample 
were determined by gel permeation chromatography (GPC) as described previously (Pinto et al. 
2016). Briefly, PHA solutions of approximately 1.0 g L-1 were prepared by dissolution in 
chloroform and passed through a syringe filter (0.45 μm PTFE). Samples were injected (50 μL) 
into a Shimadzu LC-20AD liquid chromatograph equipped with a Shimadzu SIL-20A 
autosampler, a Shimadzu CTO-20A column oven, and a Shimadzu RID-10A refractive index 
detector. Samples were passed through an 8 x 50 mm styrenedivinylbenzene (SDV) guard column 
(5 μm particles; Polymer Standards Service) and an 8 x 300 mm SDV analytical column (5 μm 
particles; mixed bed porosity; max molecular weight 1E6 Da; Polymer Standards Service product 
sda0830051lim). The column oven was maintained at 40°C with a 1 mL min-1 mobile phase of 
chloroform. Molecular weight standards of polystyrene with a narrow polydispersity index were 
used for calibration. Shimadzu’s LCsolution software was used to analyze the data. GPC 
chromatograms are available as supplemental material (Appendix C). 
2.3.6 Growth profiles of LSBJ and RSC02 
 An analysis of the growth profiles for LSBJ and RSC02 was performed under the PHA 
homopolymer biosynthesis conditions utilizing two separate substrates, sodium butyrate and 
decanoic acid. Media and growth conditions were identical to those in the PHA Production section. 
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A 1 mL aliquot was removed from each culture to measure the OD600 every hour using a 
spectrophotometer (Genesys 10S) until the stationary phase was observed. A 5 mL aliquot was 
removed from each culture at both 24 and 48 h to analyze PHA concentrations. The 5 mL samples 
were harvested and analyzed by GC as described above. 
2.3.7 RNA extraction and qPCR analysis 
 RNA from E. coli LSBJ and RSC02 was isolated and purified as described previously 
(Lundgren et al. 2013; Sarwar et al. 2016). To isolate RNA for real-time quantitative PCR (qPCR), 
each strain was grown in duplicate in 100 ml of growth media (as described above, with sodium 
phosphate dodecahydrate and decanoic acid) in 500-ml baffled shake flasks at 30°C and 250 rpm 
to an OD600 of ~0.6. Cultures were immediately stabilized by adding 1 ml of RNAprotect Bacteria 
reagent (Qiagen) to 0.5 ml of culture. Cells were then lysed with lysozyme and proteinase K as 
described in the manufacturer’s protocol. The total RNA was subsequently purified from the lysed 
cells with the RNeasy minikit (Qiagen) by using an on-column DNase digestion step. PCR and a 
Bioanalyzer were used to check the RNA for DNA contamination, quality, and concentration. 
 The iScript cDNA synthesis kit (Bio-Rad) was used to generate cDNA from 1 μg of the 
purified RNA samples. A 10-fold dilution series of the pooled cDNA from the two duplicate RNA 
samples from LSBJ or RSC02 was used for the qPCR experiments. The qPCR experiments were 
performed in triplicate. The expression of several important genes for β-oxidation was normalized 
to rpoD, a housekeeping gene with stable expression during exponential growth (Jishage et al. 
1996).  Primers for qPCR were designed to produce ~100 bp amplicons of each of the following 
genes: atoA, atoD, atoE, fadD, fadE, fadL, and rpoD (Table 2.2). The qPCR mixtures contained 
300 mM each primer, 10 μl of the 2× iQ SYBR green Supermix (Bio-Rad), 5 μl of diluted cDNA, 
and nuclease-free water to a total volume of 20 μl. qPCR was performed on the MiniOpticon 
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system (Bio-Rad) with the following conditions: 1 cycle of 95°C for 2 min and 40 cycles of 95°C 
for 15 s, 55°C for 30 s, and 72°C for 30 s. Window-of-linearity R2 values and amplification 
efficiency values ranged from 0.990 to 1.0 and 90.0% to >100%, respectively. The dilution series 
with the highest R2 values was used to calculate relative gene expression of RSC02 compared to 
LSBJ using the Pfaffl method (Fleige et al. 2006). Amplification efficiencies and threshold cycle 
(Cq) values were calculated using the program LinRegPCR (Ruijter et al. 2009). 
2.4 Results 
2.4.1 PHA homopolymer production 
Our goal was to develop a strain capable of producing PHA polymers with controlled 
repeating unit compositions and increased yields. To achieve this, the mutant strains RSC02, 
RSC04, and RSC06 were derived from E. coli LSBJ by the deletion of arcA, ompR, and a tandem 
arcA/ompR deletion, respectively. The amount of poly(3-hydroxydecanoate) (PHD) produced by 
these strains was then compared to E. coli LSBJ while expressing PhaJ4 and PhaC1(STQK) in a 
set of preliminary experiments. RSC02 produced significantly more PHD than other strains, with 
a yield of 0.353 g L-1 (Fig. 2.2). Strains RSC04 and RSC06 were not found to be significantly 













Figure 2.2: Comparison of poly(3-hydroxydecanoate) (PHD) yield between LSBJ and mutant 
strains RSC02 (ΔarcA), RSC04 (ΔompR), and RSC06 (ΔarcA, ΔompR). The average yield 
achieved by RSC02 is significantly greater than that of LSBJ, while RSC04 and RSC06 are not 
significantly different from LSBJ. All values are averages of triplicate experiments plus or minus 
the standard deviation around those averages. An asterisk denotes a statistically significant 
difference compared to LSBJ (Student’s t-test, two-tailed, α = 0.05). 
 
To further investigate the effect of the ΔarcA mutation on PHA polymer production, PHA 
homopolymer biosynthesis was characterized utilizing a variety of fatty acids. The fatty acids used 
for the production of PHA homopolymers were sodium butyrate, valeric acid, hexanoic acid, 
heptanoic acid, sodium octanoate, decanoic acid, and dodecanoic acid respectively. Analysis by 




































compared to E. coli LSBJ for nearly all fatty acid substrates, particularly for those with six or fewer 
carbons (Table 2.3). Overall the parental strain, LSBJ, produced very little short chain-length 
PHAs, with yields of only 3.04 mg L-1 of poly(3-hydroxybutyrate) (PHB) and 1.92 mg L-1 of 
poly(3-hydroxyvalerate) (PHV), and only 44.8 mg L-1 of poly(3-hydroxyhexanoate) (PHHx), the 
shortest medium chain-length polymer (Table 2.3). We observed significant increases in the 
amount of PHA synthesized by RSC02 of approximately 3750%, 6360%, and 485% when cells 
utilized sodium butyrate, pentanoic acid, or hexanoic acid as substrates, respectively (Table 2.3). 
For these shorter chain-length PHA polymers the identity was confirmed by 1H-NMR due to the 
large differences in production between strains (Fig. A1, Appendix A). Of those PHA polymers 
tested with greater than 6 carbons per repeating unit, only poly(3-hydroxyheptanoate) (PHHp) and 
PHD yields were significantly different between strains, with an increase of approximately 61 and 
115 percent observed for RSC02, respectively (Table 2.3). 
Table 2.3: PHA yield comparison between LSBJ and RSC02. 





Sodium butyrate LSBJ 0.80 ± 0.03 0.38 ± 0.05 3.04 ± 0.27 3750 
 RSC02 0.85 ± 0.03 13.7 ± 0.95 117 ± 11.1 *  
      Pentanoic acid LSBJ 0.76 ± 0.05 0.23 ± 0.02 1.92 ± 0.42 6360 
 RSC02 1.14 ± 0.04* 11.1 ± 1.01 124 ± 7.25 *  
      Hexanoic acid LSBJ 0.85 ± 0.01 5.47 ± 0.97 44.8 ± 6.13 485 
 RSC02 1.06 ± 0.01* 27.3 ± 4.28 262 ± 59.0 *  
      Heptanoic acid LSBJ 0.93 ± 0.01 23.4 ± 0.48 198 ± 4.27 61 
 RSC02 1.02 ± 0.06 30.2 ± 2.28 319 ± 22.8 *  
      Sodium octanoate LSBJ 1.22 ± 0.05 44.5 ± 8.68 543 ± 110 1.10 
 RSC02 1.03 ± 0.01* 54.1 ± 1.06 549 ± 12.5  
      Decanoic acid LSBJ 1.23 ± 0.05 29.3 ± 2.15 281 ± 152 115 
 RSC02 1.49 ± 0.02* 40.4 ± 1.30 603 ± 26.4 *  
      Dodecanoic acid LSBJ 1.31 ± 0.17 23.5 ± 5.42 303 ± 38.4 7.26 
  RSC02 1.11 ± 0.03* 29.3 ± 5.21 325 ± 64.0  
a All values are averages of biological triplicate experiments plus or minus the standard deviation 
about those averages. 
b Percent increase calculated as the increase in PHA concentration from RSC02 compared to LSBJ. 
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* Denotes statistically significant difference compared to LSBJ (Student’s t-test, two-tailed, α = 
0.05). 
 
2.4.2 Molecular weight comparison 
 To compare differences in physical properties of the polymers synthesized by E. coli LSBJ 
and RSC02, samples were analyzed by gel permeation chromatography (GPC) to determine the 
number average molecular weight (Mn), the weight average molecular weight (Mw), and the 
polydispersity (Mw/Mn) (Table 2.4). The polymers extracted from RSC02 had greater molecular 
weights than those from LSBJ for every polymer except poly(3-hydroxydodecanoate) (PHDD), 
which had a Mn of approximately 60 kDa and a Mw of approximately 172 kDa for both strains 
(Table 2.4). In addition, the polymers extracted from RSC02 had a greater degree of 
polydispersity, again with the exception of PHDD (Table 2.4). 
Table 2.4: PHA molecular weight data. 
PHAa Strain Mw (kDa) Mn (kDa) Mw/Mn 
PHB LSBJ ND ND ND 
 RSC02 390 117 3.3 
     PHV LSBJ 18 16 1.2 
 RSC02 243 79 3.1 
     PHHx LSBJ 134 77 1.7 
 RSC02 408 171 2.4 
      PHHp LSBJ 219 106 2.1 
  RSC02 319 134 2.4 
     PHO LSBJ 157 73 2.1 
 RSC02 285 99 2.9 
     PHD LSBJ 145 50 2.9 
 RSC02 234 67 3.5 
     PHDD LSBJ 173 58 3.0 
  RSC02 172 60 2.9 
a PHB, poly(3-hydroxybutyrate); PHV, poly(3-hydroxyvalerate); PHHx, poly(3-
hydroxyhexanoate); PHHp, poly(3-hydroxyheptanoate); PHO, poly(3-hydroxyoctanoate); PHD, 




2.4.3 Growth profile of LSBJ and RSC02 
 We visually observed that RSC02 cultures appeared less optically dense than those of LSBJ 
during the first day of growth, which would be indicative of an increased lag time for this strain. 
To quantify this observation, we investigated the growth profiles of LSBJ and RSC02 under PHA 
biosynthesis conditions supplemented with either sodium butyrate or decanoic acid. There was 
both an increase in lag time and a decrease in the growth rate of RSC02 relative to LSBJ for both 
substrates (Fig. 2.3). Regardless of strain, when the fatty acid substrate was sodium butyrate the 
lag phase was 1 – 2 h shorter and the stationary phase was reached more rapidly (Fig. 2.3). Despite 
the increased lag phase duration and slightly slower growth rate, RSC02 reached the same culture 
density as LSBJ when supplemented with sodium butyrate (OD600 ~3.5, 15 h), and reached a higher 






Figure 2.3: Growth profile of E. coli LSBJ and RSC02 during PHA-biosynthesis utilizing sodium 
butyrate (C4) or decanoic acid (C10). For both substrates, RSC02 displayed an extended lag time 
and slightly slower growth rate relative to LSBJ; however, RSC02 cultures reached approximately 
the same density as LSBJ upon reaching the stationary phase. For both strains, growth with sodium 
butyrate as the substrate caused a shorter lag phase than with decanoic acid substrate. All values 
are the averages of triplicate experiments plus or minus the standard deviation around those 
averages. 
 
2.4.4 PHA yield at 24 vs 48 hours 
 To determine whether the increased lag phase in RSC02 had a negative effect on PHA 
yield earlier in the production cycle, small subsamples were removed from both LSBJ and RSC02 
shake flasks after 24h and 48h during the growth profile experiments. Similar to the data shown in 
Table 2.3, LSBJ produced very little PHB at either 24 or 48 hours, and there was very little change 
between the two time points (Fig. 2.4). However, LSBJ yields of PHD increased from 22.6% to 
31.7% of cell dry weight, an increase of approximately 40% (Fig. 2.4). RSC02 produced 


















increased from 8.2% to 12.3% from 24 to 48 h, while PHD yield increased by ~20% between time 
points from 37.2% to 45.0% (Fig. 2.4). 
 
Figure 2.4: Comparison of PHA yield as a percentage of dry weight between LSBJ and RSC02 at 
24 h and 48 h, utilizing either sodium butyrate (C4) or decanoic acid (C10). LSBJ saw insignificant 
changes in PHB production between 24 and 48 h, while RSC02 increased slightly from 8.2% to 
12.3% of cell dry weight. PHD yield from LSBJ increased from 22.6% to 31.7% between 24 and 
48 h, an increase of ~40%, while PHD yield from RSC02 increased from 37.2% to 45.0%, an 
increase of ~20%. Regardless of the time, RSC02 produced more polymer than LSBJ in all cases. 
All values are the averages of triplicate experiments plus or minus the standard deviation about 
those averages. 
 
2.4.5 Relative gene expression of RSC02 
 To analyze the relative expression of fatty acid degradation genes, RNA was isolated from 
mid-exponential phase cultures of LSBJ and RSC02 and reverse transcribed into cDNA for qPCR. 
An appropriate OD600 value (~ 0.6) for mid-exponential phase was determined using the previously 
defined growth profile (Fig. 2.3). All the genes analyzed were upregulated to some degree in 
RSC02; SCL fatty acid uptake genes atoA, atoE and atoD were all upregulated to an extremely 



































10-, and 31-fold) (Fig. 2.5). It is important to note that the expression values reported for the ato 
system may be exaggerated due to the low number of transcripts observed for LSBJ (as observed 
by a late-cycle emergence of the fluorescence during qPCR analysis).  
 
Figure 2.5: Relative gene expression of RSC02 compared to LSBJ, normalized to rpoD and 
measured as fold changes. The expression of genes related to fatty acid degradation was 
significantly increased in the RSC02 strain during mid-exponential growth phase (OD600 of ~ 0.6). 
The SCL fatty acid degradation genes atoA, atoE, and atoD were massively upregulated by 103-
fold, 119-fold, and 303-fold respectively. MCL fatty acid degradation genes fadD, fadL, and fadE 
were upregulated by 2-fold, 10-fold, and 31-fold respectively. Relative gene expression was 
calculated from qPCR fluorescence data using the LineRegPCR software (Ruijter et al. 2009) to 
calculate amplification efficiency and Cq values, and the Pfaffl method used to derive relative 
expression values with LSBJ as the calibrator (Fleige et al. 2006). All values are the averages of 
triplicate experiments plus or minus the standard deviation about those averages. 
 
2.5 Discussion 
The purpose of developing the mutant strains RSC02, RSC04, and RSC06 was to improve 
PHA biosynthesis by removing regulatory genes known to interact with components of the PHA 
biosynthesis pathway. Based on the evidence seen in Fig. 2.2, the singular deletion of arcA 




























reasonable explanation for this observation is that ArcA becomes active in E. coli LSBJ during the 
growth conditions utilized for polymer production and inhibits the transcription of fadL, fadD, and 
fadE, which are known targets of ArcA regulation (Table 2.1). In an arcA deletion mutant this 
inhibition cannot occur, likely resulting in higher basal transcription of these fad genes. The 
deletion of ompR and the double deletion of ompR/arcA provided no benefit to PHD biosynthesis, 
and no statistically significant differences were observed between these mutants and LSBJ (Fig. 
2.2). One possibility for this apparent lack of effect is that OmpR regulatory target FadL is not 
active towards decanoic acid, which has been demonstrated previously (Black 1990). However, 
the similarity between the RSC06 double deletion mutant and the RSC04 mutant suggests another 
possibility; the loss of regulation by OmpR may yield a mildly toxic phenotype that inhibits cell 
growth and metabolism. This possibility is supported by both the observation that both RSC04 and 
RSC06 had significantly lower cell dry weights than either LSBJ and RSC02 (Table F1, Appendix 
F), and by previous reporting from Oshima et al. that showed a marked growth deficiency in E. 
coli ΔompR mutants (2002). These findings provided motivation for further characterization of the 
RSC02 mutant. 
 A variety of fatty acid substrates were used to characterize the differences in PHA 
homopolymer production between RSC02 and LSBJ. In nearly all cases, the deletion of arcA 
resulted in a significantly higher polymer yield (Table 2.3). Most surprisingly, the largest increases 
in polymer yield observed between RSC02 and LSBJ were for the two SCL polymers, PHB and 
PHV, as well as the shortest MCL polymer, PHHx (Table 2.3). This result is interesting 
considering that there are fewer steps involved in SCL fatty acid metabolism that are regulated by 
ArcA. Short chain fatty acids enter the β-oxidation cycle via enzymes derived from the ato operon, 
bypassing both FadL and FadD (Fig. 2.1). This operon has no known interaction with ArcA and 
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is instead regulated by the response regulator AtoC, which is present in both LSBJ and RSC02 as 
a constitutively expressed mutant that confers a high level of atoDAEB transcription (Spratt et al. 
1981; Jenkins and Nunn 1987; Kyriakidis and Tiligada 2009). One possible explanation for this 
drastic difference in SCL PHA production is that secondary metabolite pools are different between 
the two strains; polyamines for example have been shown to have significant effects on the 
regulation of AtoC (Kyriakidis and Tiligada 2009), and previous studies have shown that aspects 
of polyamine metabolism are affected by the deletion of arcA (Partridge et al. 2006).  
 The differences in MCL PHA production between LSBJ and RSC02 are more varied than 
those observed for SCL polymers. No significant difference was found between strains when 
comparing the yields of poly(3-hydroxyoctanoate) (PHO) and PHDD; however, the yields of 
poly(3-hydroxyheptanoate) (PHHp) and PHD were significantly increased in RSC02 (Table 2.3). 
The most reasonable explanation for this is that there are numerous differences in the substrate 
specificities of the enzymes involved in the PHA biosynthesis pathway. The long chain fatty acid 
transporter FadL is predominantly active on fatty acids containing 16 or more carbons, and no 
binding has been observed for decanoic acid, therefore it is unlikely that changes in fadL 
expression would account for the differences we observed (Black 1990). In contrast, the acyl-CoA 
synthetase FadD has high activity towards 12 and 10 carbon fatty acids and only low activity for 
8 and 6 carbon fatty acids (Iram and Cronan 2006; Ford and Way 2015), while the recombinant 
enzymes PhaJ4 and PhaC1(STQK) each have their own well-documented substrate specificities 
that could contribute to the observed variation without any direct regulation by ArcA (Tsuge et al. 
2003; Matsumoto et al. 2005; Sato et al. 2011). However, a complete understanding of fatty acid 
flux through this PHA biosynthesis pathway cannot be achieved with the current lack of 
information regarding the enzymatic activity of the acyl-CoA dehydrogenase FadE. 
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 The molecular weight data showed a great degree of variability between PHAs, as well as 
between LSBJ and RSC02, with polydispersity values (Mw/Mn) from 1.2 to 3.3 (Table 2.4). The 
molecular weight of polymers produced by RSC02 were higher for all PHA polymers produced 
except for PHDD, and in general the polydispersity indices were higher for RSC02-derived 
polymers as well. Both the PHO and PHD molecular-number-average-molecular weights (Mn) 
were substantially lower for LSBJ than in previous studies, while the molecular weight and 
polydispersity for PHDD was found to be significantly higher than previously reported (Liu et al. 
2011; Tappel et al. 2012b). A reliable comparison of the molecular weights observed in this study 
to other studies is difficult due to the variety of growth conditions and pathways employed. 
However, a possible explanation for the differences observed between LSBJ and RSC02 is that 
increased basal expression of β-oxidation genes improves the supply of 3-hydroxy fatty acyl-CoA 
monomers to the PhaC1 (STQK) polymer synthase. The evidence summarized in Table 2.4 
suggests that the molecular machinery in E. coli plays some role in determining the molecular 
weight of the polymers produced. 
 A comparison between the polymer yield data in Table 2.3 and the molecular weight data 
in Table 2.4 appears to support this explanation. The PHA homopolymers with the greatest 
increases in yield (PHB, PHV, and PHHx) similarly showed the greatest increases in molecular 
weight (with the partial exception of PHB, which was not extracted in a great enough quantity to 
detect by GPC). The PHHp and PHD obtained from RSC02, which also saw moderate 
improvement in terms of yield, was observed to have a higher molecular weight than that obtained 
from LSBJ, although to a lesser extent than the shorter chain length PHA homopolymers. 
Interestingly, PHO produced by RSC02 had a higher molecular weight despite there being no 
significant difference in yield, while PHDD was not significantly different in either of those 
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measurements. While it appears that improving the utilization of fatty acids also improves PHA 
molecular weight using this biosynthetic platform, these minor discrepancies with regards to PHO 
reveal that this relationship is more complex than that. 
Another possible explanation for this increase in molecular weights could be that less 
ethanol is produced by RSC02 than LSBJ. It is typical for bacterial cultures grown into stationary 
phase in shake flasks to reach some level of microaerobiosis, leading to the production of 
fermentative byproducts such as ethanol (Gupta and Rao 2003; Losen et al. 2004). It was 
previously reported that the supplementation of ethanol in cultures of recombinant E. coli led to a 
decrease in the molecular weight of PHB due to a chain transfer reaction from PhaC to ethanol 
(Hiroe et al. 2013). In E. coli, the reversible enzyme AdhE is largely responsible for ethanol flux 
within the cell, allowing for both the biosynthesis and degradation of ethanol (Membrillo-
Hernandez et al. 2000). It has been previously shown that an ΔarcA mutant has an improved 
ethanol tolerance compared to wild type, and it has been hypothesized that this tolerance is derived 
from increased expression of adhE along with enzymes involved in the tricarboxylic acid cycle 
(TCA), which could drive the breakdown of ethanol to acetyl-CoA (Goodarzi et al. 2010). There 
is also evidence in the literature showing that adhE expression is significantly higher in an E. coli 
ΔarcA mutant than in wild type under a range of microaerobic conditions (Shalel-Levanon et al. 
2005). It is therefore possible that endogenously produced ethanol is reducing PHA molecular 
weights via chain termination in LSBJ, and that this effect could be mitigated by an improved flux 
of ethanol back to acetyl-CoA. However, further investigation of this possibility is required as 
there is currently no direct evidence to support this explanation.  
 We investigated our observation that RSC02 had slower growth than LSBJ by recording 
hourly culture densities, and found that while RSC02 had a significantly longer lag phase, the 
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growth rate was nearly identical to LSBJ, with cultures reaching similar final cell densities 
regardless of which fatty acid substrate was provided (Fig. 2.3). These observations match the 
evidence found in the Keio collection of single-gene knockouts, which showed that arcA is 
nonessential, an ΔarcA mutant grows only slightly slower than wild type, and reaches only 
marginally lower culture densities (Baba et al. 2006). Despite the slightly slower growth observed 
with RSC02, the strain is capable of producing significantly more polymer than LSBJ even after 
only 24 hours of growth (Fig. 2.4). This offers an advantage when using this strain for a large-
scale continuous fermentation, and shows that the lengthened lag phase does not significantly 
impede PHA biosynthesis. 
 Our analysis of the qPCR results shows a clear increase in the expression of each of the 
fatty acid degradation genes tested (Fig. 2.5). Although the improvements to fadD, fadL, and fadE 
were expected and support our hypothesis, the magnitude of the increase in the three ato genes 
came as a surprise. As we mentioned previously, ArcA is not known to directly regulate expression 
of the ato system, and both LSBJ and RSC02 harbor a constitutively expressed mutant atoC gene 
(Spratt et al. 1981; Jenkins and Nunn 1987; Kyriakidis and Tiligada 2009). Comparing the drastic 
differences seen in SCL PHA yields between LSBJ and RSC02 provides strong evidence to 
suggest that the similarly drastic increases in gene expression are responsible for these effects 
(Table 2.3).  These results support the idea that the ΔarcA mutation indirectly effects the 
expression of the ato system, possibly mediated by an altered polyamine metabolism. 
 The differences between the relative expression of fadD, fadL and fadE also raise some 
interesting observations. For example, fadD was only modestly up-regulated (2-fold) and its 
protein product has a high activity towards both 10 and 12 carbon fatty acid substrates; however, 
while PHD biosynthesis was significantly improved PHDD biosynthesis was not (Table 2.3, Fig. 
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2.5). Similarly, fadL expression was significantly increased in RSC02 (10-fold) which does have 
limited binding affinity for 12 carbon fatty acids (Black 1990), and yet this does not appear to 
improve PHDD biosynthesis either. These results suggest that the binding affinity of FadE may be 
an important limiting factor in PHA biosynthesis using this system, considering that fadE was the 
most highly up-regulated of these three genes (31-fold) and yet only the yields of PHHx, PHHp, 
and PHD were significantly improved (Table 2.3, Fig. 2.5). While the binding affinity of FadE is 
not well-known, our results suggest that it may have low binding affinity towards octanoyl-CoA 
and dodecanoyl-CoA, although further investigation is needed to test that hypothesis. 
One of the largest challenges still facing the PHA industry is the relatively low yield of 
polymer obtained, which contributes to the overall cost (Kaur 2015). The strain E. coli RSC02 that 
was developed in this study offers a significant improvement to the previously reported strain, E. 
coli LSBJ. The most significant improvements were seen in the biosynthesis of PHB, PHV, and 
PHHx, with modest increases observed in PHHp and PHD. These results are supported by the 
increased expression of atoA, atoD, and atoE which correlates with improved PHB and PHV 
biosynthesis, and also the increased expression of fadD, fadL, and fadE which may contribute to 
the increased biosynthesis of PHHx, PHHp, and PHD. 
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Chapter 3: Increased production of the value-added biopolymers poly(R-3-
hydroxyalkanoate) and poly(γ-glutamic acid) from hydrolyzed paper recycling waste fines 
The work presented here was published in Frontiers in Bioengineering and Biotechnology (2019). 
Please see Appendix G for publication cover. 
3.1 Abstract 
Reject fines, a waste stream of short lignocellulosic fibers produced from paper linerboard 
recycling, are a cellulose-rich paper mill byproduct that can be hydrolyzed enzymatically into 
fermentable sugars. In this study, the use of hydrolyzed reject fines as a carbon source for bacterial 
biosynthesis of poly(R-3-hydroxyalkanoate) (PHA) and poly(γ-glutamic acid) (PGA) was 
investigated. Recombinant Escherichia coli harboring PHA biosynthesis genes were cultivated 
with purified sugars or crude hydrolysate to produce both poly(R-3-hydroxybutyrate) (PHB) 
homopolymer and medium chain length-containing copolymer (PHB-co-MCL). Wild-type 
Bacillus licheniformis WX-02 were cultivated with crude hydrolysate to produce PGA. Both PHB 
and short chain-length-co-medium chain-length (SCL-co-MCL) PHA yields from crude 
hydrolysate were a 2-fold improvement over purified sugars, and the MCL monomer fraction was 
decreased slightly in copolymers produced from crude hydrolysate. PGA yield from crude 
hydrolysate was similarly increased 2-fold. The results suggest that sugars from hydrolyzed reject 
fines are a viable carbon source for PHA and PGA biosynthesis. The use of crude hydrolysate is 
not only possible but beneficial for biopolymer production, eliminating the need for costly 
separation and purification techniques. This study demonstrates the potential to divert a 
lignocellulosic waste stream into valuable biomaterials, mitigating the environmental impacts of 




Paper waste fines are cellulose fibers that have become too short for incorporation into 
paper products due to repeated recycling and must therefore be rejected from this process. These 
rejected waste fines make up a significant proportion of the waste stream from paper mills, which 
is becoming increasingly difficult to landfill due to transportation costs and legislation (Laurijssen 
et al., 2010; Villanueva and Wenzel, 2007). Since reject fines are predominantly composed of 
cellulose  they can be readily hydrolyzed into monomeric sugars   making  them an attractive waste 
stream for the production of value-added products, including biofuels, platform chemicals, and 
biopolymers such as polyhydroxyalkanoates (Bhuwal et al., 2014; Galbe and Zacchi, 2002; Min 
et al., 2015; Wang et al., 2013; Zhang, 2008). Waste fines from the recycling of old corrugated 
cartons (OCC) are particularly valuable as a source of fermentable sugars, as they are typically 
high in cellulose and low in lignin and other inhibitory chemicals and minerals compared with 
deinked paper pulp from other waste streams (Min et al., 2015; Saini et al., 2020). 
Polyhydroxyalkanoates (PHAs) are a diverse class of bacterially produced polyesters 
known for their biodegradability and biocompatibility, which occur naturally as a form of carbon 
storage (Lee, 1996; Lu et al., 2009). The physical characteristics of PHAs are dependent on both 
monomeric composition and molecular weight, and they range from stiff and brittle crystalline 
materials to flexible and elastomeric amorphous polymers (Laycock et al., 2013). Poly(R-3-
hydroxybutyrate) (PHB) is the most abundant PHA from both natural and anthropogenic sources; 
however, this material is of limited use due to its high brittleness. The copolymerization of 3HB 
with other monomers, particularly those of medium chain-length (6-14 carbons), can improve 
toughness and elasticity for a more versatile material (Noda et al., 2005). The large-scale 
production and utilization of PHAs is mainly limited by the production cost, a large portion of 
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which stems from the cost of the feedstock and which is high relative to the production costs for 
petroleum-based plastics with similar properties. One way to address these costs is to examine 
alternative inexpensive feedstocks, which has sparked interest in lignocellulosic waste streams as 
a cheap carbon source. 
Poly(γ-glutamic acid) (PGA) is another biopolymer that has generated interest as a 
renewable material for a number of applications. PGA is biosynthesized naturally by a variety of 
Bacillus species, and is an edible, water-soluble, biodegradable, and anionic biopolymer (Bajaj 
and Singhal, 2011; Ogunleye et al., 2015).  These properties make PGA suited for a variety of 
applications, including metal-ion binding and flocculation for wastewater treatment, composite 
materials for tissue engineering and drug delivery, and as a medicinal metal chelator for heavy 
metal removal (Inbaraj and Chen, 2012; Shih et al., 2001; Siao et al., 2009; Ye et al., 2006; Yokoi 
et al., 1996). Current research into improving PGA production for human use is focused on the 
metabolic engineering of various Bacillus species; notably, wild-type B. licheniformis WX-02 is 
capable of producing large amounts of PGA from glucose and glutamate and has been successfully 
engineered for enhanced biosynthesis (Cai et al., 2018, 2017).  
The work presented in this study demonstrates the successful biosynthesis of both PHA 
and PGA biopolymers from crude hydrolyzed paper waste fines. 
3.3 Methods 
3.3.1 Hydrolysate from waste fines 
A recycled liner board mill provided waste fines from the screw-press sludge. The analysis 
of the waste fines is provided in Min et al., 2018.  The enzymatic hydrolysis procedure was 
conducted as described by Min and Ramarao (2017). Enzymatic hydrolysis was conducted at 50° 
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C and with commercially available CTec2 enzymes (Novozymes USA) at a substrate consistency 
of 5%. All other details are described by Min et al., (2018) and Min and Ramarao (2017). 
3.3.2 Media and cultivation 
A complete list of strains and plasmids is shown in Table 3.1. All E. coli strains were 
grown on LB-Lennox (LB; composition per liter: 10 g tryptone, 5 g yeast extract, and 5 g sodium 
chloride, pH 7.0) purchased from Difco, with 15 g L-1 agar when needed. Glucose (Acros 
Organics) and xylose (Sigma Aldrich) were supplemented as carbon sources when noted, as well 
as purified or crude linerboard waste fines hydrolysate (Min et al., 2015). Bacillus licheniformis 
WX-02 were maintained using nutrient broth no. 2 (Oxoid) media. For PGA biosynthesis, B. 
licheniformis WX-02 was cultivated in the following PGA biosynthesis media (composition per 
liter): 90 g glucose (or 10% crude hydrolysate, v/v), 40 g sodium glutamate, 10 g sodium citrate 
trihydrate, 10 g sodium nitrate, 8 g ammonium chloride, 1 g potassium phosphate trihydrate, 1 g 
magnesium sulfate heptahydrate, 1 g zinc sulfate heptahydrate, 1 g calcium chloride, 0.15 g 
manganese sulfate monohydrate, pH 7.3 ± 0.1. E. coli strains were made chemically competent 
and transformed by heat shock following standard procedures (Sambrook and Russell, 2001), and 
selection was performed on LB agar (15 g L-) plates. The antibiotics kanamycin (50 mg L-1) and 
ampicillin (100 mg L-1) were added to media for selection and plasmid retention as appropriate. 
All liquid media cultures were cultivated using a rotary shaking incubator (New Brunswick 
Scientific). 
Table 3.1: Bacterial strains and plasmids. 
Strains/Plasmids Relevant Characteristics Reference 
BW25113 E. coli, Δ(araBAD)567, ΔlacZ4787(::rrnB3), λ-, rph-1, Δ(rhaBAD)568, 
hsdR514 
Lessard et al. 1998, 
Datsenko and Wanner 2000 
LSBJ E. coli LS5218, ΔfadB, ΔfadJ, atoC512 (Const), fadR601 Tappel et al. 2012 
B. licheniformis Bacillus licheniformis WX-02, saline soil isolate. Wei et al. 2010 
   
pBBRSTQKAB pBBR1MCS-2 derivative (lac promoter); phaC1(STQK), phaA, phaB Nomura et al. 2004 




PHA biosynthesis methods were adapted from previous studies (Wang et al., 2012; Tappel 
et al., 2014). Individual colonies of transformed bacteria harboring PHA biosynthesis genes 
(pBBRSTQKAB or pBBRSTQKAB / pTrcGK) were used to inoculate separate 2 mL LB seed 
cultures, in triplicate for each strain. Seed cultures were grown for 16 h at 37 °C and 200 rpm and 
used to inoculate 100 mL of LB media in 500-mL baffled shake flasks (final concentration of 
0.5%). Shake flasks were cultivated at 30 °C and 250 rpm rotary shaking for a total of 48 hrs. After 
reaching an OD600 of 1.0, cultures were induced with isopropyl-β-D-thiogalactoside (IPTG) at a 
final concentration of 1 mM. Carbon supplements (glucose, xylose, or pure hydrolysate at 20 g L-
1; or crude hydrolysate at 8% v/v) were added 3 hours post-IPTG induction. Cells were collected 
by centrifugation at 3716 × g for 15 minutes, washed once with 45 mL of 35% ethanol and once 
with 45 mL of water, and dried via lyophilization. 
PGA biosynthesis methods were adapted from a previous study (Cai et al., 2018). 
Individual colonies were used to inoculate separate 2 mL LB seed cultures, in triplicate, and 
incubated for 12 hours at 37 °C and 200 rpm. Seed cultures were used to inoculate 100 mL of PGA 
biosynthesis media in 500-mL baffled shake flasks (final concentration of 0.5%). Shake flasks 
were cultivated at 37 °C and 200 rpm for a total of 36 hours. To collect PGA, the pH of 10 mL of 
culture was adjusted to 2.0 using HCl (conc.) and centrifuged at 8000 × g for 10 minutes. The 
supernatant was collected and neutralized with NaOH (10M), then precipitated with 30 mL of 
100% ethanol and mixed by vortex. The precipitate was collected by centrifugation at 8000 × g 
for 10 minutes, then dried via lyophilization to obtain a dry weight. 
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3.3.3 Analytical procedures  
The sugar content of the crude hydrolysate was determined using 1H-NMR (Kiemle et al., 
2003). A calibration curve was generated from the integration of α anomeric proton peaks of pure 
glucose and xylose at known concentrations relative to glucosamine added as an internal standard 
(5 g L-1). Crude hydrolysate was diluted 10-fold, doped with the glucosamine standard, and the 
sugar concentrations calculated from the calibration curve. Inductively coupled plasma optical 
emission spectroscopy (ICP-OES) was used to analyze abundance of metal ions (Optima 5300 
DV). Hydrolysate was diluted 10-fold and introduced to the ICP-OES instrument at a flow rate of 
1.5 mL min-1. Al, As, Ba, Cd, Co, Cu, Cr, Fe, Mo, P, Pb, S, and Zn were analyzed with an axial 
plasma view, while Ca, K, Mn, Mg, and Na were analyzed radially. Abundance was analyzed by 
measuring peak areas for each element compared to 4-point calibration curves of known standards. 
The yields and repeating unit compositions of PHA polymers were determined using gas 
chromatography (GC), as previously described with slight modification (Braunegg et al., 1978; 
Scheel et al., 2016). ACS HPLC-grade chloroform and methanol were used for GC sample 
preparation. Lyophilized cells (15-20 mg) were suspended in 2 mL of a 15% (v/v) sulfuric acid 
solution in methanol and 2 mL of chloroform and heated at 100 °C for 140 min in a 10 mL pressure 
vial (Kimax). The samples were cooled to room temperature, and 1 mL of Nanopure filtered water 
and 500 μL of methyl octanoate standard (0.25% v/v) in chloroform were added and mixed by 
vortex. Aqueous and organic layers were separated by centrifugation for 5 minutes at 700 rpm 
(Marathon 6K, Fisher Scientific). The organic layer was passed through a 0.2 μm 
polytetrafluoroethylene (PTFE) filter using a vacuum manifold (Millex Samplicity) into 2 mL GC 
vials. Samples were injected and separated using a GC 2010 Gas Chromatograph with an AOC-
20i autoinjector and a flame ionization detector. Shimadzu’s GCSolution software was used to 
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analyze the data. Statistical analyses were performed using the Data Analysis Toolpak for 
Microsoft Excel. 
PGA was verified by 1H-NMR spectroscopy using a Bruker AVANCE III 600 MHz 
instrument. Spectra were processed with Bruker TopSpin v3.5pI2. 
3.4 Results 
3.4.1 Hydrolysate characterization 
The concentration of glucose and xylose in the crude linerboard waste fines hydrolysate 
were calculated to be 98.5 g L-1 and 28.8 g L-1, respectively (Fig. A4, Appendix A). The metal ion 
composition of the crude hydrolysate was determined to be: Ca (5486 ppm), Na (1853 ppm), S 
(21.0 ppm), Mg (20.0 ppm), K (13.0 ppm), Zn (4.70 ppm), Mn (4.44 ppm), Al (2.24 ppm), Ba 
(1.56 ppm), P (1.12 ppm), Fe (0.30 ppm), Pb (0.24 ppm), Cu (0.19 ppm), Co (40 ppb), As (32 
ppb), Mo (17 ppb), Cd (10 ppb), and Cr (7 ppb). 
3.4.2 PHA analysis 
PHB and SCL-co-MCL PHA were synthesized in recombinant BW25113 and LSBJ using 
several different carbon sources. The yield of PHB biosynthesized by BW25113 and LSBJ when 
crude hydrolysate was the carbon source was 6.88 g L-1 and 7.65 g L-1, respectively, which was 
greater than a 2-fold increase compared with any other pure carbon source analysed (Fig. 3.1A). 
These results were determined to be statistically significant using a Student’s T-test (two-tailed, α 
= 0.05) comparing yields from each pure carbon source to that of the hydrolysate. PHB yields from 
pure carbon sources were not significantly different between BW25113 and LSBJ, except for the 
mixed glucose/xylose which led to yields of 1.18 g L-1 and 3.13 g L-1, respectively. 
The yields of SCL-co-MCL biosynthesized by BW25113 and LSBJ displayed similar 
trends to PHB homopolymer production; with crude hydrolysate, PHA yields were 6.82 g L-1 and 
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6.26 g L-1, respectively, which was slightly less than a 2-fold increase compared to the other carbon 
sources (Fig. 3.1B). These results were determined to be statistically significant using a Student’s 
T-test (two-tailed, α = 0.05) comparing yields from each pure carbon source to that of the 
hydrolysate. In LSBJ, none of the SCL-co-MCL yields from pure carbons were significantly 
different. However, in BW25113 the utilization of xylose led to significantly higher yields (3.21 g 
L-1) compared to glucose and the mixed glucose/xylose (Fig. 3.1B). 
 
 
Figure 3.1: PHA produced by E. coli strains BW25113 and LSBJ harboring (A) pBBRSTQKAB 
or (B) pBBRSTQKAB and pTrcGK. Yields of PHB in g L-1 for each carbon source are shown for 
both strains in panel (A), while yields of PHB-co-MCL are shown in panel (B). Data shown are 
averages and standard deviations of 3 biological replicates. Hydrolysate denotes the crude 
hydrolysate (white bar), Glu/Xyl denotes purified hydrolysate sugars (grey striped bar), and 
Glucose and Xylose are store-bought pure sugars (black and solid grey bars, respectively). 
 
The 3HB monomer fractions were substantially different between BW25113 and LSBJ, 
with the former strain producing copolymers with greater than 99.5% 3HB regardless of carbon 
source (Fig. 3.2). LSBJ produced copolymers with greater variability in their monomer content, 
though still dominated by 3HB monomers which ranged from 95.1% to 98.4% (Fig. 3.2). Due to 
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the high variation observed in copolymer composition from LSBJ, only PHAs produced from 
glucose and the mixed glucose/xylose were found to be significantly different between LSBJ and 
BW25113 using a Student’s T-test (two-tailed, α = 0.05). The MCL monomer composition 
followed similar trends between carbon sources, but not between strains; polymers produced by 
BW25113 contained no observable 3-hydroxyoctanoate (3HO) monomers, whereas 3HO 
constituted a significant percentage of the MCL fraction of PHA produced by LSBJ (Fig. 3.3). 3-
hydroxydecanoate (3HD) was the other dominant MCL monomer in PHA produced by LSBJ, with 
the combined 3HO and 3HD fractions making up greater than 87% of the total MCL fraction. The 
MCL monomer compositions were compared between each pure carbon source and the 
hydrolysate separately for both LSBJ and BW25113 using a two-factor ANOVA with replication 
(α = 0.05), and each comparison was found to be statistically significant with the exception of 
xylose from the LSBJ strain. 
 
Figure 3.2: 3HB monomer content of PHB-co-MCL produced by E. coli strains BW25113 and 
LSBJ harboring pBBRSTQKAB (phaC, phaA, phaB) and pTrcGK (phaG, alkK). Data shown are 
averages and standard deviations of 3 biological replicates. Hydrolysate denotes the crude 
hydrolysate (white bar), Glu/Xyl denotes purified hydrolysate sugars (grey striped bar), and 




3.4.3 PGA analysis 
PGA was synthesized by Bacillus licheniformis WX-02 from either pure glucose or the crude 
hydrolysate. PGA yields from these two carbon supplements were 3.25 g L-1 and 6.46 g L-1 
(standard deviations of 0.32 and 0.90), respectively, and were determined to be significantly 
different using a Student’s T-test (two-tailed, α = 0.05). The identity of the PGA was confirmed 
by 1H-NMR (Fig. A5, Appendix A). A minor impurity was observed in the 1H-NMR spectrum 
(3.08–2.88 ppm), which was confirmed to be unconnected to the polymer backbone by COSY-
NMR (Fig. A6, Appendix A). 
 
 
Figure 3.3: MCL monomer content of PHB-co-MCL produced by E. coli strains BW25113 and 
LSBJ harboring pBBRSTQKAB and pTrcGK. No 3HO monomers were detected in polymer 
produced by BW25113. 3HDD, 3-hydroxydodecanoate (grey striped bar); 3HD, 3-
hydroxydecanoate (solid grey bar); 3HO, 3-hydroxyoctanoate (dotted bar); 3HHx, 3-
hydroxyhexanoate (white bar). 
 
3.5 Discussion 
In this study there was a marked increase in both PHA and PGA biopolymer yields when 
substituting the crude hydrolysate for the pure sugar carbon sources. In comparison with previous 
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studies, PHB and SCL-co-MCL PHA yields from crude hydrolysate were significantly improved. 
Using similar methodologies and an unrelated E. coli strain (JM109), Nomura et al. achieved a 
yield of 2.31 g L-1 of PHB from pure glucose (Nomura et al., 2004). Similarly, SCL-co-MCL 
polymers were previously produced with a yield of 3.49 g L-1 using the same growth conditions 
and E. coli LS5218, the parental strain of LSBJ (Tappel et al., 2014). For the PGA production 
experiment, our results are an improvement over early studies that use similar media and growth 
methods, where researchers observed a yield of 2.16 g L-1 (Wei et al., 2010). However, there have 
been much greater improvements in yield by optimizing media formulations and genetically 
modifying WX-02 to improve ATP supply, with recent yields as high as 43.81 g L-1 (Cai et al., 
2018, 2017; Wei et al., 2010). 
Due to the complex composition of the crude hydrolysate, it is difficult to pinpoint and 
investigate specific hypotheses for the observed increase in biopolymer yield. One possible 
explanation for these results is the abundance of several important metal ions in the hydrolysate. 
The most abundant metal in the hydrolysate was calcium which was present at physiologically 
relevant concentrations (~10 mM in hydrolysate supplemented shake flasks) (Holland et al., 1999). 
Although the role of calcium in prokaryotes is not completely understood, it has been implicated 
in processes such as cell division, chemotaxis, and regulation of mechanosensitive ion channels 
(Booth, 2014; Domínguez et al., 2015; Kung et al., 2010; Martins et al., 2011; Norris et al., 1996). 
Interestingly, there is also evidence of non-proteinaceous PHB and polyphosphate acting as 
voltage-gated calcium channels in E. coli as a strategy to maintain calcium homeostasis, and the 
increased PHB yield observed in this study could be partially attributed to that (Das et al., 1997; 
Reusch et al., 1995). However, the extraction and analysis methods in this study cannot 
differentiate between transmembrane PHB and intracellular granules, so this is merely speculation. 
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Mg2+ and K+ are both vital to bacterial survival, and the presence of these two ions in the 
hydrolysate may have enhanced bacterial growth (Epstein, 2003; Romani and Scarpa, 2000). A 
recent study found evidence that peptide-based media may be Mg2+-limited, and that E. coli grown 
on tryptone-based media supplemented with glucose were unable to completely utilize that glucose 
unless supplemented with Mg2+(Christensen et al., 2017). However, this would not explain the 
enhancement of PGA biosynthesis which was carried out in a defined medium with abundant 
Mg2+. Transition metal cofactors such as Fe, Zn, Mn, and Cu are also beneficial for bacterial 
growth in modest concentrations, and the trace amounts present in the hydrolysate could have also 
contributed to improved biomass and biopolymer yields (Hood and Skaar, 2012). Although heavy 
metals such as Pb, As, and Cd are toxic to bacteria, they were not present in high enough 
concentrations to inhibit bacterial growth (Mitra et al., 1975; Neumann and Leimkühler, 2008; 
Peng et al., 2007). 
The concentration of glucose and other sugars in bacterial media is an important parameter 
to consider, and under-feeding or over-feeding can significantly alter metabolism (Stephanopoulos 
et al., 1998). Although 20 g L-1 of glucose is often used in PHA experiments, there is evidence that 
this concentration is above the optimum for sustained bacterial growth (Christensen et al., 2017; 
Shang et al., 2003). In fed-batch cultures of Ralstonia eutropha, PHB yields were highest when 
glucose was maintained at 9 g L-1 and a decrease in biomass and PHB yield was observed as 
glucose concentration increased (Shang et al., 2003). Other studies have found evidence that 
carbon or nitrogen limitation can increase PHB yields in recombinant E. coli (Wang et al., 2009). 
This may have contributed to the increased biopolymer yields observed in this study, as the crude 
hydrolysate was supplemented at lower sugar concentrations than pure sugars (7.30 g L-1 glucose 
and 2.13 g L-1 xylose for PHA experiments, 8.95 g L-1 glucose and 2.62 g L-1 xylose for PGA 
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experiments). Additionally, acetate was present in the hydrolysate at 1 g L-1 and has been 
previously shown to be utilized by E. coli LS5218 derivatives and incorporated into PHB 
(Salamanca-Cardona et al., 2016, 2014). However, this amount of acetate would only contribute a 
maximum theoretical yield of 0.865 g L-1 PHB, which does not account for the total increase of 
PHB in cells grown on hydrolysate as opposed to pure sugars (Fig. 3.1). 
The copolymerization of PHB with MCL 3HA monomers often gives desirable material 
properties by reducing the crystallinity and brittleness of the resulting polymers, even with MCL 
fractions as low as 6 mol% (Matsusaki et al., 2000; Sudesh et al., 2000). The SCL-co-MCL PHAs 
produced by LSBJ in this study only incorporated a small amount of MCL monomers, and almost 
no MCL monomers were incorporated by BW25113 regardless of the carbon source (Fig. 3.2 & 
3.3). There are several potential reasons for the low MCL incorporation; these MCL monomers 
are scavenged from fatty acid biosynthesis by the transacylase activity of PhaG, a putative 3-
hydoxyacyl-ACP-CoA acyltransferase (Fiedler et al., 2000; Rehm et al., 2001). Free 3-hydroxy 
fatty acids can also be incorporated through the 3-hydroxyacyl-CoA ligase activity of AlkK (Wang 
et al., 2012). The reduced concentration of sugars from crude hydrolysate is likely to slow the 
growth rate of the cultures and shift metabolism away from fatty acid biosynthesis, resulting in 
less availability of 3-hydroxyacyl compounds (Li and Cronan, 1993; Takamura and Nomura, 
1988). In E. coli LSBJ, the transcriptional regulator FadR, which both activates fatty acid 
biosynthesis and represses β-oxidation, is non-functioning (DiRusso et al., 1992; Iram and Cronan, 
2005). This may explain why LSBJ was able to incorporate a greater percent of MCL monomers 
than BW25113, which has a fully functioning fatty acid biosynthesis pathway and is less likely to 
have large pools of 3-hydroxyacyl-ACP available. 
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In this study we have successfully biosynthesized PHB, SCL-co-MCL PHA, and PGA using 
sugars derived from the hydrolysis of linerboard recycling waste fines. Although sugars obtained 
from this hydrolysis can be purified and do indeed result in PHA biosynthesis, this can be a costly 
and time-consuming process and generates a low-concentration sugar solution that must be 
concentrated for bacterial fermentation. The work here has shown that the crude waste fines 
hydrolysate is a good source of lignocellulosic sugars for value-added biopolymer production. 
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 Chapter 4: Optimizing a fed-batch high-density fermentation process for medium chain-
length poly(3-hydroxyalkanoates) in Escherichia coli 
The work presented here is being prepared for submission to Frontiers in Bioengineering and 
Biotechnology. 
4.1 Abstract 
Production of medium chain-length (MCL) poly(3-hydroxyalkanoates) (PHA) of homopolymeric 
composition via high-density fed-batch fermentation was investigated in β-oxidation deficient 
Escherichia coli LSBJ. These homopolymeric PHAs exhibit attractive material properties such as 
increased flexibility and elasticity relative to PHB; however, these polymers are difficult to 
biosynthesize in native PHA-producing organisms, and there is a paucity of research towards 
developing high-density cultivation methods while retaining compositional control. In this study, 
we developed and optimized a fed-batch fermentation process in a stirred tank reactor, beginning 
with the biosynthesis of poly(3-hydroxydecanoate) (PHD) from decanoic acid by recombinant E. 
coli LSBJ with glucose as an energy source for growth. Bacteria were cultured in two phases, a 
biomass accumulation phase (37°C, pH 7.0) and a PHA biosynthesis phase (30°C, pH 8.0). 
Through iterative optimizations of semi-defined media composition and glucose feed rate, 6.0 g 
of decanoic acid was converted to PHD with an 87.5% yield (4.54 g L-1). Stepwise increases in the 
amount of decanoic acid fed during the fermentation correlated with an increase in PHD, resulting 
in a final decanoic acid feed of 25 g converted to PHD at a yield of 89.4% (20.1 g L-1, 0.42 g L-1 
h-1), at which point foaming became uncontrollable. Hexanoic acid, octanoic acid, 10-undecenoic 
acid, and 10-bromodecanoic acid were all individually supplemented at 20 g each and successfully 
polymerized with yields ranging from 66.8 to 99.0% (9.24 to 18.2 g L-1). Using this bioreactor 
strategy, co-fatty acid feeds of octanoic acid/decanoic acid and octanoic acid/10-azidodecanoic 
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acid (8:2 mol ratio each) resulted in the production of their respective copolymers at nearly the 
same ratio and at high yield, demonstrating that these methods can be used to control PHA 
copolymer composition. 
4.2 Introduction 
 High-density fermentation of Escherichia coli has been studied for the last 50 years in an 
effort to achieve maximal cell densities (~200 g L-1 dry cell weight), frequently to attain high 
volumetric productivity (g L-1 h-1) of a heterologously-expressed product (Shiloach and Fass, 
2005). While this is often a product such as a protein or antibiotic, these techniques have also been 
employed to produce biopolymers such as poly(hydroxyalkanoates) (PHAs). PHAs are a broad 
class of bacterially-derived polyesters prized for their biodegradability and biocompatibility, 
which can be produced from renewable carbon sources such as sugars and lipids (Lu et al., 2009). 
There are two dominant types of PHA characterized by the number of carbons present in each 
monomer, short chain-length (SCL) PHA containing 3-5 carbons, and medium chain-length 
(MCL) PHA containing 6-14 carbons. The most commonly discussed PHAs in the literature are 
poly[(R)-3-hydroxybutyrate] (PHB) and SCL copolymers of PHB with 3-hydroxyvalerate, which 
exhibit stiff and brittle material properties with a high Young’s modulus (i.e. the measured stiffness 
of a material) (Lu et al., 2009), while MCL PHAs and SCL-co-MCL copolymers are the subject 
of more recent studies due to their more viscoelastic properties (Rai et al., 2011; Tappel et al., 
2012a). 
Control over the monomeric composition of MCL PHAs can be achieved by culturing β-
oxidation deficient (ΔfadBJ) E. coli LSBJ harboring the PHA biosynthesis genes phaJ4 and 
phaC1(STQK) in the presence of fatty acid substrates as previously described by our laboratory 
(Tappel et al., 2012a, 2012b). Controlling the monomer composition confers control over the 
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material properties, which can be further customized by the incorporation of functionalized fatty 
acids that enable post-production chemical modifications (Levine et al., 2015; Pinto et al., 2016). 
One of the main limitations of this MCL PHA biosynthesis platform is the low polymer yields 
obtained; the first reported MCL PHA biosynthesis in E. coli LSBJ reported yields from shake 
flask cultivations of approximately 0.26 – 0.4 g L-1 (Tappel et al., 2012b), which were later 
improved slightly by the deletion of the arcA transcriptional regulator to 0.26 – 0.6 g L-1 (Scheel 
et al., 2016), and most recently improved to 5.44 g L-1 by utilizing glucose as a co-substrate, 
doubling the culture duration, and heterologously expressing an acyl-CoA synthetase from 
Pseudomonas putida (Mohd Fadzil et al., 2018). 
Cultivating PHA-producing bacteria to a high-density in stirred tank reactors (STR, 
bioreactors) rather than shake flasks has been shown to greatly enhance volumetric productivity, 
and is a necessary step to scaling up production (Blunt et al., 2018; Koller, 2018; Lee et al., 1999). 
However, the most common products created using these high-density fermentation techniques are 
SCL PHAs and MCL ter- and quadripolymers with uncontrolled monomer composition, with only 
a few reports of successful MCL biosynthesis with controlled compositions. One notable exception 
is the biosynthesis of near-homopolymeric poly(3-hydroxydecanoate) (PHD) reported by Gao et 
al., who obtained a yield of 11.8 g L-1 (0.41 g L-1 h-1) from β-oxidation deficient Pseudomonas 
putida KT2440 (Gao et al., 2018). 
 The goal of this study was to optimize a fed-batch fermentation process for the high-density 
cultivation of recombinant E. coli LSBJ to produce MCL PHA polymers with controlled 
composition from fatty acid substrates. PHA biosynthesis from fatty acids is mostly decoupled 
from primary metabolism; exogenous fatty acids are imported and converted into 3-hydroxyacyl-
CoA via three steps of a modified β-oxidation pathway and are polymerized by the PHA synthase 
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PhaC1(STQK), while glucose catabolism drives cell growth and provides ATP and reducing 
equivalents (Fig. 5.1). Catabolite repression induced by the presence of glucose is one regulatory 
network expected to bridge the gap between primary metabolism and β-oxidation. Fatty acid 
metabolism is tightly regulated in E. coli and is subject to catabolite repression through the activity 
of the cyclic AMP receptor protein – cyclic AMP complex (CRP-cAMP), a global transcriptional 
regulator that activates transcription of fad genes in response to elevated cAMP levels in the 
absence of glucose (see Chapter 1 for more information on CRP); this activation is lost when 
glucose is present in sufficient concentrations (Deutscher, 2008; Feng and Cronan, 2012; Fic et 
al., 2009; Iram and Cronan, 2006). 
 The work presented in this study demonstrates the first successful biosynthesis of MCL 
PHAs in E. coli LSBJ via high-density fermentation, and a subsequent process optimization to 




Figure 4.1: Simultaneous glucose consumption and PHA biosynthesis in E. coli LSBJ. Glucose is 
metabolized solely for cell growth, generating ATP and reducing equivalents via glycolysis and 
the tricarboxylic acid (TCA) cycle. Extracellular fatty acids (R = 1-9 carbon) cross the outer 
membrane by diffusion and are simultaneously transported and activated by the acyl-CoA 
synthetase FadD (Kameda and Nunn, 1981; Lepore et al., 2011). Acyl-CoAs are converted to 
enoyl-CoAs by the acyl-CoA dehydrogenase FadE and are unable to proceed by native β-oxidation 
due to the absence of FadB and FadJ (Tappel et al., 2012b). Recombinant enzymes PhaJ4 and 
PhaC1(STQK), an R-specific enoyl-CoA hydratase and an engineered PHA synthase respectively, 
are conferred by the pBBR-C1J4SII plasmid and complete the PHA biosynthesis pathway (Table 
4.1). MCL PHA biosynthesis from fatty acids is largely uncoupled from cell growth; however, 
both fadD and fadE expression are activated by the binding of the cyclic AMP receptor protein – 
cyclic AMP (CRP-cAMP) complex (Feng and Cronan, 2012). A high ATP concentration inversely 
lowers cAMP concentration, reducing the amount of complexed CRP and potentially decreasing 
the expression of fadD and fadE and preventing PHA biosynthesis. ATP shown in this figure is a 
product of the intermediates NADH1, GTP2, and FADH2
3 (with the exception of some ATP 





4.3.1 Media and inoculum preparation 
A complete list of strains, plasmids, and primers used for this study can be found in Table 
4.1. Unless otherwise specified, all strains were maintained in LB-Lennox (LB; composition per 
liter: 10 g tryptone, 5 g yeast extract, and 5 g NaCl, pH 7.0) purchased from Difco, and the 
antibiotics kanamycin (50 mg L-1) and ampicillin (100 mg L-1) were added to media as necessary. 
When necessary, Bacto agar (Difco) was added to media at a concentration of 15 g L-1 to make 
plates. 
The fatty acids hexanoic acid (Sigma Aldrich), sodium octanoate (Sigma Aldrich), 
decanoic acid (Alfa Aesar), 10-undecenoic acid (Sigma Aldrich). 10-bromodecanoic acid (A.K. 
Scientific), and 10-azidodecanoate (synthesized as described below) were supplemented as 
substrates for polymer production as noted. Fatty acid feed solutions for bioreactor fermentations 
were brought to pH 8.0 by the addition of NaOH (10 M) to form the respective conjugate base and 
either autoclaved (saturated fatty acids) or filter-sterilized (functionalized fatty acids) prior to 




Table 4.1: Strains, plasmids, and primers. 
Escherichia coli Relevant characteristics Source or reference 
LSBJ ΔfadB, ΔfadJ, atoC512 (Const), fadR601 Tappel et al., 2012 
RSC02 ΔarcA LSBJ Scheel et al., 2016 
LSBJ Δcrp Δcrp LSBJ This study 
LSBJ CRP* crp*(I112L, T127I, A144T) LSBJ This study 
SM02 Δdld LSBJ CRP* This study 
SM04 Δdld, ΔarcA LSBJ CRP* This study 
SM06 Δdld, ΔarcA, Δaas LSBJ CRP* This study 
Plasmids   
pKD46 λ Red recombinase expression plasmid; expresses exo, β, and γ genes 
from λ phage; ParaB promoter; araC; ApR; temperature sensitive replicon 
Datsenko and 
Wanner, 2000 
pKD13 Neomycin phosphotransferase flanked by FLP recombinase recognition 
targets, ApR, KmR 
Datsenko and 
Wanner, 2000 
pCP20 FLP recombinase expression plasmid, ApR, temperature sensitive replicon Datsenko and 
Wanner, 2000 
pJet1.2/blunt Linear blunt cloning vector with interruptible eco471R lethal gene, ApR Fisher Scientific 
pBBR-C1J4SII pBBR1MCS-2 derivative, phaJ4, phaC1 (STQK), KmR Tappel et al. 2012 
pZS411 pTrc99a derivative, pct (Megasphaera elsdenii), ApR This study 
pBRL690 pBBR-C1J4SII derivative, tac promoter This study 
pRAS02 pJet1.2/blunt derivative, native crp (E. coli MG1655) This study 
pRAS05 pJet1.2/blunt derivative, engineered crp* This study 
pTrcDAEB pTrc99a derivative, atoDAEB operon (E. coli MG1655) This study 









crpM1.F/R AAACCCGGACcttCTGATGCGTT / ACCTGAATCAATTGGCGAAATTTTTTG 
crpM2.F/R TCTGCAAGTCattTCAGAGAAAGTGGG / CGACGCGCCATCTGTGCA 
crpM3.F/R GGGCCGCATTacaCAGACTCTGC / GTCACGTCGAGGAACGCC 
BL621.F/R TGATTAATTGTCAAGCCTGGGGTGCCTAATGA / TCGGCTCGTATAATGTGTGGAATTGTGAGCGG 
native.crp.F/R ATGGTGCTTGGCAAACCGCA / TAAACGAGTGCCGTAAACGAC 
atoDAEB.F GCAGAGCTCAAGGAGAAAATGAAAACAAAATTGATGACATTACAAGACGCCACC 
atoDAEB.R GCAGGTACCTTGATTAATTCAACCGTTCAATCACCATCGCAATTCC 
arcA.check.F/R GTTAATTTGCAGCATGCATCAGG / GACGATGAGTTACGTATCTGG  
aas.check.F/R AAATTGTTGCGAACCTTTGG / GCAATAACGTACGGGCAAAT 
crp.check.F/R ATCCAGAGACAGCGGCGTTA / AATGGCGCGCTACCAGGTAA 
dld.check.F/R CTCGCTGAATTGTTATACAAGGC / CACAGAACGATTAAGTGAATTCGG 
a Underlined sequences are homologous to the gene to be deleted. 
b Forward and reverse primers are denoted with an F or R, respectively. 
c Lowercase base-pairs indicate codons subjected to site-directed mutagenesis. 
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4.3.2 E. coli engineering and plasmid construction 
 The dld, arcA, and aas genes were deleted using homologous recombination via the λ Red 
recombinase protocol described by Datsenko and Wanner (2000). Knockout cassettes were 
generated by PCR (PrimeSTAR HS polymerase, Takara) using gene-specific primers to amplify 
the kanamycin resistance marker from pKD13, gel-purified, and concentrated by ethanol 
precipitation. Knockout cassettes were introduced to parental strains harboring pKD46 by 
electroporation (1500V, 5m; BTX ECM 399), recovered in 1 mL LB at 30 °C and 250 rpm for 1 
h, and plated on LB agar supplemented with kanamycin at 37 °C for 24 h. For the dld knockout, 
colonies were patched onto minimal media agar plates (22 mM KH2PO4, 42 mM Na2HPO4, 
8.6 mM NaCl, 2.0 mM MgSO4, 18.9 mM NH4Cl, 15 g L
-1 agar, pH 7.0) that were supplemented 
with 25 mM D-lactate. Colonies that did not grow on the D-lactate minimal agar plates were 
considered putative dld::KmR mutants. Successful gene replacement for the arcA::KmR and 
aas::KmR mutants was confirmed by loci screening using PCR. The temperature-sensitive pKD46 
plasmid was removed by growth for 12 hours at 42 °C. Antibiotic markers were removed by 
expression of FLP recombinase from the pCP20 plasmid, which was confirmed by the loss of 
kanamycin resistance and loci screening by PCR. The temperature-sensitive pCP20 plasmid was 
removed by growth for 12 hours at 42 °C. Successful mutants were prepared as 30% glycerol 
stocks and stored at -80 °C. 
 The crp* mutation, a group of mutations that exhibit reduced dependence on cAMP for 
DNA binding and subsequent transcriptional regulation (Guidi-Rontani et al., 1981; Khankal et 
al., 2009), was introduced to E. coli LSBJ by first deleting the native crp gene and then replacing 
it with the mutated crp* gene. Native crp was removed following the same λ Red recombinase 
protocol described above. The crp* gene was generated from the native E. coli MG1655 crp gene 
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using the Q5® Site-Directed Mutagenesis Kit (New England Biolabs) following manufacturers 
recommendations. In brief, native crp was PCR amplified from MG1655 genomic DNA using the 
native.crp.F/native.crp.R primers and blunt ligated into pJet1.2/blunt to generate pRAS02. This 
plasmid was subjected to three successive rounds of site-directed mutagenesis using the crpM1, 
crpM2, and crpM3 primer sets to make the following substitutions, respectively: I112L, T127I, 
and A144T. The final crp* gene harboring all three mutations, designated pRAS05, was verified 
by Sanger sequencing (GENEWIZ, NJ). 
 The crp* gene was PCR amplified from pRAS05 using the native.crp.F/native.crp.R 
primers. The PCR mixture was treated with Dpn I and the desired 700 bp crp* product was gel 
purified. The purified crp* was concentrated via ethanol precipitation and subsequently 
electroporated into LSBJ ∆crp cells harboring the  Red plasmid pKD46.  Cells were recovered 
in 1 mL of LB at 30 °C and 250 rpm for 1 h, and 0.5 mL of recovery culture was harvested by 
centrifugation and suspended in 0.2 mL of sterile water.  Cell suspension (0.1 mL) was plated onto 
minimal medium agar consisting of 22 mM KH2PO4, 42 mM Na2HPO4, 8.6 mM NaCl, 2.0 mM 
MgSO4, 20 mM pyruvate (carbon source), and 20 mM L-tryptophan (nitrogen source). This 
selection method was chosen because crp is required for growth on L-tryptophan as a nitrogen 
source in the presence of pyruvate as a carbon source (Isaacs et al., 1994). Plates were incubated 
at 37 °C for 48 h, and colonies visible after 48 h were patched onto LB agar plates and subsequently 
screened via Sanger sequencing to verify the presence of the crp* gene. The LSBJ CRP* mutant 
was prepared as a 30% glycerol stock and stored at -80 °C. 
 The pZS411 plasmid, harboring the pct gene necessary for lactyl-CoA formation from 
lactate, was constructed by excising the pct gene from the pTV118NpctC1AB(STQK) plasmid 
(Taguchi et al., 2008) using 5` and 3` EcoRI sites and ligating into pTrc99a following standard 
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cloning procedures (Sambrook and Russell, 2001). The pTrcDAEB plasmid was constructed by 
amplifying the atoDAEB operon using the atoDAEB.F/R primer set and ligating this fragment into 
the blunt cloning vector pJet1.2/blunt following manufacturer’s specifications. The operon was 
then excised with 5` SacI and 3` KpnI, purified by gel electrophoresis, and ligated into pTrc99a. 
The pBRL690 plasmid was constructed by mutating the lac promoter of pBBRC1J4SII into the 
tac promoter by site-directed mutagenesis of the -35 region using the BL621.F/R primer set and 
the Q5® site-directed mutagenesis kit. 
4.3.3 Shake flask production 
 PHA production in shake flasks was performed as described in Chapter 2 (Scheel et al., 
2016). In brief, chemically competent E. coli LSBJ was transformed with MCL PHA biosynthesis 
plasmid pBBR-C1J4SII by heat-shock following standard procedures (Sambrook and Russell, 
2001). Transformants were grown on LB-agar plates, and single colonies were used to inoculate 
three separate 2.5 mL LB seed cultures. Seed cultures were grown for 16 h at 37 °C and 200 rpm 
rotary shaking, and 500 μL were used to inoculate 100 mL of growth media (LB, 4.0 gL-1 Brij-35, 
10 mM decanoic acid, 8 mM sodium phosphate dodecahydrate, kanamycin, pH 7.0) in 500-mL 
baffled shake flasks. Cultures were grown for 12, 24, 36, or 48 h at 30°C and 220 rpm, then 
harvested by centrifugation as previously described (Tappel et al., 2012b). Before harvesting, the 
pH of each culture was measured (Accumet® pH meter, Fisher Scientific) immediately after 
removal from the incubator. 
4.3.4 Low-density fed-batch production 
 A summary of all bioreactor trials outlining the E. coli strains, plasmids, and conditions 
can be found in Table 4.2.  All fed-batch fermentations were performed in a 2-L vessel with a 
BioFlo 310 benchtop bioreactor system (New Brunswick Scientific) using conditions and media 
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adapted from Pfeifer et al. (2002). A schematic of this bioreactor assembly is shown in Fig. F5 
(Appendix F). For initial experiments, the assembled bioreactor containing 750 mL of defined 
medium (F1 Salts; 0.4 g L-1 (NH4)2SO4, 1.5 g L
-1 KH2PO4, and 4.35 g L
-1 K2HPO4, pH 7.0) was 
autoclaved at 121 °C for 35 min. Prior to inoculation, 7.5 g glucose, 1.5 g yeast extract, 0.12 g 
MgSO4, 1 mL of 0.05 g L
-1 kanamycin sulfate, and 0.75 mL of trace metal solution were added 
aseptically. Trace metal solution contained 5 g L-1 NaCl, 1 g L-1 ZnSO4 · 7H2O, 4 g L
-1 MnCl2 · 
4H2O, 4.75 g L
-1 FeCl3, 0.4 g L
-1 CuSO4 · 5H2O, 0.58 g L
-1 H3BO3, 0.5 g L
-1 NaMoO4 · 2H2O, and 
8 mL L-1 concentrated H2SO4. The bioreactor was inoculated with 40 mL of bacterial seed culture, 
which was grown in LB for 16 h at 37 °C and 200 rpm rotary shaking, pelleted at 3,716 × g for 10 
min, and resuspended in 2 mL PBS buffer before sterile transfer to the bioreactor vessel. 
Fermentation was carried out in two phases, a biomass accumulation phase (Phase 1) and 
a polymer biosynthesis phase (Phase 2). The first phase of fermentation was performed at 37 °C 
with an initial agitation rate of 200 rpm and an aeration rate of 5.0 L min-1, and pH was maintained 
at 7.0 by automated addition of concentrated NH4OH (17M). Dissolved oxygen was maintained at 
50% air saturation controlled by agitation and air (compressed atmospheric) sparging cascades 
(200 to 950 rpm, then 5.0 to 20.0 L min-1 air flow). Foaming was controlled by automated addition 
of Antifoam B (J.T. Baker, 10% v/v unless otherwise noted). Once the initial glucose was 
consumed (as evidenced by a sudden increase in dissolved oxygen), a glucose feed solution (500 
mL, filter-sterilized) consisting of 430 g L-1 glucose, 3.9 g L-1 MgSO4, 110 g L
-1 (NH4)2SO4, and 
50 mg L-1 kanamycin was supplied at a rate of 14.5 mL min-1 with a separate peristaltic pump. 
OD600 measurements were made on 1 mL culture aliquots each hour using a Genesys 10S UV-Vis 
spectrophotometer (Thermo Scientific). 
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After 12 h of growth in Phase 1, Phase 2 was initiated by decreasing the fermentation 
temperature to 30 °C, increasing the pH setpoint to 8.0 (with the exception of preliminary 
experiments, Table 4.2), decreasing the dissolved oxygen setpoint to 30% air saturation, and 
beginning the addition of a fatty acid feed solution supplied at a rate of 5.5 mL min-1 (except where 
otherwise noted for preliminary experiments) with another peristaltic pump. For Trial 1, D-lactate 
(11 g) was added alongside octanoic acid as a bulk supplement. Glucose feed addition during the 
second phase was either maintained at 14.5 mL min-1 or reduced to 9.7 mL min-1 where noted. 
Culture samples (10 mL) were removed at 24 and 48 h and stored at -80 °C for later quantitative 
PHA analysis. The remaining culture at 48 h was harvested as described below. 
4.3.5 High-density fed-batch production 
 High-density fermentations were carried out in the same 2-L vessel, using media adapted 
from Lau et al. (2004). The F1 Salts medium was replaced with 750 mL of defined medium 
consisting of 0.4 g L-1 (NH4)2SO4, 4.16 g L
-1 KH2PO4, and 11.95 g L
-1 K2HPO4. Prior to 
inoculation, 7.5 g glucose, 1.5 g yeast extract, 0.12 g MgSO4, 1 mL of 0.05 g L
-1 kanamycin sulfate, 
and 2.25 mL of trace metal solution were added aseptically. The amount of yeast extract was 
increased to 3.0 g for trial 15 and for each subsequent trial (Table 4.2). The amount of (NH4)2SO4 
in the glucose feed was reduced to 6 g L-1, and 15 mL of trace metal solution was added to the feed 
as well. All other bioreactor conditions were the same as for the low-density production process. 
 Fatty acid feed solutions initially contained 40 g L-1 decanoic acid (6 g in 150 mL H2O, pH 
8.0), and were raised in subsequent trials as shown in Table 4.2. To maintain a constant volume 
of the combined glucose and fatty acid feeds, as fatty acid feed volumes increased (due to a 
maximum decanoic acid solubility of 100 g L-1 at pH 8.0) the glucose feed volume was decreased 
by the same magnitude while holding the mass of feed components constant. To account for this 
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change in glucose feed concentration, the addition rate was reduced proportionally so that the g 
glucose h-1 was kept constant. Antifoam concentration was increased to 20% for Trials 18 and 24 
to combat excessive foaming. 
Table 4.2: Summary of Bioreactor Conditions 
Trial1 Strain Plasmid Glucose Feed 
Rate (mL h-1) 
Fatty Acid Feed3; 
Total Mass (g) 
Fatty Acid Feed 
Rate (mL h-1) 
pH 
1 SM02 pBBRC1J4SII/pZS411 14.5 C8; 0.8 Bulk 7 
2 SM04 pBBRC1J4SII 14.5 C8; 6 10 7 
3 SM06 pBBRC1J4SII 14.5 / 9.7 C8; 1.0 Bulk 7 
4 SM06 pBBRC1J4SII 14.5 / 9.7 C8; 1.5 Bulk 7 
5 SM06 pBBRC1J4SII 14.5 / 9.7 C8; 6 8.3 7 
6 SM06 pBBRC1J4SII 14.5 / 9.7 C8; 6 5.5 7 
74 SM06 pBRL690 14.5 / 9.7 C8; 6 5.5 7 
84 LSBJ pBBRC1J4SII / 
pTrcDAEB 
14.5 C10; 6 5.5 7 
9 LSBJ pBBRC1J4SII 14.5 C10; 6 5.5 7 / 8 
10 RSC02 pBBRC1J4SII 14.5 C10; 6 5.5 7 / 8 
11 LSBJ CRP* pBBRC1J4SII 14.5 C10; 6 5.5 7 / 8 
12 LSBJ pBBRC1J4SII 14.5 / 9.7 C10; 6 5.5 7 / 8 
13 LSBJ pBBRC1J4SII 14.5 / 9.7 C10; 6 5.5 7 / 8 
14 LSBJ pBBRC1J4SII 14.5 / 9.7 C10; 12 5.5 7 / 8 
 152 LSBJ pBBRC1J4SII 14.5 / 9.7 C10; 12 5.5 7 / 8 
16 LSBJ pBBRC1J4SII 14.5 / 9.7 C10; 15 5.5 7 / 8 
17 LSBJ pBBRC1J4SII 12.9 / 8.7 C10; 20 6.5 7 / 8 
18 LSBJ pBBRC1J4SII 11.4 / 7.7 C10; 25 7.5 7 / 8 
19 LSBJ pBBRC1J4SII 12.9 / 8.7 C6; 20 6.5 7 / 8 
20 LSBJ pBBRC1J4SII 12.9 / 8.7 C8; 20 6.5 7 / 8 
21 LSBJ pBBRC1J4SII 12.9 / 8.7 C11Δ10; 20 6.5 7 / 8 
22 LSBJ pBBRC1J4SII 12.9 / 8.7 C10Br; 20 6.5 7 / 8 
23 LSBJ pBBRC1J4SII 12.9 / 8.7 C8/C10; 15.4/4 6.5 7 / 8 
24 LSBJ pBBRC1J4SII 12.9 / 8.7 C8/C10N3; 15.4/4.95 6.5 7 / 8 
1 Trials 1 – 8 are preliminary experiments which did not result in polymer production. Trials 1 – 
12 were performed following low-density fermentation methods, while trials 13 – 24 were 
performed following high-density fermentation methods. Trials 9 – 17 were performed in duplicate 
as two consecutive bioreactor fermentations, with the exception of trial 14. 
2 Yeast extract in culture medium was doubled to 3.0 g total for trial 15, and this amount was 
maintained for each subsequent trial. 
3 Fatty acids are abbreviated as follows: octanoic acid (C8), decanoic acid (C10), hexanoic acid 
(C6), 10-undecenoic acid (C11Δ10), 10-bromodecanoic acid (C10Br), 10-azidodecanoic acid 
(C10N3). Feed volume was held at 150 mL for Trials 2-16, increased to 200 mL for Trial 17 and 
250 mL for Trial 18. Trials 19-24 were reduced back to 200 mL. 
4 Isopropyl β-D-1-thiogalactopyranoside (IPTG) added to Trials 7 and 8 at a final concentration of 




4.3.6 PHA quantification 
 Shake flask cultures were harvested as described in Chapter 3 (Scheel et al., 2019). In brief, 
cells were collected by centrifugation at 3716 × g for 15 minutes, washed once with 45 mL of 35% 
ethanol and once with 45 mL of Nanopure filtered water, frozen at -80 °C, and dried via 
lyophilization. 
 The 10 mL culture samples from bioreactor fermentations were thawed and pelleted by 
centrifugation at 7,000 × g for 15 min. The supernatant was reserved and frozen at -80 °C for 
lyophilization and later analysis. Cell pellets were washed once with 40% ethanol (40 mL) and 
once with Nanopure filtered water (40 mL), pelleting with the same centrifugation conditions after 
each wash. Pellets were then resuspended in 5 mL Nanopure filtered water, frozen at -80 °C, and 
dried via lyophilization. 
The PHA yields and repeating unit compositions were analyzed by GC as described in 
Chapter 3 (Scheel et al., 2019). In brief, lyophilized cells (10-15 mg) were suspended in 2 mL of 
a 15% (v/v) sulfuric acid solution in methanol and 2 mL of chloroform and heated at 100 °C for 
140 min in a 10 mL pressure vial (Kimax). The samples were cooled to room temperature, and 1 
mL of Nanopure filtered water and 500 μL of methyl octanoate standard (0.25% v/v) in chloroform 
were added and mixed by vortex. Aqueous and organic layers were separated by centrifugation for 
5 minutes at 700 rpm (Marathon 6K, Fisher Scientific). The organic layer was passed through a 
0.2 μm polytetrafluoroethylene (PTFE) filter using a vacuum manifold (Millex Samplicity®) into 
2 mL GC vials. Samples were injected and separated using a GC 2010 Gas Chromatograph 
(Shimadzu) with an AOC-20i autoinjector and a flame ionization detector. Shimadzu’s 
GCSolution software was used to analyze the data based on 3-hydroxyacyl methyl ester standard 
curves (except for 3-hydroxy-10-azidodecanoate monomers, which is described below). 
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4.3.7 10-azidodecanoic acid synthesis 
The 10-azidodecanoic acid substrate was synthesized following previously described 
methods (Riva et al., 2014), and is summarized in Scheme 4.3.1. Sodium azide (15.01 g, 231 
mmol) was added to a solution of 10-bromodecanoic acid (1, 40.00 g, 159 mmol) in dimethyl 
sulfoxide (1000 mL). The mixture was stirred at room temperature for 24 hours and then water 
(2000 mL) was added. The aqueous solution was extracted with ethyl acetate (4 x 700 mL) and 
then washed with half-saturated brine (6 x 500mL) and brine (2 x 400mL) and dried over sodium 
sulfate. The sodium sulfate was filtered off and ethyl acetate was removed in vacuo to yield the 
azide (2, 32.84 g, 94%). 
 
Scheme 4.3.1: Synthesis of 10-azidodecanoic acid. 
4.3.8 PHA purification and molecular weight analysis 
 Bioreactor cultures were harvested after 48 h by dividing the volume equally among 800-
mL centrifuge buckets and centrifuging at 3,716 × g for 45 min. Cell pellets were washed once 
with 40% ethanol (approximately 400 mL) and once with Nanopure filtered water (400 mL), 
pelleting with the same centrifugation conditions after each wash. Final cell pellets were 
transferred to a tared 250-mL centrifuge tube, frozen at -80 °C, and dried via lyophilization. 
 PHA was isolated from dried cells by Soxhlet extraction. Approximately 5-10 g of cells 
were transferred to 80 × 25 mm cellulose extraction thimbles (Whatman) and refluxed with 150 
mL chloroform for 6 h. Crude polymer was concentrated by rotary evaporation and purified by 
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dropwise addition to stirring methanol (180 mL, 4°C) without exceeding a 1:10 ratio of chloroform 
to methanol. The methanol solution was centrifuged at 7,000 × g and 4°C for 20 min to collect any 
suspended polymer. This methanol purification process was repeated twice, and purified PHA was 
dissolved in chloroform and passed through a syringe filter (0.45 μm PTFE) before drying in 
vacuo.  
 The weight average (Mw) and number average (Mn) molecular weights for each sample 
were determined by gel permeation chromatography (GPC) as described in Chapter 2 (Scheel et 
al., 2016). In brief, PHA solutions of approximately 5.0 g L-1 were prepared by dissolution in 
chloroform and passed through a syringe filter (0.45 μm PTFE). Samples were injected (50 μL) 
into a Shimadzu LC-20AD liquid chromatograph equipped with a Shimadzu SIL-20A 
autosampler, a Shimadzu CTO-20A column oven, and a Shimadzu RID-10A refractive index 
detector. Samples were passed through an 8 x 50 mm styrenedivinylbenzene (SDV) guard column 
(5 μm particles; Polymer Standards Service) and an 8 x 300 mm SDV analytical column (5 μm 
particles; mixed bed porosity; max molecular weight 1E6 Da; Polymer Standards Service product 
sda0830051lim). The column oven was maintained at 40°C with a 1 mL min-1 mobile phase of 
chloroform. Molecular weight standards of polystyrene with a narrow polydispersity index were 
used for calibration. LCsolution software (Shimadzu) was used for data analysis. 
 The presence of functional groups on applicable PHAs was verified by 1H-NMR 
spectroscopy using either a Bruker AVANCE III 600 MHz or Bruker AVANCE III HD 800 MHz 
instrument as noted. 1H-NMR was also used to confirm PHA production from the first successful 




 PHA yields (g L-1) were calculated from the weight percent obtained using GC calibration 
curves as described above and the dried cell weight of 10.0 mL samples, dividing by the sample 
volume: 
𝑃𝐻𝐴 𝑦𝑖𝑒𝑙𝑑 (𝑔 𝐿−1) = (
𝑊𝑒𝑖𝑔ℎ𝑡 % ×  𝐷𝑟𝑖𝑒𝑑 𝐶𝑒𝑙𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 (𝑔)
0.010 𝐿
) 
The total PHA accumulated for each bioreactor fermentation was calculated by multiplying the 
PHA yield by the final culture volume from the bioreactor: 
𝑇𝑜𝑡𝑎𝑙 𝑃𝐻𝐴 (𝑔) = 𝑃𝐻𝐴 𝑦𝑖𝑒𝑙𝑑 (𝑔 𝐿−1)  ×  𝐹𝑖𝑛𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (𝐿) 
Maximum theoretical yields of PHA were calculated from the total mass of fatty acid substrate 
available, multiplied by the molecular weight ratio of diradical monomeric equivalents to fatty 
acid precursor, assuming complete 1:1 conversion: 
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 (𝑔) = 𝐹𝑎𝑡𝑡𝑦 𝑎𝑐𝑖𝑑 𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒 (𝑔)  × (
𝑀𝑊𝑑𝑖𝑟𝑎𝑑𝑖𝑐𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 (𝑔 𝑚𝑜𝑙
−1)
𝑀𝑊𝑓𝑎𝑡𝑡𝑦 𝑎𝑐𝑖𝑑 (𝑔 𝑚𝑜𝑙−1)
)  
The mole fraction (χ) of 3-hydroxy-10-azidodecanoate (DN3) monomers in the PHODN3 
copolymer was calculated via 1H-NMR (Appendix A). Peak integrations (A), calibrated to the 
three protons of the terminal methyl group on 3-hydroxyoctanoate (3HO) monomers (δ 0.88), were 
used to determine the ratio of the DN3 protons in the alpha position (with respect to the azido 











The PHODN3 yield (g L
-1) for trial 24 (Table 4.2) was calculated by first obtaining the yield of 
the 3HO fraction using GC as described above. This was multiplied by the ratio of the mole 
fractions of DN3 and 3HO to find the yield of the DN3 fraction, and added to the yield of 3HO: 
𝑃𝐻𝑂𝐷𝑁3 𝑦𝑖𝑒𝑙𝑑 (𝑔 𝐿
−1) = 3𝐻𝑂 (𝑔 𝐿−1)  ×  
(𝑀𝑊𝐷𝑁3  ×  𝜒𝐷𝑁3)
(𝑀𝑊3𝐻𝑂  ×  𝜒3𝐻𝑂)
+ 3𝐻𝑂 (𝑔 𝐿−1) 
4.4 Results 
4.4.1 Preliminary trials and the effect of pH 
 The goal of this investigation was to enhance the production of MCL PHA by developing 
high density fermentation methods for our engineered production platform, E. coli LSBJ. Previous 
attempts by this lab have been unsuccessful using LSBJ (unpublished data). Preliminary trials 
(trials 1-8, Table 4.2) sought to address this by generating several further mutations hypothesized 
to eliminate negative regulation of the PHA biosynthesis pathway. The mutant strains LSBJ CRP*, 
SM02, SM04, and SM06 were developed and cultured by high-density fermentation in an attempt 
to produce either poly(3-hydroxyoctanoate), poly(3-hydroxydecanoate), or poly(lactate-co-3-
hydroxyoctanoate) (PHO, PHD, PLA-co-PHO; Fig. 4.2A). Despite some improvement in biomass 
accumulation, no observable polymer was produced in any of these experiments. 
 Based on previous observations that LSBJ would not produce PHA during bioreactor 
fermentation unless the pH was left uncontrolled, LSBJ was cultured in baffled shake flasks 
supplemented with decanoic acid using typical PHA biosynthesis conditions (Chapter 2), and both 
pH and PHA yield were measured every 12 h during growth (Fig. 4.2B). The pH of culture media 
increased substantially over 48 h to a final pH of 8.8. PHA was present after 12 h at 6.01% of dry 
cell weight, and more than tripled to 19.7% by 24 h while the pH increased to 8.5. The amount of 
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PHA continued to increase at a pH between 8.5 and 8.8 for the remainder of the experiment. These 
results suggest a correlation between an alkaline pH and PHA biosynthesis from fatty acids. 
 Based on our findings from the shake flask experiment, LSBJ harboring pBBRC1J4SII was 
cultured in the bioreactor and supplemented with decanoic acid, and upon initiating Phase 2 the 
pH was increased to 8.0 and maintained there for the duration of the fermentation. PHD was 
observed by GC analysis at a concentration of 0.16 g L-1, which was confirmed by NMR 
spectroscopy on purified polymers obtained by Soxhlet extraction due to the presence of 




Figure 4.2: Summary of initial bioreactor experiments leading to successful PHD biosynthesis. 
(A) Results of preliminary fermentations that did not result in polymer accumulation. (B) Culture 
pH and PHA accumulation in LSBJ harboring pBBRC1J4SII over 48 h growth in shake flasks, 
sampling every 12 h. PHA was measured as a percent of dry cell weight. Data shown is the average 
of triplicate cultures; errors bars represent minus 1 standard deviation. (C) Photograph and 1H 
NMR (600 MHz) spectrum of PHD extracted from LSBJ-pBBRC1J4SII bioreactor fermentation 
(Trial 9). Diagnostic chemical shift for PHA at δ 5.17 – 5.13 ppm (pentet, 1H); 2.59 – 2.45 
(multiplet, 2H), 1.61 – 1.47 (multiplet, 2H), 1.33 – 1.18 (multiplet, 10H), 0.8 – 0.9 (triplet, 3H). 





4.4.2 Optimization of PHD production 
 After successfully producing PHD in trial 9, mutant strains RSC02 (ΔarcA) and LSBJ 
CRP* were analyzed to determine the effects of removing these transcriptional regulators (Trials 
10 & 11, Table 4.2). Little difference was observed between LSBJ, RSC02, and LSBJ CRP*; 0.48 
g L-1, 0.39 g L-1, and 0.44 g L-1 of PHD were produced by each strain after 48 h, respectively, with 
no observable difference between 24 h and 48 h, and high variation between duplicate 
fermentations (Fig. 4.3B). Dry biomass yield decreased for both mutants relative to LSBJ, 
reflecting a higher weight percent of PHD, and biomass decreased between 24 h and 48 h for all 
three strains (Fig. 4.3A). Total polymer accumulation after 48 h was low relative to the maximum 
theoretical yield, ranging from 5.6 to 8.3% with high variation between duplicate fermentations 
(Fig. 4.3C). 
 Next, we reduced the rate of glucose feed addition during Phase 2 to 9.7 mL h-1 and cultured 
LSBJ harboring pBBRC1J4SII to determine the effect on PHD biosynthesis (LSBJ-2, Fig. 4.3). 
Biomass yield increased by approximately 50% at 24 h relative to LSBJ (29.6 g L-1); biomass still 
decreased between 24 h and 48 h to a final concentration of 21.3 g L-1 (Fig. 4.3A).  PHD 
accumulation increased considerably to 2.48 g L-1 after 48 h, with no observable difference 
between 24 h and 48 h (Fig. 4.3B). Total polymer accumulation after 48 h was 2.60 g, a yield of 
43.8 % (Fig. 4.3C). 
 With bioreactor fermentations continuing to show a decrease of biomass and unchanged 
PHA accumulation between 24 h and 48 h, believed to be due to culture death, the bioreactor 
medium was changed to that described in high-density fed-batch production to support greater 
growth of LSBJ harboring pBBRC1J4SII (LSBJ-3, Fig. 4.3). Biomass yield increased relative to 
LSBJ-2 to 41.3 and 52.0 g L-1 at 24 and 48 h, respectively (Fig. 4.3A). PHD accumulated at a 
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concentration of 2.27 g L-1 by 24 h, which doubled to 4.54 g L-1 by 48 h (Fig. 4.3B). Total polymer 
accumulation after 48 h was 5.12 g, a yield of 87.5% (Fig. 4.3C). 
 With PHD yields approaching the theoretical maximum, we increased the amount of 
decanoic acid added to the feed solution from 6.0 to 12.0 g (LSBJ-3 (12g), Fig. 4.3). This resulted 
in increased PHD yields of 3.87 and 6.18 g L-1 at 24 and 48 h, respectively, with a total yield of 
7.35 g, or 62.0% of the theoretical maximum (Fig. 4.3BC). Biomass accumulation decreased 
slightly relative to LSBJ-2 in response to the additional fatty acid (Fig. 4.3A). To further support 
cell growth and PHA biosynthesis, the amount of yeast extract added to the culture medium was 
increased from 1.5 to 3.0 g (LSBJ-4, Fig. 4.3). This again resulted in increased PHD yields, up to 
5.38 and 10.1 g L-1 at 24 h and 48 h, bringing the total yield to 10.6 g (89.7%). As the amount of 
decanoic acid was increased from 12 g to 25 g over subsequent trials, PHD accumulation continued 
to increase as well until reaching 20.1 g L-1 at 48 h, a total yield of 22.1 g (89.4%), at which point 
excessive foaming became an issue and the optimization process was halted (Fig. 4.3BC). 
 Purified polymers from each optimization experiment were analyzed by GPC to determine 
the number average molecular weight (Mn), weight average molecular weight (Mw), and 
polydispersity index (PDI, Mw/Mn) (Table 4.3). Mn values ranged from 28.6 to 64.3 kDa with no 
discernable trend and a high degree of variation. The polydispersity index was similarly variable, 




Figure 4.3: Optimization of PHD biosynthesis. (A) Biomass) and (B) PHD accumulation (g L1) 
at 24 (light grey) and 48 h (dark grey) from bioreactor fermentations. (C) Total PHD yield in grams 
(dark grey), displayed as an overlay of the maximum theoretical yield (light grey). All data shown 





Table 4.3: PHD Molecular Weight from Optimization Experiments. 
Experiment Mn (kDa) Mw (kDa) 
PDI 
(Mw/Mn) 
LSBJ 28.6 ± 13.9 81.5 ± 54.1 2.7 ± 0.6 
RSC02 64.3 ± 25.4 157 ± 23.7 2.6 ± 0.6 
LSBJ CRP* 40.2 ± 6.4 127 ± 4.4 3.2 ± 0.4 
LSBJ-2 31.6 ± 9.8 80.4 ± 28.7 2.5 ± 0.1 
LSBJ-3 35.9 ± 4.8 81.0 ± 9.5 2.3 ± 0.1 
LSBJ-4 (12g) 44.7 ± 4.7 125 ± 4.4 2.8 ± 0.4 
LSBJ-4 (15g) 37.3 ± 0.1 117 ± 0.6 3.1 ± 0 
LSBJ-4 (20g) 37.3 ± 4.8 103 ± 26.0 2.8 ± 0.4 
LSBJ-4 (25g) 42.0 ± 3.7 164 ± 43.7 3.9 ± 0.7 
 
4.4.3 Production of alternative MCL PHA 
 To further investigate the capabilities of the optimized high-density fermentation process, 
LSBJ harboring pBBRC1J4SII was supplemented with two other saturated MCL fatty acids in 
place of decanoic acid: hexanoic acid and octanoic acid (Trials 19 & 20, Table 4.2). Feed rates 
and fatty acid concentrations (20 g in 200 mL) were kept the same as Trial 17 to avoid the foaming 
issue observed at higher decanoic acid concentrations (Trial 18). High biomass accumulation was 
observed for both trials, similar to biomass yields obtained for Trial 17 (Fig. 4.4A). Both fatty 
acids were successfully converted into their corresponding polymers, PHHx and PHO, with yields 
of 18.2 and 17.3 g L-1 after 48 h, respectively, and followed a similar trend of increased PHA 
accumulation between 24 h and 48 h (Fig. 4.4B). Total polymer accumulation approached the 
maximum theoretical yield for both PHHx and PHO (99.0% and 90.8%) (Fig. 4.4C). The 
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molecular weights of the resulting polymers were higher than those obtained for PHD, while the 
PDI remained consistent (Table 4.4). 
 Biosynthesis of functionalized PHAs, desirable materials that are more challenging to 
produce, was also attempted using the optimized high-density fermentation process (Trial 21 & 
22, Table 4.2). Utilizing the same culture conditions and inoculum, 10-undecenoic acid and 10-
bromodecanoic acid were supplemented to produce their corresponding polymers, poly(3-
hydroxy-10-undecenoate) (PHU) and poly(3-hydroxy-10-bromodecanoate) (PHDBr) (Fig. 4.4). 
PHU yield was lower at 48 h compared to other polymers at 9.24 g L-1, although due to excessive 
foaming and subsequent antifoam addition the final culture volume was high and the total polymer 
accumulation was 13.2 g (66.8% of theoretical, Fig. 4.4BC). Similarly, 10-bromodecanoic acid 
caused excessive foaming and resulted in a lower yield and higher final volume, although to a 
lesser extent; PHDBr yield at 48 h was 14.3 g L-1 with a total accumulation of 18.0 g (90.7%). The 
Mn of PHU was similar to that of PHD at 39.1 kDa, while the Mn of PHDBr was low at 21.6 kDa 
(Table 4.4). 
 Biosynthesis of copolymers was also demonstrated using the high-density fermentation 
process by supplementing the feed with two fatty acids simultaneously. Octanoic acid was first 
mixed with decanoic acid (Trial 23), then with 10-azidodecanoic acid (Trial 24), both with 80 
mol% octanoic acid (0.58 M total fatty acid). The copolymers poly(3-hydroxyoctanoate-co-3-
hydroxydecanoate) (PHOD) and poly(3-hydroxyoctanoate-co-3-hydroxy-10-azidodecanoate) 
(PHODN3) were both produced successfully, with yields at 48 h of 16.7 g L
-1 and 18.7 g L-1 and 
total accumulation of 16.7 (97.4%) and 17.8 g (97.9%), respectively (Fig. 4.4BC). The Mn of 




Figure 4.4: Alternative MCL PHA biosynthesis. (A) Biomass) and (B) PHD accumulation (g L1) 
at 24 (light grey) and 48 h (dark grey) from bioreactor fermentations. (C) Total PHD yield in grams 
(dark grey), displayed as an overlay of the maximum theoretical yield (light grey). Trials were not 
performed with replicates and demonstrate proof-of-concept for expanding the possible substrates 





Table 4.4: Alternative MCL PHA Molecular Weights 
Polymer Mn (kDa) Mw (kDa) PDI 
PHHx 117.8 334.9 2.8 
PHO 66.3 192.3 2.9 
PHU 39.1 132.9 3.4 
PHDBr 21.6 70.5 3.3 
PHOD 104.7 286.7 2.7 
PHODN3 47.1 149.0 3.1 
 
4.5 Discussion 
 The goal of this study was to develop a fed-batch high-density fermentation process 
capable of producing MCL PHA with controlled monomer compositions at a higher titer than that 
previously achieved in shake flasks. Based on the evidence in Fig. 4.3 and Fig. 4.4b, this process 
offers a significant improvement over previous shake flask studies, and a variety of MCL PHA 
homopolymers and copolymers were made successfully (Scheel et al., 2016; Tappel et al., 2012b). 
 In initial experiments with high-density fermentation of LSBJ, including those published 
here as well as unpublished data from our research group, we were unable to detect any evidence 
of PHA biosynthesis. Preliminary experiments sought to address this through a series of genetic 
engineering experiments, beginning with the creation of LSBJ CRP*. In LSBJ, which has a wild-
type CRP, catabolite repression plays an important role in regulating primary and secondary 
metabolism (Franchini et al., 2015; Perrenoud and Sauer, 2005). In the bioreactor fermentation, 
which used glucose as the carbon source, we hypothesized that low levels of CRP-cAMP were 
preventing the expression of β-oxidation genes necessary for PHA biosynthesis, and that 
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conferring the CRP* mutation to LSBJ would alleviate this repression (Clark, 1981; Khankal et 
al., 2009; Wade et al., 2001). This was not found to be the case in initial experiments (data not 
shown), and further mutations were made to this strain in the subsequent preliminary experiments 
(Trials 1-8, Table 4.2, Fig. 4.2A).  
Production of PLA-co-PHO, a novel copolymer that has generated research interest, was 
attempted in Trial 1 in conjunction with an ongoing project in the Nomura Research Group. 
Deletion of the dld gene from LSBJ CRP*, which encodes for D-lactate dehydrogenase and has 
been shown to prevent the accumulation of PLA in E. coli (Taguchi et al., 2008), did not result in 
any detectable PLA-co-PHO. Although attempts to incorporate lactate monomers were abandoned 
in subsequent trials, the Δdld mutant (SM02) was further engineered by deletion of the arcA gene. 
Deletion of arcA was previously shown to upregulate expression of β-oxidation genes and enhance 
MCL PHA biosynthesis, and we hypothesized that the removal of arcA combined with the CRP* 
mutation (SM04) would enable PHA biosynthesis during bioreactor fermentation (Scheel et al., 
2016). Again, this was not supported by the evidence, with no detectable polymer observed (Trial 
2). 
We next hypothesized that the exogenous octanoic acid was being directed towards fatty 
acid biosynthesis rather than degradation, and that this could be prevented by deletion of the aas 
gene encoding for acyl-acyl carrier protein (acyl-ACP) synthetase. Acyl-ACP synthetase has a 
high affinity towards octanoate, and coupled with the increased membrane biosynthesis necessary 
for rapid culture growth during high-density fermentation it is possible that the octanoic acid was 
routed away from β-oxidation (Black and DiRusso, 2003; Ray and Cronan, 1976). However, the 
aas-deficient strain SM06 was unable to produce PHO from octanoic acid (Trial 3). Increasing the 
amount of octanoic acid available, both in bulk addition and continuous feeding strategies with 
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SM06, likewise did not result in polymer accumulation (Trial 4-6). A stronger promoter, generated 
by converting the lac promoter of pBBRC1J4SII into the tac promoter by mutagenesis of the -35 
region, was hypothesized to enable PHA biosynthesis by increasing expression of phaJ4 and 
phaC1 (Trial 7). This did not work, however this is unsurprising as those two genes are under the 
control of a low-expressing constitutive Cupriavidus necator promoter inserted before the lac 
promoter of pBBRC1J4SII, and PHA biosynthesis has been demonstrated with this system 
numerous times during growth in shake flasks (Tappel et al., 2012b; Wang et al., 2012). 
Overexpression of the atoDAEB operon, which was previously shown to occur in the arcA-
deficient LSBJ strain RSC02 (Scheel et al., 2016), was also unsuccessful in enabling PHA 
biosynthesis (Trial 8). 
 The effect of increasing the culture pH to 8.0 during Phase 2 is simultaneously the most 
profound and confounding result from this study (Trial 9). It was essential to the production of 
MCL PHA from exogenous fatty acids in LSBJ (Fig. 4.2C); maintaining the pH at 7.0 prevented 
PHA accumulation in all preliminary trials (Fig. 4.2A), as well as numerous trials not shown here. 
It is well-documented that growing E. coli to stationary phase in LB (and other tryptone-based 
media) commonly results in alkalinization, which explains the results of Fig. 4.2B and could 
explain why shake flask production is successful at producing MCL PHA. The literature does not 
offer any clear connections between MCL fatty acid uptake and catabolism at an alkaline pH, 
although there is a paucity of research in this area relative to growth conditions at a neutral pH 
(Maurer et al., 2005; Padan et al., 2005; Stancik et al., 2002; Yohannes et al., 2004). Despite no 
clear connections, several aspects of E. coli pH homeostasis in alkaline environments may have 
an indirect effect on PHA biosynthesis. Numerous transport systems are up-regulated to direct the 
H+ flow into the cell, and FadD does transport H+ concomitantly with fatty acids (Weimar et al., 
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2002). No evidence of differential expression for fadD has been observed, however transcriptome 
studies can not capture proteins that are regulated at the activity level rather than expression, which 
is common for many Na+/H+ antiporters (Maurer et al., 2005; Padan et al., 2005). Another 
contributing factor could be the repression of the flagellar biosynthesis and chemotaxis regulons, 
which are down-regulated extensively (47 out of 50 genes, pH 8.7) at an alkaline pH (Maurer et 
al., 2005). Repression of this energy-intensive process could have freed up cellular resources such 
as ATP for PHA biosynthesis. Further research into fatty acid uptake and metabolism would be 
necessary to determine the direct effects of pH on PHA biosynthesis, which falls far beyond the 
scope of this study.  
 Although successful, the PHD yield in Trial 9 did not offer an improvement over typical 
shake flask production. To test the earlier hypotheses of low CRP-cAMP inhibiting biosynthesis 
and repression by ArcA, we repeated the conditions used in Trial 9 with both RSC02 (Trial 10) 
and LSBJ CRP* (Trial 11). No benefit to PHD yield was observed for either Trial; PHD weight 
percent was improved slightly, but this was offset by a reduced biomass (Fig. 4.3AB). 
 Reducing the rate of glucose addition during Phase 2 (Trial 12) increased the yield of PHD 
to 2.48 g L-1, greater than a 5-fold improvement (LSBJ-2, Fig. 4.3B). One explanation for this is 
the overabundance of glucose in previous trials and the subsequent increase in overflow 
metabolism. Overflow metabolism in E. coli occurs during high levels of aerobic glucose 
consumption, and results in the excretion of acetate which can become toxic and growth-limiting 
(Vemuri et al., 2006). This is particularly pronounced in E. coli K-12 strains, which LSBJ is 
derived from, due to an inactive or low-activity glyoxylate shunt (Noronha et al., 2000; Rand et 
al., 2017; Walle and Shiloach, 1998). An increase in biomass of approximately 50% provides 
additional evidence to support this explanation, however this biomass increase is not enough to 
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account for the magnitude of the increase in PHD yield (Fig. 4.3A). Another effect of the reduced 
glucose feed rate could be an increase in the cAMP pool resulting from increased adenylate cyclase 
activity due to decreased glucose transport (Notley-McRobb et al., 1997). This in turn would 
increase CRP-cAMP abundance and could lead to upregulation of fadD and fadE, resulting in 
enhanced PHD biosynthesis. 
 One issue that needed to be addressed was the apparent death of the bacterial culture during 
Phase 2, as evidenced by a reduction in biomass and lack of PHA accumulation between 24 and 
48 h (Fig. 4.3AB), and by a marked decrease in oxygen consumption as early as 13 h until DO% 
remained nearly saturated (Fig. D1-6, Appendix D). Previous research has indicated that high 
ammonia concentrations during high-density fermentation inhibit the growth of E. coli and limit 
secondary metabolism, which could explain the results observed in this study (Lau et al., 2004; 
Riesenberg et al., 1991; Shiloach and Fass, 2005). Reformulating the culture medium and glucose 
feed based on low ammonia alternatives described by Lau et al. (2004) appeared to eliminate the 
issue of culture death (Trial 13); biomass and PHD yield increased between 24 and 48 h (Fig. 
4.3AB), oxygen demand slowly increased over the entire fermentation (Fig. D7, Appendix D), and 
total PHD accumulation at 48 h reached 87.5% of the theoretical yield (Fig. 4.3C). In addition to 
drastically reducing the ammonium concentration, the new formulation contained more phosphate 
to support a higher cell density and more trace metals to ensure adequate cofactor abundance 
(Herbert et al., 1965; Neidhardt et al., 1974). 
 With a media formulation capable of supporting high-density fermentation and the majority 
of fatty acid substrate being converted to polymer, the next logical step was the optimization of 
the fatty acid feed; specifically, increasing the amount and rate of decanoic acid addition (Trials 
14-18). Progressively increasing the amount of decanoic acid added to totals of 12 g, 15 g, 20 g, 
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and 25 g (addition rates of 0.44, 0.55, 0.65, and 0.75 g h-1, respectively) correlated with an increase 
in PHD yield, culminating in a final titer of 20.1 g L-1 (Fig. 4.3B). However, adding 25 g of 
decanoic acid resulted in excessive foaming likely as a result of exogenous decanoate behaving as 
a surfactant, and replication of this feeding strategy proved to be difficult due to uncontrollable 
foaming and loss of culture. Alternative strategies exist to control foam in an industrial bioprocess 
setting, such as mechanical disruption or ultrasound, but these are incompatible with the small 
benchtop vessel used in this study (Delvigne and Lecomte, 2009; Routledge, 2012). As such the 
optimization of the fatty acid feed was halted, and analysis of previous metabolic engineering 
strategies (CRP*, ΔarcA, etc.) was deemed unnecessary due to the physical nature of the foaming 
limitation. It is also important to note that the amount of yeast extract added to the initial culture 
medium was doubled to 3.0 g for Trial 15 and for each subsequent Trial. This was in response to 
a decrease in % yield when decanoic acid was increased to 12 g, believed to be due to an increased 
fatty acid toxicity. Fadzil et al. has previously shown that increasing the concentration of yeast 
extract for E. coli LSBJ cultures utilizing co-carbon sources (glucose and decanoic acid) increases 
their tolerance towards fatty acids and enhances MCL PHA biosynthesis (2018). Our results 
support this observation; increasing the concentration of yeast extract led to improved biomass, 
PHD yield, and decanoic acid utilization (89.7% yield) (LSBJ-4 (12g), Fig. 4.3). 
 The optimized high-density fermentation process developed here was also shown to be 
flexible with regard to fatty acid substrate; hexanoic acid, octanoic acid, 10-undecenoic acid, 10-
bromodecanoic acid, and 10-azidodecanoic acid were all successfully polymerized in addition to 
decanoic acid (Fig. 4.4), with confirmation by NMR for the functionalized PHU, PHDBr, and 
PHODN3 (Appendix A). Each alternative MCL PHA tested was produced at yields of 9.24 g L
-1 
or higher and with no detectable co-monomers present except for the intentional copolymers 
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PHOD and PHODN3. These copolymers contained monomer compositions closely resembling the 
mol% of the feed solution (81.8 and 80.4% 3HO, respectively), which is unsurprising given the 
high fatty acid utilization observed (approximately 97% for both) (Fig. 4.4C). This control over 
monomer composition is one of the primary benefits to using E. coli LSBJ as the production host, 
particularly over a wide range of fatty acid substrates (Tappel et al., 2012b). Although numerous 
high-density cultivation methods have been reported using native producers such as Pseudomonas 
species, only PHD has previously been produced at near-homopolymeric compositions and high 
titers, and there are no reported bioprocesses for the production of PHHx, PHO, PHU, or PHDBr 
homopolymers to the best of our knowledge (Follonier et al., 2015; Gao et al., 2018; Jiang et al., 
2013; Oliveira et al., 2020; Sun et al., 2007). 
 The molecular weights varied for the PHAs produced, and the PDIs ranged from 2.3 to 3.9 
(Table 4.3 & 4.4). The molecular weights (Mn) of PHD showed considerable variation, ranging 
between 28.6 and 64.3 kDa. This is comparable and slightly less than previous work performed in 
shake flasks, where Mn values of 61.5 to 111 kDa were observed (Mohd Fadzil et al., 2018; Tappel 
et al., 2012b). Similarly, the Mn value of PHU was slightly less than previously observed (39.1 vs. 
60 kDa) (Tappel et al., 2012a), while the Mn of PHHx was higher than previous reports (118 vs. 
77 kDa) (Scheel et al., 2016). Overall molecular weights are comparable to those from similar 
studies, however with the high degree of variation and lack of replicates for alternative MCL PHAs 
only limited comparisons can be made. 
The high-density fermentation process described here was developed to allow for MCL 
PHA biosynthesis with controlled monomer composition at a higher yield than shake flask 
production can accommodate. The productivity shown here of PHD biosynthesis from 25 g 
decanoic acid (0.42 g L-1 h-1) rivals that of the highest published productivity for nearly 
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homopolymeric PHD (0.41 g L-1 h-1), although this work had issues with reproducibility (Gao et 
al., 2018). High MCL PHA yields were demonstrated from a variety of fatty acid substrates, both 
saturated and functionalized, showing that this is a versatile process capable of producing unique 
and valuable materials. 
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Chapter 5: Progress towards a poly(3-hydroxyoctanoate-co-3-hydroxy-10-azidodecanoate) 
nanoparticle drug delivery system 
5.1 Abstract 
This chapter describes progress towards the production of nanoparticles made from azide-
containing poly(3-hydroxyalkanote) copolymers (Azido PHAs), with the purpose of developing a 
targeted drug-delivery system. Two azido PHAs, poly(3-hydroxybutyrate-co-3-hydroxy-10-
azidodecanoate) (PHBDN3) and poly(3-hydroxyoctanoate-co-3-hydroxy-10-azidodecanoate) 
(PHODN3), were biosynthesized in recombinant Escherichia coli RSC02 harboring PHA 
biosynthesis genes. Bacterial endotoxin was removed from isolated polymers by a combination of 
sodium hydroxide treatment and methanol precipitation, which were effective individually and in 
combination to reduce endotoxin below 0.01 endotoxin units per mg (EU mg-1). Polymer 
molecular weights were largely unaffected by the sodium hydroxide treatment. Nanoparticles were 
iteratively produced by single emulsion or nanoprecipitation techniques to determine the most 
effective method for generating nanoparticles <100 nm in diameter. The ideal production method 
was nanoprecipitation of PHODN3 dissolved in 15% ethanol/acetone solution and precipitated in 
Nanopure filtered water, which yielded particles with an average diameter of 70.6 nm. With this 
process, paclitaxel was encapsulated by PHODN3 with an encapsulation efficiency as high as 
80.8% when 1% w/w paclitaxel was administered, with a decrease in efficiency as the 
concentration of paclitaxel was increased. PLGA nanoparticles were prepared by the same process, 
wherein encapsulation efficiencies under 14.3% were achieved. Nanoparticle uptake kinetics and 






 Polymeric nanoparticles have received considerable attention in recent years as potential 
drug-delivery systems, particularly for use in targeted chemotherapy treatments (Hans and 
Lowman, 2002; Hillaireau and Couvreur, 2009; Lee et al., 2017). Nanoparticles are generally 
defined as spherical, solid particles approximately 100 nm in size. They have been produced using 
a variety of polymers, though most commonly with poly(lactide-co-glycolide) (PLGA) due to its 
biocompatibility and biodegradability into common metabolites (lactate and glycolate), 
commercial availability, and its approval by both the U.S. Food and Drug Administration (FDA) 
and European Medicine Agency (EMA) for use in therapeutic devices (extensively reviewed by 
Danhier et al., 2012). 
 Numerous nanoparticle targeting strategies have been investigated as a way to selectively 
administer drugs to target cells and reduce systemic toxicity, most commonly by the conjugation 
of targeting moieties to the exterior particle surface (Yu et al., 2012). These strategies include; 
antibodies such as anti-prostate stem cell antigen antibody and mutant anti-epidermal growth 
factor receptor antibody (Hadjipanayis et al., 2010; Ling et al., 2011), peptides and proteins like 
transferrin (Petrelli et al., 2010; Sarris et al., 2000), and small molecules such as riboflavin and 
folic acid (Foraker et al., 2003; Kennedy et al., 2003). Folic acid in particular has generated 
significant research interest due to its low cost and high availability, and more importantly because 
of the high folate-receptor expression observed in many types of cancerous cells (Bahrami et al., 
2015). Folate receptor-α (FR-α) has a high binding affinity for folate and induces uptake by 
endocytosis when bound, and folate-conjugated nanoparticles have been shown to be similarly 




 Poly[(R)-3-hydroxyalkanoates] (PHAs) are another class of biodegradable, biocompatible 
polymers that are promising biomedical materials (Rai et al., 2011). These bacterially-derived 
polyesters have been investigated as a potential nanoparticle drug-delivery platform, with limited 
success; the predominant PHAs employed for nanoparticle synthesis included the short chain-
length (SCL) PHA poly(3-hydroxybutyrate) and its copolymers containing 3-hydroxyvalerate, 
which were characterized by low drug encapsulation efficiency, large particle size (>160 nm), and 
poor drug retention (Poletto et al., 2008; Pramual et al., 2016; Xiong et al., 2010). These SCL 
PHAs also suffer from chemical intractability, making them difficult to functionalize with 
targeting moieties. Additionally, PHAs biosynthesized via gram-negative bacteria contain 
lipopolysaccharides (LPS, endotoxin), a component of the outer membrane of gram-negative 
bacteria that can induce a severe inflammatory response in humans known as endotoxic shock 
(Calvano and Coyle, 2012; Rietschel et al., 1994). Endotoxins are persistent, requiring additional 
purification steps to remove them from PHAs (Furrer et al., 2007; Lee et al., 1999).  
 Recently, a number of medium chain length (MCL) PHAs have been biosynthesized 
containing terminal alkene, alkyne, azide, and bromo functional groups (Nkrumah-Agyeefi and 
Scholz, 2017; Pinto et al., 2016; Tappel et al., 2012b, 2012a). These functional PHAs are produced 
in both native-producing (e.g. Pseudomonas sp.) and recombinant bacteria (e.g. Escherichia coli) 
from functionalized fatty acid substrates, which enter the β-oxidation pathway and are converted 
to 3-hydroxyacyl-CoA esters, and subsequently polymerized by a PHA synthase. These functional 
groups confer significant chemical reactivity to the polymer and are notably amenable to the so-
called “Click” reactions, which are desirable due to their selectivity, high yield, stereospecificity, 
and benign reaction conditions (Kolb et al., 2001). In particular, the strain-promoted azide-alkyne 
cycloaddition (SPAAC) reaction has seen significant utilization as a conjugation method for 
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nanomedicine, owing to its simple reaction conditions (room temperature, aqueous solvents) and 
the omission of toxic copper-catalysts, summarized in Scheme 5.1 (Dommerholt et al., 2016). 
 
Scheme 5.1: General strain-promoted alkyne-azide cycloaddition (SPAAC) reaction. For our 
studies, R1 denotes the alkyl side-chain of azido-PHA monomers and R2 denotes a di-benzyl 
substitution on the cyclooctyne ring (dibenzylcyclooctyne, DBCO). 
 
 The goal of this study was to utilize newly characterized copolymers poly(3-
hydroxybutyrate-co-3-hydroxy-10-azidodecanoate) (PHBDN3) and poly(3-hydroxyoctanoate-co-
3-hydroxy-10-azidodecanoate) (PHODN3) to develop a targeted nanoparticle drug delivery system 
based on folate receptor-mediated endocytosis and the model chemotherapeutic paclitaxel (Fig. 
5.1) (Pinto et al., 2016).  
 
Figure 5.1: Proposed synthesis of targeted nanoparticles for drug delivery. Azide-containing PHA 
copolymers (Azido PHA) will be used to encapsulate the chemotherapeutic agent paclitaxel (PTX, 
yellow dots). Folic acid analogs will be conjugated to surface-exposed azides (red dots) via strain-





5.3.1 Bulk polymer biosynthesis 
 Azido-PHAs were biosynthesized as previously described (Pinto et al., 2016). In brief, E. 
coli RSC02 was transformed with pBBRC1J4SII by heat shock following standard procedures 
(Sambrook and Russell, 2001). A 50-mL seed culture (LB-Lennox, composition per liter: 10 g 
tryptone, 5 g yeast extract, 5 g sodium chloride) supplemented with 50 μg mL-1 kanamycin sulfate 
was inoculated with LSBJ-pBBRC1J4SII and grown for 16 h at 37°C and 200 rpm rotary shaking. 
Growth media (6 × 400 mL LB in 2-L flasks) was supplemented with synthetic 10-azidodecanoic 
acid (2 mM) and either sodium octanoate or sodium butyrate (8 mM), along with kanamycin sulfate 
(50 μg mL-1). The surfactant Brij-35 (4.0 g L-1, Sigma-Aldrich) was added to ensure dissolution of 
the fatty acids. Growth flasks were inoculated with 0.5% (v/v) seed culture and grown for 48 h at 
30°C and 250 rpm. Bacteria were harvested by centrifugation at 3,716 × g for 15 min in 800-mL 
buckets, washed once with 200-mL 40% ethanol and once with 200-mL Nanopure filtered water. 
Cell pellets were transferred to 50-mL centrifuge tubes and resuspended 5-15 mL Nanopure water, 
frozen, and dried via lyophilization. 
 Polymer was isolated from dried cells by Soxhlet extraction with 250 mL chloroform 
(HPLC Grade, Fisher Scientific) for 6 h, with the extract then concentrated by rotary evaporation. 
Polymer was purified via non-solvent precipitation by drop-wise addition to cold methanol (4°C) 
with moderate stirring, at a 1:10 ratio of chloroform:methanol. Precipitated polymer was collected 
by centrifugation at 8000 × g and 4°C for 20 min. Polymers were subjected to three rounds of 
methanol purification, then dried in vacuo and stored at 4°C until needed. Polymer was produced 
using these procedures as necessary to generate more material. 
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5.3.2 Endotoxin removal and analysis 
Growth media for azido PHA endotoxin analysis experiments was composed of; LB, Brij-
35 (4.0 gL-1), kanamycin (50 mg L-1), and the fatty acids 10-azidodecanoic acid (2 mM) and either 
sodium octanoate or sodium butyrate (8 mM). E. coli RSC02 was transformed with the pBBR-
C1J4SII plasmid by heat shock, and grown on an LB-agar plate at 37°C for 16 hours with 
kanamycin selection. Individual colonies were picked to inoculate 5 mL LB seed cultures, in 
triplicate, and grown for 16 h at 37°C and 200 rpm rotary shaking. Seed cultures were used to 
inoculate triplicate groups of 6 baffled shake flasks each containing 100 mL of growth media at a 
final seed concentration of 0.5%, for a total of 18 flasks per copolymer. Flasks were cultured for 
48 h at 30°C and 250 rpm. 
 Cells were harvested by centrifugation at 3,716 × g, washed once with 40 mL of 45% 
ethanol and then once with 40 mL of Nanopure water. Each 600 mL triplicate group was divided 
in half to have a 3 × 100 mL control group and a 3 × 100 mL sodium hydroxide (NaOH) treatment 
group. The control groups were resuspended in 5 mL of endotoxin-free water (Fisher Scientific) 
after harvest, frozen, and dried via lyophilization. The NaOH groups were resuspended in 35 mL 
of NaOH (0.2 M) in endotoxin-free water and incubated for 5 h at 37°C with 80 rpm reciprocal 
shaking, in a protocol adapted from Lee et al. (1999). The cell suspension was neutralized with 
endotoxin-free hydrochloric acid (HCl, 2 M), harvested by centrifugation at 6000 × g for 20 min, 
and washed once with endotoxin-free water before being frozen and dried via lyophilization. 
 From this point forward, all glassware was heat-treated at 250° for 1 h to destroy endotoxin, 
prior to coming in contact with polymer. Polymer from both the control and NaOH treated cells 
was isolated by Soxhlet extraction (150 mL chloroform, 6 h reflux), then transferred to tared 20-
mL scintillation vials. A sample of this crude polymer was set aside (~20 mg) using flame-treated 
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steel implements, with the remainder being purified by non-solvent precipitation in cold methanol 
(4°C) with moderate stirring, at a 1:10 ratio of chloroform:methanol. The precipitated polymer 
was collected by centrifugation at 8000 × g and 4°C for 20 min, re-dissolved in chloroform, and 
transferred to tared scintillation vials. Each polymer underwent 3 cycles of methanol purification, 
with 20 mg samples removed each time for endotoxin testing. All samples were dried in vacuo to 
remove residual solvents before weighing and recorded masses were used for calculations. 
 Endotoxin testing was conducted using the Pierce™ LAL Chromogenic Endotoxin 
Quantitation Kit following the manufacturers recommended procedure. Endotoxin-free water was 
added to the dried polymer samples at a concentration of 40 μL mg-1 of polymer and incubated at 
37°C with 200 rpm rotary shaking for 24 h, adapted from previously described methods (Furrer et 
al., 2007; Lee et al., 1999). This water was used for the endotoxin assay (50 μL per sample). The 
absorbance was measured at 410 nm using a Synergy™ H4 microplate reader (BioTek), and 
endotoxin was quantified as endotoxin units (EU) using a calibration curve of known endotoxin 
concentrations. 
5.3.3 Molecular weight determination 
Both weight average (Mw) and number average (Mn) molecular weights were determined 
using gel permeation chromatography as described previously (Scheel et al., 2016). Polymer 
samples were dissolved in chloroform to an approximate concentration of 1.0 mg mL-1 and passed 
through a 0.45 μm PTFE syringe filter.  Samples were injected at a volume of 50 μL into a 
Shimadzu LC-20AD liquid chromatograph equipped with a Shimadzu SIL-20A autosampler, a 
Shimadzu CTO-20A column oven, and a Shimadzu RID-10A refractive index detector.  Samples 
were passed through an 8 × 50 mm styrenedivinylbenzene (S-DVB) guard column (5 μm particles; 
Polymer Standards Service) and an 8 × 300 mm S-DVB analytical column (5 μm particles; mixed 
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bed porosity; max molecular weight 1 × 106 Da; Polymer Standards Service product 
sda083005lim).  The column oven was maintained at 40 °C, and chloroform was used as the mobile 
phase at 1 mL min-1. Polystyrene molecular weight standards with a narrow polydispersity index 
were employed for calibration.  Data analysis was performed using Shimadzu LCSolution 
software. 
5.3.4 Production of PHA nanoparticles 
Numerous nanoparticle production strategies were tested using a variety of conditions, 
including two techniques (single emulsion-solvent evaporation and nanoprecipitation), two 
different surfactants, seven different organic solvent mixtures, and two different aqueous:organic 
ratios, which is summarized in Appendix B. The method that produced the smallest average 
diameter and the most stable nanoparticles (least aggregation) was used for subsequent paclitaxel 
encapsulation and conjugation experiments; this method is described in detail below. 
Polymer solutions of PHODN3 or 50:50 poly(DL-lactide-co-glycolide) (PLGA, purchased 
from DURECT) were prepared via nanoprecipitation by dissolution in 85:15 acetone:ethanol to a 
2.8 mg mL-1 final concentration. The drug paclitaxel (PTX, LC Laboratories) was also dissolved 
in 85:15 acetone:ethanol to final concentrations of 0.028, 0.14, and 0.28 mg mL-1, corresponding 
to 1%, 5%, and 10% w/w of the polymer employed. In quadruplicate, the PTX and polymer 
solutions were combined in equal volumes to produce 20 mL solutions, followed by slow drop-
wise addition (~1 mL min-1 by addition funnel) to a beaker containing vigorously stirred deionized 
water (20 mL; prefiltered through a 0.20 μm PES syringe filter). Paclitaxel-free nanoparticles were 
produced by combining the polymer solution with pure 85:15 acetone:ethanol and following the 
same procedure. The resulting solution was left to stir uncovered at room temperature for 24 h. 
The resulting aqueous heterogeneous suspension was purified, first through a plug of cotton, and 
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then by gel filtration chromatography (GFC). Aqueous nanoparticle suspensions were loaded (2.5 
mL aliquots) onto PD-10 desalting columns containing 8.3 mL of Sephadex G-25 medium (GE 
Healthcare Life Sciences) and eluted by gravity with 3.5 mL Nanopure filtered water following 
manufacturer specifications. 
Nanoparticle sizes were determined by dynamic light scattering (DLS) with a Zetasizer 
Nano ZS (Malvern) equipped with a 4.0 mW He-Ne laser (λ = 633 nm), operated at room 
temperature, and at a scattering angle of 173°.  Polystyrene cells with 10 mm optical paths were 
used for DLS experiments, with ~1 mL sample volume and a concentration of polymer 
nanoparticle suspensions of 0.50–1.0 mg mL-1.  Each sample was analyzed in triplicate. Following 
DLS analysis, samples were either frozen and lyophilized for paclitaxel quantification or used in 
subsequent conjugation experiments. 
5.3.5 Quantification of paclitaxel by HPLC 
High performance liquid chromatography (HPLC) was performed with a Shimadzu 
LC2010A HT HPLC system equipped with a reverse phase Zorbax Eclipse XDB-C18 (4.6 x 15 
mm, particle size 5 μm, Agilent) analytical column and a UV detector. Two mobile phases were 
employed, mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in 
acetonitrile).  Lyophilized nanoparticle samples were dissolved in 1 mL of acetonitrile, injected (5 
μL), and analyzed by isocratic elution consisting of 55% B over 10 min with a flow rate of 1 mL 
min-1 while monitoring at 227 nm. Column oven was maintained at 40°C. Paclitaxel was quantified 
using Shimadzu’s LabSolutions LC software based on calibration curves generated with pure 
paclitaxel. Encapsulation efficiency (EE) was calculated as shown here: 
𝐸𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 % (𝐸𝐸) = (
𝑀𝑎𝑠𝑠 𝑑𝑟𝑢𝑔 𝑙𝑜𝑎𝑑𝑒𝑑 (𝑚𝑔)
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑎𝑑𝑑𝑒𝑑 𝑡𝑜 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (𝑚𝑔)
) × 100 
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5.3.6 Conjugation of PEG to PHODN3 and PLGA nanoparticles 
 Dibenzocyclooctyne-poly(ethylene glycol) (DBCO-PEG, 5kDa, purchased from Nanocs) 
was conjugated to 5% of the azido moieties on PHODN3 via the SPAAC reaction. The mol% of 
PHODN3 was calculated by 
1H-NMR as described in Chapter 4. PHA was dissolved in 1.0 mL 
chloroform at a concentration of 100 mg mL-1 and combined with 2.0 mL of DBCO-PEG solution 
(27 mg mL-1). The reaction was carried out at room temperature for 1 h, and successful conjugation 
was determined by 1H-NMR by the appearance of a multiplet peak at δ 4.5-4.0 corresponding to 
the two protons alpha to the triazole (Fig. A11, Appendix A). The resulting pegylated-polymer 
(PHODN3-PEG) was dried in vacuo and used for nanoparticle production as described above. 
 PLGA was conjugated to PEG (5 kDa, Sigma Aldrich) as described by El-Gogary et al., 
with minor adaptations (2014). In brief, PLGA (500 mg, 0.12 mmol), N-hydroxysuccinimide (4 
eq, Acros Organics), and N,N`-dicyclohexylcarbodiimide (4 eq, Acros Organics) were dissolved 
in 1.2 mL dry dichloromethane at room temperature. This solution was filtered (0.45 μm PTFE, 
Restek) and added to 1.05 eq PEG and stirred overnight. N,N-diisopropylethylamine (10 eq, Acros 
Organics) was added, and the solution was stirred for 48 h. The product was precipitated with cold 
diethyl ether and collected by centrifugation for 30 min at 3500 rpm. PLGA-PEG was verified by 
1H-NMR based on characteristic peaks at δ 5.3, 4.9, and 1.46 (PLGA) and δ 3.3 (PEG), as well as 
its high solubility in dimethyl sulfoxide (DMSO). 
5.4 Results 
5.4.1 Endotoxin removal and molecular weight analysis 
 The endotoxin content of PHBDN3 and PHODN3 was measured using a Limulus 
amoebocyte lysate chromogenic assay (LAL). Treatment with 0.2M NaOH was effective at 
removing nearly all endotoxin from both PHBDN3 and PHODN3, reducing the measured 
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endotoxin units (EU) per mg by 96% and 98%, respectively (Fig. 5.2A). Polymer molecular weight 
(Mn) remained relatively unchanged between the NaOH and control groups (Fig. 5.2B). Both 
polymers responded similarly to the treatment; endotoxin was drastically reduced in treated groups 
and molecular weights were unaffected. 
 
Figure 5.2: (A) Endotoxin present (EU mg-1) in crude PHBDN3 (dark gray) and PHODN3 (striped) 
as determined by the LAL chromogenic endpoint assay. The sodium hydroxide treatment (0.2 M 
NaOH) removed 0.22 EU mg-1 (~96%) of detectable endotoxin compared to the untreated 
(Control) PHBDN3, and 0.19 EU mg
-1 (~98%) was removed from PHODN3. (B) Average 
molecular weight (Mn) of crude polymer samples as determined by GPC. Values shown in both 
(A) and (B) are an average of triplicate experiments, plus or minus the standard deviation around 
those averages. 
 
 The two polymers responded differently to successive methanol purifications. The 
endotoxin measured from the PHBDN3 control group was reduced by 97% after the first methanol 
purification down to the same level as the NaOH group, while endotoxin measured from the 
PHODN3 control remained unchanged until the final round of purification (Fig. 5.3AB). An 
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increase in endotoxin was observed for PHODN3 after the second round of purification, which is 
believed to be due to external contamination (Fig. 5.3B). A minor decrease in Mn was observed 
for both polymers in the NaOH treatment group, which was only observed after methanol 
purification (Fig. 5.3CD). However, molecular weights increased slightly by the third round of 
purification for the PHODN3 control and PHBDN3 NaOH groups. No data was collected for the 
thrice purified PHBDN3 control, as the polymer samples became insoluble in chloroform. 
 
Figure 5.3: Change in endotoxin content (EU mg-1) and molecular weight (Mn) over successive 
methanol (MeOH) purifications for PHBDN3 (A, C) and PHODN3 (B, D). An increase in 
endotoxin for NaOH-treated PHODN3 (light gray diamonds) was observed after the second 
methanol purification, believed to be due to contamination from an external source. Endotoxin 
content of control PHODN3 (dark gray squares) remained high for the first 2 methanol 
purifications before decreasing dramatically. All values are an average of triplicate experiments, 





5.4.2 Comparison of nanoparticle production methods 
 Numerous methodologies were tested to determine a reproducible production process for 
uniform nanoparticles <100 nm in diameter. More information on the initial methods used to 
generate nanoparticles can be found in Appendix B, and a summary of the nanoparticle sizes 
produced is shown in Fig. 5.4. Initial experiments with PHBDN3 formed large aggregates (data 
not shown), and the remainder of the experiments were performed exclusively with PHODN3. 
Particles produced by single emulsion in sodium dodecyl sulfate (SDS, 4.4 mg mL-1) were much 
smaller than those produced in poly(vinyl alcohol) (PVA, 4.4 mg mL-1) at 160.7 nm (Fig. 5.4A), 
and SDS was used in subsequent experiments.  Varying the duration of ultrasonication had little 
effect on particle size (Fig. 5.4B) and reducing the polymer concentration to 15 or 7.6 mg mL-1 
only resulted in minor decreases (Fig. 5.4C). Particles produced by the nanoprecipitation method 
varied widely depending on the organic solvent system used, and most organic solvents resulted 
in particles of a large range (Fig. 5.4D). Particles were centrifuged and washed to remove residual 
SDS, which resulted in the precipitation of larger particles but not smaller ones, depending on the 
organic solvent used. The acetone/ethanol and dimethylformamide (DMF) solvent systems were 
chosen for further analysis (Fig. 5.5). Longer centrifugation times enabled the precipitation of 
larger particles produced using DMF, however the smaller particles remained in suspension, and 
the acetone/ethanol mixture produced smaller particles overall. Replacing the SDS solution with 
pure water and using acetone/ethanol as the organic solvent generated the smallest particles yet, 
and with the narrowest polydispersity. No particles could be precipitated by centrifugation, 





Figure 5.4: Survey of PHODN3 nanoparticle production methods by size. Particles produced by 
single emulsion via ultrasonication (A-C) were selected for smallest size using an iterative 
approach. (A) The surfactants poly(vinyl alcohol) (PVA) and sodium dodecyl sulfate (SDS) were 
compared first, and SDS selected for subsequent experiments. (B) Effect of varying ultrasonication 
durations, 50 sec duration used in prior and subsequent experiments. (C) Effect of PHODN3 
concentration on size. Particles produced by nanoprecipitation (D) were compared according to 
organic solvent system and by the ratio of organic solvent to aqueous SDS (4.4 mg mL-1) solution 
(1:1 or 1:10). Particles in panel D were measured first by DLS after 24 h (SDS, striped) and after 
pelleting by centrifugation and resuspending in water (Pellet, light gray). Particles suspended in 
the supernatant after centrifugation were also analyzed (Supernatant, dark gray). Abbreviations: 
tetrahydrofuran (THF), acetone (ace), ethanol (EtOH), dimethyl sulfoxide (DMSO), 






Figure 5.5: Size comparison of PHODN3 nanoparticles produced by nanoprecipitation. Polymers 
dissolved in DMF and acetone/ethanol (Ace/EtOH, 85% acetone v/v) were added dropwise to 
aqueous SDS solutions (4.4 mg mL-1) and centrifuged after 24 h. Particle size was measured by 
DLS for both the supernatant and the resuspended pellet. Polymers dissolved in acetone/ethanol 
(Ace/EtOH, 85% acetone v/v) were also added dropwise to pure water, which produced uniform 
particles measuring 70.6 nm and no pelleted particles. Data shown are the average of triplicate 
experiments, plus or minus the standard deviation around those averages. 
 
5.4.3 Paclitaxel encapsulation efficiency 
 PHODN3 and PLGA nanoparticles, along with their pegylated counterparts, were 
compared with regard to their ability to encapsulate PTX at three loading concentrations (Fig. 5.6). 
PHODN3 was far more effective at encapsulating PTX at all three concentrations, and un-
pegylated PHODN3 encapsulated approximately 80% of PTX when it was combined at 1% (w/w). 





Figure 5.6: Encapsulation efficiency of polymeric nanoparticles. Particles were prepared using 
the nanoprecipitation method and varying concentrations of paclitaxel (PTX). Data shown are the 
average of quadruplicate experiments, plus or minus the standard deviation around those averages. 
 
5.5 Discussion 
The NaOH treatment was very effective at reducing endotoxin toxin levels, bringing these 
values to below 0.01 EU mg-1, a decrease of approximately 97% compared to the control (Fig. 
5.2A). At this concentration of endotoxin, up to 71.4 mg of PHBDN3 or 125 mg of PHODN3 per 
mL could be administered intravenously under the FDA guidelines of 0.5 EU mL-1, with a 
maximum of 2.8 g or 5.0 g per dose, respectively (20 EU/device limit) (U.S. Food and Drug 
Administration, 2016). However, additional purification is necessary to remove other hydrophobic 
contaminants such as lipids and proteins, which can be achieved by precipitation in a non-solvent 
such as methanol (Sevastianov et al., 2003). Precipitation in methanol appeared to remove 
endotoxin quite readily from the PHBDN3 control group, which was reduced to the same EU mg
-
1 as the NaOH group with a single purification step (Fig. 5.3A). This phenomenon was not 
observed with PHODN3; the endotoxin was only removed from the control after the final 
purification (Fig. 5.3B). It is unclear why endotoxin remained associated with PHODN3 through 
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several rounds of purification; it is possible that the lipid A component of LPS formed stronger 
hydrophobic interactions with the longer side chains of 3-hydoxyoctanoate monomers in 
comparison with the short side chains of 3-hydroxybutyrate, although this speculation is based 
solely on the structural characteristics of LPS (Rietschel et al., 1994). 
 As a polyester, PHAs can be susceptible to backbone cleavage under basic conditions. To 
determine the effects of our 0.2 M NaOH treatment, we used GPC to analyze the polymer 
molecular weights with and without treatment (Fig. 5.2B). We found that there was no change in 
molecular weight observed for the crude polymer after treatment. As the polymers were 
successively purified by methanol precipitation, the molecular weights of the PHODN3 control 
group increased incrementally, likely as a result of the loss of lower molecular weight species (Fig. 
5.3A). A similar trend was observed for the PHBDN3 NaOH group (Fig. 5.3C). Based on the 
inconsequential changes observed in the molecular weight post-NaOH treatment, and the efficacy 
of both methods for removing endotoxin, both purification methods were deemed viable options 
for low-endotoxin nanoparticle production. 
 One of the key characteristics of nanoparticle drug-delivery platforms is their size. The 
circulation time (Ahmed et al., 2005; Hoshyar et al., 2016), rate and mechanism (diffusion, 
endocytosis, or phagocytosis) of cellular uptake and/or expulsion (Lu et al., 2009; Peruzynska et 
al., 2015), and intracellular localization (Wu et al., 2019) of nanoparticles have all been shown to 
be highly dependent on size, with differences observed for sizes in a range as small as 20 nm. 
Optimal size depends on the target cell type and the desired route of internalization, however most 
of these studies concluded that nanoparticles of approximately 90-100 nm show desirable 
internalization efficiency. Over numerous iterative experiments comparing nanoparticle 
production methods, we were able to determine the ideal conditions for producing PHODN3 
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nanoparticles of a consistent, uniform size (Fig. 5.4 & 5.5). Nanoprecipitation of our polymer into 
pure water not only resulted in a desirable particle size, it also eliminated time-consuming 
surfactant removal steps and the use of poorly scalable techniques such as ultrasonication and 
centrifugation. 
 The PHODN3 far outperformed the PLGA, regarded as the gold standard for polymeric 
nanoparticles, in its ability to encapsulate paclitaxel in this study (Fig. 5.6). PLGA has been shown 
to be capable of higher efficiency with respect to PTX encapsulation, with efficiencies of 
approximately 70-75% reported (Betancourt et al., 2009; Danhier et al., 2009; Wang et al., 2011). 
These studies differed in the techniques used to prepare nanoparticles (single emulsion, double 
emulsion, and nanoprecipitation), the organic and aqueous solutions employed, and the use of 
polymer blends, demonstrating that drug encapsulation is dependent on multiple factors. These 
studies also produced nanoparticles larger than the sizes achieved here with PHODN3, ranging 
from 112-240 nm, which as described above is an important factor in cell uptake. Further 
characterization of our nanoparticles with regard to cellular uptake and drug release is needed to 
determine their efficacy. 
 The data presented in this chapter is largely preliminary, setting the foundation for a new 
polymeric drug delivery system. The next steps needed are to evaluate the shelf-life stability of 
PTX-loaded PHODN3 nanoparticles and the release of PTX over time, the in vitro cellular uptake 
kinetics of folate-conjugated nanoparticles by human cancer cells, and the cytotoxicity of these 
nanoparticles. Currently, work is underway assessing cellular uptake of folate-labelled 
nanoparticles by human breast cancer cells, which will be analyzed by live-culture fluorescence 
microscopy (IncuCyte®, Sartorius) with fluorophore-conjugated nanoparticles. Once cell uptake 
kinetics have been established, cell viability after exposure to paclitaxel-loaded nanoparticles will 
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be assessed to determine the cytotoxicity, and these experiments are in the preliminary stages of 
study design. 
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Chapter 6: Conclusions and future outlook 
6.1 Discussion 
 The most significant finding of this dissertation is that Escherichia coli LSBJ is able to 
produce homopolymeric MCL PHAs from fatty acid substrate at yields approaching the theoretical 
maximum using an optimized fed-batch, high-density fermentation process. Although other recent 
works using engineered Pseudomonas putida KT2440 have achieved similar yields for near-
homopolymeric PHD (highest to date; 11.8 g L-1 , productivity of 0.41 g L-1 h-1), none have 
succeeded in expanding this compositional control to other MCL PHAs (Gao et al., 2018; Oliveira 
et al., 2020). Furthermore, no other described processes have successfully produced PHAs from 
functionalized fatty acids (10-undecenoic acid, 10-bromodecanoic, and 10-azidodecanoic) at the 
yields demonstrated in Chapter 4. This has the considerable potential to expand the production of 
PHAs for biomedical materials, which require tightly controlled material properties and can benefit 
greatly from chemically reactive moieties (Hazer et al., 2012; Kai and Loh, 2014; Rai et al., 2011). 
 Removal of the arcA transcriptional regulator from E. coli LSBJ was shown to enhance 
both SCL and MCL PHA biosynthesis from the respective fatty acid substrates (Chapter 2). This 
is believed to have occurred due to the increased expression of the β-oxidation genes fadD, fadE, 
and fadL in the mutant strain, which saw relative increases of 2-fold, 31-fold, and 10-fold 
compared to E. coli LSBJ, respectively (Scheel et al., 2016). Interestingly, the expression of the 
atoDAEB operon (implicated in SCL fatty acid uptake and activation) was greatly upregulated 
despite no previously reported interactions between the ArcA and Ato systems (Cho et al., 2006; 
Theodorou et al., 2011, 2006). These results suggest that ArcA-mediated transcriptional regulation 
plays a role in PHA biosynthesis in E. coli, and that crosstalk between ArcA and SCL fatty acid 
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metabolism may be more complex than previously assumed. Removal of the OmpR regulator was 
also shown to deleteriously affect PHA biosynthesis, likely due to a toxic phenotype. 
 The use of lignocellulosic waste substrates as bacterial feedstock has experienced 
significant interest in recent years due to growing concerns about environmental sustainability 
(H. Isikgor and Remzi Becer, 2015; Zhang, 2008). One such substrate, enzymatically hydrolyzed 
paper mill waste fines, was a surprisingly effective feedstock for the biosynthesis of PHB and 
PHB-co-MCL PHAs in E. coli LSBJ, discussed in Chapter 3 (Min et al., 2015; Scheel et al., 2019). 
Both PHB and PHB-co-MCL PHA yields increased by approximately 100% when pure sugar 
substrates were replaced with hydrolysate, although the MCL monomer content was reduced. 
 Progress towards the nanoparticle drug delivery system discussed in Chapter 5 is still 
underway, with promising preliminary results presented therein. The field of nanomedicine, of 
which nanoparticle drug delivery is a subset, is rapidly expanding but limited in scope to a narrow 
selection of materials including PLGA and PEG (Danhier et al., 2012; Lee et al., 2017; Santander-
Ortega et al., 2010). Previous studies investigating PHB and PHBV nanoparticles found them to 
be inferior materials compared to PLGA and PLGA-based blends, which is why the objective of 
Chapter 5 was to produce superior particles using functional MCL PHAs (Pinto et al., 2016; Poletto 
et al., 2008; Pramual et al., 2016). Future experiments are needed to evaluate the shelf-life stability 
of PTX-loaded PHODN3 nanoparticles and the release of PTX over time, the in vitro cellular 
uptake kinetics of folate-conjugated nanoparticles by human cancer cells, and the cytotoxicity of 
these nanoparticles. The results of these experiments will ultimately determine the efficacy of this 
novel drug-delivery platform. 
 Limitations in the production of MCL PHAs are largely due to expensive feed stocks, 
limited bioprocess productivity, and difficulty in controlling the monomeric composition to 
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achieve desired material properties (Blunt et al., 2019; Hazer et al., 2012; Rai et al., 2011). The 
work presented here has made some advancements in this field, although the current dependence 
on expensive fatty acid substrates limits the applicability to higher-performance biomedical 
materials rather than more common consumer plastics (Kai and Loh, 2014; Sparks and Scholz, 
2009). Further modification to the bioprocess described in Chapter 4 to allow the production of 
SCL monomers such as 3HB or 4HB from glycolytic metabolites, while simultaneously 
incorporating desirable MCL monomers from fatty acid substrates, would go a long way towards 
expanding the availability of these novel materials. 
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Appendix A: Nuclear Magnetic Resonance Spectroscopy Data 
The data presented in this appendix are from nuclear magnetic resonance (NMR) experiments 
performed to characterize PHAs and other small molecules as described in each appropriate 
chapter. Unless otherwise specified, 1H NMR spectra were recorded on a Bruker AVANCE III 
600 MHz instrument, and were calibrated using residual undeuterated solvents as internal 
reference (chloroform, δ = 7.26 ppm; water, δ = 4.79 ppm).  Chemical shifts (δ) are reported in 
parts per million (ppm); NMR peak multiplicities are denoted by the following abbreviations: s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, sext = sextet, dd = doublet of doublets, dt = 





Fig. A1: 1H-NMR (600 MHz, CDCl3) spectrum of poly(R-3-hydroxybutyrate) (PHB) extracted 








Fig. A.2: 1H-NMR (600 MHz, CDCl3) spectrum of poly(R-3-hydroxyvalerate) extracted from E. 
coli RSC02; δ 5.17-5.13 (p, 1H), 2.59-2.50 (m, 2H), 1.66-1.59 (m, 2H), 0.91-0.88 (t, 3H). The 





Fig. A3: 1H-NMR (600 MHz, CDCl3) spectrum of poly(R-3-hydroxyhexanoate) extracted from 
E. coli RSC02; δ 5.21-5.18 (p, 1H), 2.59-2.48 (m, 2H), 1.60-1.54 (m, 2H), 1.35-1.27 (m, 2H), 0.91 
(t, 3H). The asterisk (*) at δ 1.53 denotes a water impurity (Fulmer et al., 2010).  
3 2 4 5 
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Fig. A4: 1H-NMR (600 MHz, 50% D2O) of crude hydrolysate in a 1:10 dilution with glucosamine 
as an internal standard; δ 5.45 (d, glucosamine α-anomeric H), δ 5.24-5.23 (d, glucose α-anomeric 
H), δ 5.20-5.19 (d, xylose α-anomeric proton), δ 4.95-4.94 (d, glucosamine β-anomeric H), δ 4.65-




Fig. A5: 1H-NMR (600 MHz, D2O) of poly(γ-glutamic acid) (PGA); δ 4.41 (m, 1H), δ 3.08-2.88 







Fig. A6: COSY spectra (600 MHz, D2O) of poly(γ-glutamic acid). Determined that the unknown 
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Fig. A7: 1H-NMR (600 MHz, CDCl3) spectrum of poly(R-3-hydroxy-10-undecenoate) extracted 
from E. coli LSBJ after bioreactor fermentation; δ 5.83-5.76 (m, 1H), 5.21-5.18 (p, 1H), 5.00-4.92 




Fig. A8: 1H-NMR (600 MHz, CDCl3) spectrum of poly(R-3-hydroxy-10-bromodecanoate) 
extracted from E. coli LSBJ after bioreactor fermentation; δ 5.21-5.18 (p, 1H), 3.37 (t, 2H), 2.59-
2.48 (m, 2H), 1.84-1.82 (p, 2H), 1.60-1.54 (m, 2H), 1.35-1.27 (m, 2H), 1.28 (m, 6H). The asterisk 





Fig. A9: 1H-NMR (800 MHz, CDCl3) spectrum of poly(R-3-hydroxyoctanoate-co-3-hydroxy-10-
azidodecanoate) extracted from E. coli LSBJ after 24 h bioreactor fermentation; δ 5.19-5.17 (p, 






Fig. A10: 1H-NMR (800 MHz, CDCl3) spectrum of poly(R-3-hydroxyoctanoate-co-3-hydroxy-
10-azidodecanoate) extracted from E. coli LSBJ after 48 h bioreactor fermentation; δ 5.19-5.17 (p, 







Fig. A11: 1H-NMR (600 MHz, DMSO-d6) spectrum of poly(R-3-hydroxyoctanoate-co-3-
hydroxy-10-azidodecanoate)-graft-dibenzocyclooctyne-poly(ethylene glycol methyl ether), 
prepared by strain-promoted azide-alkyne cycloaddition as described in Chapter 5. 
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Appendix B: Nanoparticle Methods Development 
This appendix contains supplemental information on the methodologies used to produce 
nanoparticles in Figure 5.4 and Figure 5.5. 
Nanoparticle production by single emulsion 
 Nanoparticles produced for Figure 5.4ABC were produced using a single emulsion 
technique adapted from (Budhian et al., 2007; Mainardes and Evangelista, 2005). Poly[(R)-3-
hydroxyoctanoate-co-(R)-3-hydroxy-10-azidodecanoate] (PHODN3) was dissolved in 0.5 mL 
chloroform, then added to 1 mL of surfactant solution (4.44 mg mL-1, sodium dodecylsulfate or 
poly[vinyl alcohol]) while continuously mixing vigorously by vortex. This solution was then 
sonicated using a Branson Analog Sonifier 250A fitted with a 1/8” microtip at an output of 4 for 
50 seconds (unless otherwise noted), with 10 second on/off pulses. The test tube containing the 
emulsion was kept in an ice bath during the off cycles. 
 The sonicated emulsion solution was transferred to 45 mL of surfactant solution (SDS or 
PVA, the same as the initial solution) and stirred for 3 hours to evaporate the organic solvent. The 
resulting particles were analyzed by DLS, without the centrifugation and cleaning procedure 
utilized for later methods. 
Nanoparticle production by nanoprecipitation 
Nanoparticles prepared by nanoprecipitation followed a similar procedure as that described 
in Chapter 5, but on a smaller scale and with additional cleaning steps (Chang et al., 2009; Cheng 
et al., 2007). PHODN3 was dissolved in one of several organic solvent systems: tetrahydrofuran 
(THF), dioxane, acetone, 15% dimethyl sulfoxide (DMSO) in acetone, 15% ethanol in acetone, 
and dimethylformamide. Polymer solutions were added dropwise to rapidly stirring SDS solutions 
(4.44 mg mL-1) in one of two ratios; for a 1:1 ratio, 2 mL of 1 mg mL-1 polymer solution was added 
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to 2 mL SDS solution, and for a 1:10 ratio 1 mL of 1 mg mL-1 polymer solution was added to 10 
mL SDS. The combined solutions were stirred for 24 hours to evaporate the organic solvents. 
To remove the SDS from the nanoparticles, 1 mL of nanoparticle solution was transferred 
to a 1.5 mL microcentrifuge tube and centrifuged for 30 min at 16,100 × g (Eppendorf 5415R). 
The supernatant was carefully removed by aspiration and analyzed by DLS, while the pelleted 
nanoparticles were resuspended in 1 mL Nanopure water and centrifuged again. This supernatant 
was discarded, and the pellets resuspended in 1 mL water for DLS analysis. For 1:10 samples, 4 
aliquots were centrifuged, resuspended in 0.25 mL, and combined to obtain more nanoparticles. 
Both the initial supernatant and the cleaned nanoparticle solutions were filtered through 0.2 um 
Nylon filters prior to DLS. 
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Appendix C: Gel permeation chromatography data 
The weight average (Mw) and number average (Mn) molecular weights for each sample were 
determined by gel permeation chromatography (GPC) as described previously (Pinto et al., 2016). 
Briefly, PHA solutions of approximately 1.0 g L-1 were prepared by dissolution in chloroform and 
passed through a syringe filter (0.45 μm PTFE). Samples were injected (50 μL) into a Shimadzu 
LC-20AD liquid chromatograph equipped with a Shimadzu SIL-20A autosampler, a Shimadzu 
CTO-20A column oven, and a Shimadzu RID-10A refractive index detector. Samples were passed 
through an 8 x 50 mm styrenedivinylbenzene (SDV) guard column (5 μm particles; Polymer 
Standards Service) and an 8 x 300 mm SDV analytical column (5 μm particles; mixed bed porosity; 
max molecular weight 1E6 Da; Polymer Standards Service product sda0830051lim). The column 
oven was maintained at 40°C with a 1 mL min-1 mobile phase of chloroform. Molecular weight 
standards of polystyrene with a narrow polydispersity index were used for calibration. Shimadzu’s 
LCsolution software was used to analyze the data, and these sample chromatograms were 
generated using RStudio. Figs. C1-C7 show data generated from experiments in Chapter 2, Figs. 
C8-C19 were generated from experiments in Chapter 4. 
 
Fig. C1: GPC chromatogram of purified poly(3-hydroxybutyrate) (C4) produced by RSC02, 





Fig. C2: GPC chromatogram of purified poly(3-hydroxyvalerate) (C5) produced by LSBJ (A) and 










Fig. C3: GPC chromatogram of purified poly(3-hydroxyhexanoate) (C6) produced by LSBJ (A) 










Fig. C4: GPC chromatogram of purified poly(3-hydroxyheptanoate) (C7) produced by LSBJ (A) 











Fig. C5: GPC chromatogram of purified poly(3-hydroxyoctanoate) (C8) produced by LSBJ (A) 











Fig. C6: GPC chromatogram of purified poly(3-hydroxydecanoate) (C10) produced by LSBJ (A) 











Fig. C7: GPC chromatogram of purified poly(3-hydroxydodecanoate) (C12) produced by LSBJ 










Fig. C8: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-




Fig. C9: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by RSC02 via fed-





Fig. C10: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-




Fig. C11: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-







Fig. C12: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-




Fig. C13: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-






Fig. C14: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-




Fig. C15: GPC chromatogram of purified poly(3-hydroxydecanoate) produced by LSBJ via fed-







Fig. C16: GPC chromatogram of purified poly(3-hydroxyhexanoate) produced by LSBJ via fed-





Fig. C17: GPC chromatogram of purified poly(3-hydroxyoctanoate) produced by LSBJ via fed-






Fig. C18: GPC chromatogram of purified poly(3-hydroxy-10-undecenoate) produced by LSBJ via 




Fig. C19: GPC chromatogram of purified poly(3-hydroxy-10-bromodecanoate) produced by LSBJ 
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Appendix D: Bioreactor Run Parameters 
The representative data presented in this appendix are from the dissolved oxygen (DO), pH, 
temperature (T), agitation speed, and air sparging rate which were monitored and recorded every 
30 seconds during each fermentation. One replicate per Trial (starting with 9) is shown. 
 
Fig. D1: Trial 9A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 6 g 




Fig. D2: Trial 9B. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 6 g 





Fig. D3: Trial 10A. Bioreactor fermentation of E. coli RSC02 harboring pBBRC1J4SII, with 6 g 




Fig. D4: Trial 11A. Bioreactor fermentation of E. coli LSBJ CRP* harboring pBBRC1J4SII, with 




Fig. D5: Trial 12A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 6 g 




Fig. D6: Trial 13A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 6 g 
decanoic acid added at 0.22 g h-1. Media formulation changed to that described in Chapter 4, 
high-density fed-batch production. Rate of glucose feed slowed to 9.7 mL h-1 during phase 2. First 





Fig. D7: Trial 14. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 12 g 
decanoic acid added at 0.44 g h-1. Media described in Chapter 4, high-density fed-batch 




Fig. D8: Trial 15A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 12 g 
decanoic acid added at 0.44 g h-1. Media described in Chapter 4, high-density fed-batch 





Fig. D9: Trial 16A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 15 g 
decanoic acid added at 0.55 g h-1. Media described in Chapter 4, high-density fed-batch 





Fig. D10: Trial 17A. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 20 g 
decanoic acid added at 0.65 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 12.9 mL h-1, slowed 




Fig. D11: Trial 18. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 25 g 
decanoic acid added at 0.75 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 11.4 mL h-1, slowed 




Fig. D12: Trial 19. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 20 g 
hexanoic acid added at 0.65 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 12.9 mL h-1, slowed 




Fig. D13: Trial 20. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 20 g 
octanoic acid added at 0.65 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 12.9 mL h-1, slowed 





Fig. D14: Trial 21. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 20 g 
10-undecenoic acid added at 0.65 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 12.9 mL h-1, slowed 





Fig. D15: Trial 22. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 20 g 
10-bromodecanoic acid added at 0.65 g h-1. Media described in Chapter 4, high-density fed-batch 
production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 12.9 mL h-1, slowed 




Fig. D16: Trial 23. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 15.4 g 
octanoic acid and 4 g decanoic acid added at 0.632 total g h-1. Media described in Chapter 4, high-
density fed-batch production, with 3.0 g of yeast extract. Initial rate of glucose feed reduced to 




Fig. D17: Trial 24. Bioreactor fermentation of E. coli LSBJ harboring pBBRC1J4SII, with 15.4 g 
octanoic acid and 4.95 g 10-azidodecanoic acid added at 0.663 total g h-1. Media described in 
Chapter 4, high-density fed-batch production, with 3.0 g of yeast extract. Initial rate of glucose 





Appendix E: HPLC Sample Chromatograms 
The data presented in this appendix are a sample high performance liquid chromatography (HPLC) 
chromatogram of paclitaxel and the standard curve generated for paclitaxel quantification. HPLC 
was performed as described in Chapter 5. Paclitaxel absorbance was measured at 227 nm. 
 



































Fig. E2: Sample HPLC chromatogram of paclitaxel encapsulated in PHODN3 nanoparticle 






Appendix F: Additional Supplemental Data 
This section contains additional supplemental data published with Scheel et al. 2016 (Chapter 2), 
as well as GC chromatograms for poly[(R)-3-hydroxy-10-bromodecanoate] (PHDBr) and a 
schematic of the bioreactor used for experiments in Chapter 4.  
 
Table F1: Poly(3-hydroxydecanoate) yield comparison between LSBJ, RSC02, RSC04, and 
RSC06 
Strain CDWa (g L-1) PHAa (wt%) PHA Concentrationa (mg L-1) 
LSBJ 1.13 ± 0.02 17.4 ± 3.7 196 ± 40 
RSC02 1.33 ± 0.04* 26.4 ± 4.7* 353 ± 77* 
RSC04 0.93 ± 0.00* 16.5 ± 1.9 154 ± 18 
RSC06 0.99 ± 0.02* 17.9 ± 3.0 179 ± 31 
a All values are averages of biological triplicate experiments plus or minus the standard deviation 
about those averages. 




Fig. F1: Sample GC chromatogram of purified PHDBr subjected to methanolysis as described in 
Chapter 4. Several peaks were generated by the polymer, possibly due to side reactions from 
methanolysis. Broad peak at ~28 – 30 min is likely the 3-hydroxy-10-bromodecanoate methyl 
ester; however, this region is often populated by background peaks from methanolyzed cell 
components and the peak at 25 min was calibrated as a proxy for the polymer. 
 












Fig. F2: Sample GC chromatogram of control lyophilized cells (polymer-free, 12h fermentation) 
subjected to methanolysis. Note 2 peaks at ~28.5 min; these background peaks grow with increased 
fermentation time and are the reason for choosing the peak at 25 min for PHDBr calibration. 
 
 
Fig. F3: Sample GC chromatogram of methanolyzed cells from Trial 22 at 48h (PHDBr 
production, Table 4.2). 
 
  





















Fig. F4: Calibration curve generated for quantification of methanolyzed PHDBr. 
 
 
Fig. F5: Schematic of the New Brunswick BioFlo 310 2L bioreactor vessel used in Chapter 4. 
Four sensors were installed to measure dissolved oxygen (DO), pH, temperature (Temp), and the 
culture level (for foam detection). Glucose and fatty acid feeds, as well as concentrated ammonium 
hydroxide and 10% anti-foam B in water, were added by peristaltic pumps as described in Chapter 
4. 
  







Y = aX + b 
a = 1.574496e-004 
b = 0.0 
R^2 = 0.9918222 
R = 0.9959027 
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